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Defects in bone are a constant and serious problem. They occur as a result of high energy 
trauma, congenital conditions or are created surgically to treat bone tumours or infection. 
Currently the treatment for these conditions is awkward for the patient, takes a long time and 
has a high complication rate.  
An elegant solution would be to mend the bone defect using the patient own cells; 
osteoblasts or mesenchymal stem cells seeded onto a supportive material scaffold. For 
successful regeneration of bone structures, a scaffold production technique has to be adopted 
that can precisely control porosity, internal pore architecture and fibre thickness, as well as 
maximising media diffusion and optimising scaffold mechanical properties so that the 
scaffold can withstand bone bearing pressures. It would also be beneficial if the scaffold 
uniformly distributed surface strain along the fibres throughout the entire scaffold as this 
would encourage more even cell proliferation/differentiation in the structure. 
This was addressed by performing a series of finite element analyses on the computer 
aided design model where the mechanical properties of the natural or synthetic polymer used 
have been incorporated to yield an accurate strain profile of the entire scaffold. The process 
used here to generate the scaffolds is a Rapid Prototyping method that creates a three-
dimensional object through the repetitive deposition of fibres in layers via extrusion. Due to 
the high accuracy and versatility of the extruder, the diameter of the pores can be precisely 
controlled to an accuracy of 10µm, in the manufactured scaffolds the pore size ranges from 
100 to 300µm as that is what is found in trabecular bone. Natural and synthetic polymers 
were plotted which altered the biodegradability properties of the scaffold and the degrees of 
cell adhesion, proliferation and differentiation in the structure. Scaffolds were manufactured 
that demonstrated compatibility with cell adhesion, proliferation and osteogenic 
differentiation. On completion of the scaffolds, the latter were seeded with osteoblasts or 
marrow stromal cells and put into a mechanically stimulating bioreactor machine to induce a 
small strain in the scaffold; this was performed to encourage cell proliferation/differentiation. 
The structure was left until the osteoblasts or marrow stromal cells modified the scaffold 




Preliminary data indicated an effect of mechanical stimulation of the cell/scaffold 
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The number of patients needing organ transplants far exceeds the number of organs 
available. In the UK, for the financial year 2005-06, approximately 8300 people were on the 
active waiting lists for an organ transplant which represents an increase of 9% on the same 
figures at the end of the previous year. 2,794 transplants occurred, which represents a 3% 
increase compared to last year, with 78% of those transplants being from a deceased donor 
(Figure 1). Unfortunately, 483 patients died while waiting for their transplant. 
In addition 2,502 patients had their sight restored by a cornea transplant. Compared to 
last year, these figures represent a 5% increase in corneal transplants. With regards to 
cardiothoracic transplants, there has been a decrease of 9% in 2005-2006 with a decrease of 
9% in the number of heart transplants and a 3% drop in the number of lung transplants. This 
is linked to the number of donors also falling from 238 to 216. 
The number of liver transplants has fallen by 7% due to a decrease of 35 donors. With 
regards to renal transplantations, the number of kidney only transplants increased by 6% and 
the number of kidney and pancreas transplants increased to 107 which represents an increase 
of 35% on last year. (www.uktransplant.org.uk 2006). 
In the United Kingdom, nearly 50,000 total hip replacements (arthroplasties) are 
performed each year. The operation is highly successful in reducing pain and disability of a 
damaged or a worn joint which involves replacing the acetubulum (the natural socket) and the 
femoral head with a prosthetic. Although the general success of the operation, 10% of hip 
replacements need revision surgery after ten years due to the loosening of the shaft of the 
prosthetic in the hollow of the femur. 
Total knee replacements (total knee arthroplasties) are another common musculoskeletal 
operation with over 35,000 knee replacements carried out every year. Knee arthroplasties are 
routine operations that are performed on patients with knee pain and damaged knee joints 
mainly through osteoarthritis. Osteoarthritis occurs when the knee cartilage becomes thin and 




which causes pain and in some cases inflammation. Patients that undergo a knee replacement 
are able to walk without discomfort after six months and in 90% of cases will last between 
ten and fifteen years, however in about 6% of cases, the knee fails within five years. 
This lack of available organs and the need for artificial joints, has motivated the progress 
of tissue engineering. The concept proposed is that cells will be able to organise into tissues 
and ultimately replace failed organs if the appropriate three dimensional conditions are 
applied (Langer and Vacanti 1993). In order to create a three-dimensional environment, 
scaffolds need to be designed that enable cellular attachment, proliferation and differentiation 
(Lavik and Langer 2004).  
 
 
Figure 1: Number of deceased donors and transplants in the UK 
 
Fully differentiated cells, progenitors and stem cells have shown potential in creating 
complex and functional tissues that might one day reduce the shortfall of tissues and organs. 




cells and progenitors have been shown to differentiate into a variety of cell types, the 
challenge of differentiating the cells in a controlled and reproducible manner still remains. 
Tissue engineering is a cross-disciplinary field that involves the application of cell 
biology, engineering and material science to develop biological substitutes that restore, 
sustain or improve the tissues function. The aim of tissue engineering is to avoid having to 
use conventional solutions such as organ transplants and biomaterial implants, and create a 
supply of immunologically sound organs and tissues under laboratory conditions that can 
grow with the patient. Tissue engineering is being widely used in medicine to try and create, 
regenerate and aid tissue repair. Most major organs have been attempted for generation, e.g. 
the small intestine (Gupta et al. 2006), the trachea (Kobayashi et al. 2006a), smooth muscle 
(Rodriguez et al. 2006), liver and kidneys (Leclerc et al. 2006) and heart valves (Mendelson 
and Schoen 2006) 
 
 





One of the principle strategies of tissue engineering involves growing relevant cells in 
vitro into a three dimensional (3D) arrangement. Unfortunately, many cells are not capable of 
growing in a 3D orientation without a scaffold. A notable exception are embryonic stem cells 
that grow in colonies (Tremoleda et al. 2008).Three dimensional growth of tissues can be 
achieved by seeding cells onto a scaffold to which the cells attach and colonise (Stock and 
Vacanti 2001). Thus the scaffold is potentially a very important part of tissue engineering. 
There are several crucial requirements that need to be considered before the production 
of tissue engineering scaffolds can be undertaken:  
 the scaffold should contain interconnecting pores of appropriate scale to favour 
tissue integration and vascularisation, which permits fluid and oxygen diffusion. 
 be made from material where biodegradability and bioresorbability can be 
controlled, so that the scaffold will be replaced by the tissue at the required rate, 
 have appropriate surface chemistry to favour cellular attachment, differentiation 
and proliferation, 
 possess adequate mechanical properties to match the intended site of 
implantation,  
 should not induce any adverse response 
 should be easily fabricated into a variety of shapes and sizes. (Stock and Vacanti 
2001) 
Bearing these conditions in mind, several scaffold manufacturing techniques have been 

















Chapter 1.  












1.1.1 Scaffold manufacturing techniques 
 Numerous techniques have been adapted and developed to make use of synthetic and 
natural polymers to create scaffolds that may be used for tissue engineering. Besides basic 
material properties such as polymer biocompatibility with cells and the materials being non-
toxic, a number of other scaffold properties are essential for cell growth and survival: 
Pore interconnectivity and porosity: Scaffolds must have an open pore geometry with a 
very porous surface which will allow cell in-growth and organization in vitro and enable 
vascularisation from surrounding tissues. The degree of pore interconnectivity will have a 
direct affect on the diffusion of physiological nutrients and gases to the penetrated pores and 
also the removal of cellular waste (Vacanti et al. 1988).  
Pore size: In bone regeneration in vitro, the quoted pore sizes that have been utilised 
range from 200 to 400μm (Dennis et al. 1992, Robinson et al. 1995). If the pores are too 
small, pore occlusion may occur and prevent cell infiltration within the scaffold. 
Surface area: It has been proposed that high internal surface area to volume ratio is vital 
in order to accommodate the vast number of cells that are needed to replace or restore tissue 
(Leong et al. 2003).  
A description of some of the scaffold manufacturing techniques will be provided. Some 
of the techniques cannot be mathematically modelled and thus the effect of strain and cell 
behaviour cannot be investigated. It would be beneficial in terms of our ability to design 
mechanically competent scaffolds if a manufacturing process had all aspects controlled and 






In 1934, a process was patented (Formhals 1934) in which an experimental setup was 
outlined for the production of polymer filaments using electrostatic force. When used to spin 
filaments this way, the term is called electrospinning. 
The setup for electrospinning consists of a syringe with a metallic needle, a syringe pump 
and a high voltage supply. The desired polymer or polymer solution is loaded into the syringe 
and the polymer is forced to the needle tip by the syringe pump thus forming a droplet which 
is held in place at the tip by surface tension. When a voltage is applied to the needle, a mutual 
charge repulsion causes a force directly opposite to the surface tension of the droplet (Doshi 
and Reneker 1995) . As the intensity of the electric field is increased, the hemispherical 
surface of the solution at the tip of the needle elongates to form a conical shape known as the 
Taylor cone (Taylor 1964). When the electric field reaches a critical value at which the 
repulsive electric force overcomes the surface tension force, a charged jet of the solution is 
ejected from the tip of the Taylor cone. Since the jet is charged, its trajectory can be 
controlled by an electric field. As the jet travels in the air, the solvent evaporates leaving 
behind a charged polymer fibre which lays itself randomly on a collected metal screen 
(Figure 3). 
 




Several groups have used this technique to create scaffolds for tissue engineering  i.e. to 
generate muscle tissue in vitro, briefly human muscle cells were seeded on a poly (L-lactide-
co-epsilon-caprolactone) [P(LLA-CL)] (75:25) and analyzed after 7 days (Xu et al. 2004). To 
deliver plasmid DNA for therapeutic applications by incorporating the DNA in the polymer 
solution prior to electrospinning (Luu et al. 2003), create bone tissue (Sakai et al. 2006, 
Thomas et al. 2006), differentiate MSC to chondrocytes (Li et al. 2005) and to prevent post 
surgery abdominal adhesion by introducing a polycaprolactone electrospun sheet on the 
peritoneum of the abdominal wall (Bolgen et al. 2006). Electrospinning is a popular 
technique for tissue engineering but it involves a random deposition of fibres. This produces 
a scaffold with an interconnecting network of pores but the technique does not control the 
internal geometry of the produced scaffold. This makes it difficult to predict the strain 
distribution throughout the scaffold and due to the random orientation of the strands, difficult 
to distribute the strain within the scaffold evenly. 
 
1.1.1.2 Freeze drying 
There are various techniques for scaffold production that make use of freeze drying. One 
of the simplest scaffolds produced using this technique involves a natural or synthetic 
polymer which is dissolved in a solution and then placed into a mould, with the solution then 
being lyophilised (freeze dried) to yield a porous matrix. The pores are created by the 
formation of ice crystals in the initial freezing stage and then the removal of them in the 
freeze drying part. The pore size can be controlled by the freezing rate and by altering the pH; 
a fast freeze produces a smaller pores (Doillon et al. 1986). This is a fairly simple technique 
and has been extensively reported in the literature. It has been used with natural materials 
such as chitosan, alginate and collagen to create porous scaffolds that are then seeded with 
cells to generate cartilage (Li and Zhang 2005, Shi et al. 2005, Xia et al. 2004), to create 
artificial skin in vitro (Liu et al. 2004), to differentiate stromal cells (Oliveira et al. 2006). 
Lyophilising has also been performed on dissolved synthetic materials to remove solvents 
(Cao et al. 2006) and in combination with salt leaching to increase the pore connectivity (Hou 




is no control in defining the pore connectivity and the internal geometry of the scaffold. From 
the literature, the pore sizes in chitosan, ranges from approximately 80 ± 30μm to 720 ± 
150μm depending on the freeze drying rates (Lee et al. 2004a). This demonstrates that there 
is a large variability in pore size. 
 
1.1.1.3 Gas foaming 
This scaffold manufacturing technique avoids the use of organic solvents which could 
have a toxic effect on cells and it is also an inexpensive and simple method. A synthetic 
polymer i.e. poly(lactide-co-glycolide) (PLGA) is placed in a mould and compressed into a 
disk. The latter is then saturated with carbon dioxide (CO2) by exposing to high pressure CO2 
gas. The solubility of the gas in the polymer is then decreased very quickly by releasing the 
CO2 pressure back to atmospheric level. This technique can yield scaffolds with a porosity of 
approximately 93% with pore sizes ranging from 100 to 500µm (Mooney et al. 1996). This 
scaffold manufacturing method is used to enhance osteoconductivity without the presence of 
cells in a critical size defect in rat skulls, in this case the implanted scaffold enhances bone 
regeneration (Kim et al. 2006a) and by using adult osteoblasts seeded on the scaffold and 
maintained in vitro (Kim et al. 2006b, Montjovent et al. 2005). It has also been reported that 
the gas foaming method was used for DNA delivery by incorporating the plasmid in PLGA 
before manufacturing the scaffold (Jang et al. 2005). The described technique is simple and 
several different polymers can be used, i.e. polylactic acid (PLA), poly(DL-lactide-co-
glycolide) (PLGA) and chitosan. The main disadvantage is that the pores created are not 
completely connected and some of the pores remain in the polymer (Mathieu et al. 2006) 
which depending the chemicals used during manufacture of the scaffold, might release 
harmful substances that would affect cells and tissue. In addition, the pores created vary in 
size and their orientation is random, which would create a problem in determining the areas 





1.1.1.4 Scaffold production by moulding 
Moulds can be used to fabricate scaffolds indirectly; this increases the range of 
biopolymers for tissue engineering to include many materials that could not be processed 
using any of the previously mentioned methods. An example of this technique was described 
by Orton et al, where an epoxy negative mould of the required scaffold design was created by 
using 3D printing. A thermal-curable hydroxyapatite/acrylate suspension is cast into the 
epoxy mould and cured in low temperature oven (85
o
C). The cured part is then placed into a 
furnace at high temperature to burn out the mould and the acrylate binder simultaneously. 
The hydroxyapatite body is then completely sintered into a 3D scaffold (Chu et al. 2002). 
 
1.1.1.5 Woven scaffolds 
This technique involves a microscale weaving technology (3Tex, 3Weave™ process) 
which generates three-dimensional (3D) structures. Weaving in this case is defined as the 
formation of a scaffold by the interlacing of two sets of yarns, the warp (x-direction) and the 
weft (y-direction) (or filling). A single filling yarn is inserted through an opening in a set o 
warp yarn. The principles of the 3Weave™ process is that two or more filling yarns are 
simultaneously from one or both sides, thus building the 3D scaffold. In the 3Weave process, 
a third set of yarns, called the Z-yarns, then integrates all sets of yarns (layers) of the scaffold 
(Figure 4). The 3D structure with fibres orientated in three orthogonal directions were 
specifically constructed to produce orthotropic, porous textile structures that have prescribed 
mechanical properties that can be controlled by the small diameter, biodegradable yarns 
(Mohamed et al. 2001). In contrast to standard weaving methods, this process eliminates fibre 
crimp and creates a 3D structure by interlocking multiple layers of two perpendicularly 
orientated sets of in-plane fibres with a third set of fibres that pass through the thickness of 





Figure 4: Illustration of 3Weave ™ multiple insertion process 
 
The 3D scaffold was produced using 104μm diameter continuous multifilament 
polyglycolic acid yarn. The latter was woven into two different 3D structures with a 
combined total of 11 fibre layers; five layers orientated in the warp direction and six layers 
orientated 90° to the lengthwise fibres (weft direction). The resulting scaffold had 
interconnecting pores which had dimensions of 390μm x 320μm x 104μm, which yielded a 
total void volume of 70% (Moutos et al. 2007). 
The scaffolds were then seeded with porcine articular chondrocytes in 2% agarose. Using 
this technique, it was reported that the scaffold was readily seeded with cells with a spatially 
uniform distribution with the cells maintaining a rounded morphology which is important in 
promoting a chondrogenic phenotype. The group did not go into any further detail about the 
survival or if there was any cartilage formation. 
 
1.1.1.6 Solid free-form fabrication 
 The above scaffold manufacturing techniques described are extremely limited in the 
control over scaffold architecture. They all lack the ability to dictate geometry, and the 
control of the pore size is limited to the accuracy of the process involved (Woodfield et al. 




fabrication (SFF) which is also commonly known as rapid prototyping (RP) techniques, for 
producing porous scaffolds. RP is a subset of a mechanical engineering process that allows 
complex structures to be created layer by layer in a reproducible fashion. Complex objects 
can be created using SFF techniques by generating data from a CAD (computer aided design) 
model or other computer based medical imaging modalities. The models are then sent 
digitally to a computer aided manufacture (CAM) system which interprets the data and 
manufactures the scaffold. The principal concept of SFF is layered manufacturing which 
involves a three-dimensional object being built up layer-by-layer.  
The flexibility and the manufacturing ability of SFF and its enormous potential for 
creating complex and precise scaffolds is widely recognised and there has also been reports 
of replicas of human bones and other body organs (Leong et al. 2003). 
The following section will describe the small number of SFF techniques that have been 
used successfully to create tissue engineering scaffolds. 
 
1.1.1.6.1 Laser stereolithography 
Lasers can be used to create polymer structures which can be achieved by 
photopolymerisation which uses light energy to initiate a chain reaction that solidifies a liquid 
polymer solution. The laser beam is focused onto a layer of liquid polymer which also 
contains a photoinitiator, when the light hits the surface it causes the polymer to solidify. The 
stage is then lowered covering the solid layer with a fresh layer of liquid polymer and the 





Figure 5: Stereolithography, laser is used to cross-link polymer (Cooke et al. 2003) 
 
The desired structure is made up using a computer aided design (CAD) package which 
creates a virtual model. This CAD file is then processed and sliced data is generated which is 
sent to the computer that controls the stereolithography process and the structure is created 
layer by layer. This manufacturing technique has been used to create aortic valves (Gilon et 
al. 2002) and as a model for surgeons to visualize cleft lip (Kobayashi et al. 2006b).  
 
1.1.1.6.2 Selective laser sintering 
Selective laser sintering (SLS) uses a laser beam to sinter polymer or composites, i.e. 
polymer/ceramics (Tan et al. 2005b), to form material layers. The laser beam is directed onto 
the powder bed by a precise laser scanning system. The materials are fused and are stacked 
on top of one another to the CAD object‟s height. During manufacture, the object is 
supported and embedded by the surrounding unprocessed powder, on completion of the layer, 
rollers spread the fresh powder evenly across the top of the sintered layer. The created 
structure can either occur through the direct melting and solidification of the powder (direct 
laser sintering) or by the use of a binder which has a lower melting point and is mixed in with 




created part to undergo a further heat treatment to remove the binder material and to modify 
and further react the powder (Goodridge et al. 2006). This method of manufacture has a few 
limitations, since the powder is not compacted during the sintering, the objects are porous and 
this porosity might be difficult to control. Furthermore, the smallest feature is primarily 
governed by the powder particle size, the laser beam diameter and the heat transfer in the 
powder bed. Large particle sizes increase the roughness of the surface whereas small 
particles, less than 10μm, exhibit poor flow and spreading properties. Small particles also 
sinter faster which can lead to dimensional inaccuracies especially at the boundaries of the 
part. The commercially available SLS machines are normally fitted with a Gaussian CO2 
laser which has a maximum focused spot of 450μm which also limits the smallest feature that 
can be created. It also has been reported that the smallest pores that have been successfully 
created are 1.75 mm (Williams et al. 2005). 
 
1.1.1.6.3 Adhesives used for scaffold production 
Another approach to manufacturing scaffolds is to bind polymers by using solvents or 
adhesives. This eliminates any limitations of the biomaterial such as heat and dependence on 
a photoinitiator. One example of adhesive use for scaffold manufacture is three dimensional 
printing (3D-P). This involves the use of a binder solution which is deposited onto a 
biomaterial powder bed using ink jet printing technology. The versatility of 3D-P allows the 
processing of a wide range of powdered materials including polymers, metals and ceramics. 
The three-dimensional scaffold is created as the printer head dispenses liquid binder onto a 
thin layer of powder. The printer head is controlled by a computer which has a virtual model 
of the desired part. The repetitive stacking and printing of material layers recreates the 
desired structure (Figure 6) (Park et al. 1998). The finished object is embedded inside the 
unprocessed powder and is extracted by removing the loose powder.  
The advantage of 3D-P is that complex scaffold designs with through channels and 
overhanging features may be manufactured; this is due to the unprocessed powder which 




the processing of a wide range of biomaterials i.e. polymers, ceramics and metals. In addition 
it operates at room temperature so temperature sensitive materials may be used.  
The limitations of 3D-P include the fact that the porosity of the scaffold is dependent on 
the size of the powder. In general, the smallest pore sizes available are limited to <50μm, 
which are well distributed throughout. Porogens such as salt (NaCl) and sucrose, can be 
added to generate more consistent pore sizes, however this may lead to the porogens not 
being completely removed through leaching (Kim et al. 1998). For processing polymers, 3D-
P relies on the use of organic solvents as a binder which could remain in the scaffold and 
effect cells and tissue in-growth (Taboas et al. 2003).  
 
Figure 6: Three-dimensional printing 
 
1.1.1.6.4 Fused deposition modelling and the Bioplotter 
The principle of fused deposition modelling (FDM) is the continuous extrusion of molten 
polymer in a series of parallel fibres to form a layer. The polymer is fed and melted inside a 
heated syringe before being extruded through a needle. The pressure in the syringe is 
generated by a gas supply that is passed through the FDM machine. The machine can provide 
both a positive and a negative pressure allowing very accurate deposition. The negative 
pressure is very useful when low viscose polymers are used and tend to leak out from the 




creates a uniform structure and complete pore interconnectivity. This also allows the designer 
of the scaffold to alter the porosity, pore size and interconnectivity (Leong et al. 2003).  
The Bioplotter (Envisiontec GmbH, Germany) which is a fused deposition device (Figure 
7) also has several other advantages; it can extrude natural and synthetic polymers, it 
possesses a heating jacket that can melt a polymer and extrude it into a cooled medium to 
form a 3D structure. It is also capable of extruding at low pressures that limits the damage to 
cells whilst they are extruded in natural polymers such as alginate (Khalil et al. 2005a). 
Another natural polymer that has been plotted into a scaffold using FDM is a chitosan-
hydroxyapatite mix, this yielded a good scaffold but there was a 31% shrinkage. There was 
good attachment between layers therefore providing good interconnected pore architecture. 
An in vitro experiment with human osteoblasts was carried out and good cell attachment was 
concluded (Ang et al. 2002). Another group (Malda et al. 2005), used a synthetic 
biodegradable polymer poly(ethylene glycol)-terephthalate/ poly(butylene terephthalate) 
(PEGT/PBT) to create a scaffold that was then seeded with chondrocytes to evaluate tissue 
formation. The results obtained were interesting as cartilage matrix formation was increased 
but further work needs to be done and the technique further developed in order to treat 
articular cartilage defects.  
In general FDM is a more precise method of scaffold manufacture as it relies on fibres 
being deposited in a controlled and systematic way. There is also a complete pore 
interconnection which is not always the case with the non-free form fabrication methods. 
There are some limitations to this manufacturing technique. In order to generate overhangs, 
supports need to be in place a situation that is not easy to accomplish. In addition not all 
biologically appropriate materials can be used as some have inherent chemical properties 





Figure 7: The Bioplotter has an X, Y and Z axis that can plot a scaffold layer by layer 
 
1.1.2 Scaffold materials 
1.1.2.1 Natural polymers 
 There has been a lot of work undertaken with natural polymers and most of them 
considered are used in form of hydrogels in the tissue engineering applications. The most 




Alginate is a naturally occurring biopolymer that is finding increasing applications in the 
cell biology and tissue engineering. Alginate has been useful for many years in the food and 
beverage industry as a thickening agent, a gelling agent and a colloidal stabilizer. Alginate 
also has several inherent properties that permit it to be used as a matrix for cell entrapment 
and/ or delivery of various proteins, drugs and cells. These properties include: a) a relatively 




process free of organic solvents; c) a high gel porosity which allows for high diffusion rates 
of macromolecules; d) the ability to control porosity by coating and e) dissolution and 
biodegradation of the system under normal physiological conditions (Wee and Gombotz 
1998).  
Alginates are random, anionic, linear polymers belonging to the group of polyanionic 
copolymers derived from brown sea algae and comprises 1,4-linked β-D-mannuronic (M) and 
α-L-guluronic (G) residues in varying proportions. The residues may vary widely in 
composition and sequence and are arranged in a pattern of blocks along the chain. Salts of 
alginate are formed when metal ions react with the guluronic or mannuronic acid residues. 
Alginate is soluble in aqueous solutions and forms stable gels at room temperature in the 






), whereas monovalent cations do 
not induce gelation. The gelation and crosslinking of alginate is mainly achieved by the 
exchange of sodium ions from the guluronic acids with the divalent cations, and the stacking 
of these guluronic groups to form the characteristic „egg-box‟ structure shown in figure 8.  
Figure 8 represents the alteration of random coils to crosslinked strip like structures 
which include arrays of Ca
2+
 ions. The lower diagram represents the determined 
stereochemistry of Ca
2+
 ion. The filled circles represent the oxygen atoms involved in the 
coordination sphere (Wee and Gombotz 1998). 
The divalent cations bind to the α-L-guluronic acid blocks in a highly cooperative manner 
and the size of the cooperative unit is more than 20 monomers. Each alginate chain can 
dimerise to form junctions with many other chains and as a result gels networks are formed 







Figure 8: Schematic representation of the egg-box association of the poly-L-guluronate 
sequences of alginate crosslinked by calcium ions 
 
1.1.2.1.2 Chitosan 
 Chitosan is obtained by deacetylation which involves removal of acetyl group from an 
organic compound, in this case of chitin. The latter is the primary structural polymer in 
arthropod exoskeletons. Chitosan is a natural, hydrophilic, non-toxic, biocompatible and 
biodegradable polysaccharide suitable for applications in medicine (Ang et al. 2002, 
Miyazaki et al. 1981). 
Chitosan is a non-branched homopolymer formed by β-(1,4)-linked glucosamine units 
(Di Martino et al. 2005). Chitosan is insoluble in aqueous solutions above pH 7, yet in weak 
acidic conditions (pH <6), the molecule becomes soluble due to the protonation of the free 





Figure 9: Chitosan molecular structure (Madihally and Matthew 1999) 
 
Due to its polymeric nature, chitosan has been studied in many biomedical applications, 
these include wound dressing, drug delivery systems and for filling in spaces in implants, 
(Madihally and Matthew 1999). 
 
1.1.2.1.3 Gelatin 
Gelatin is a derivative of collagen created by breaking the natural triple helix structure of 
collagen into random single strand molecules. There are two types of gelatin, gelatin type A 
and type B. Gelatin type A is produced by acidic treatment before thermal denaturation, while 
gelatin type B is prepared by alkaline treatment that leads to a high carboxylic content (Lee 
and Mooney 2001). At temperatures of about 40°C, a gelatin aqueous solution is created and 
forms a physical thermoreversible gel on cooling. During gelling, the chains undergo a 
conformational change from a random to a orderly transition and tend to recover the triple 
helix structure (Bigi et al. 2001a). Gelatin is widely used in the pharmaceutical industry as 
well as the biomedical field in the form of  porous scaffolds for tissue engineering (Kang et 
al. 1999), wound dressings (Lee et al. 2005, Liu et al. 2004, Otani et al. 1998), drug release 
(Yong et al. 2006) and capsules production (Digenis et al. 1994, Mei et al. 2006). However, 
the poor mechanical properties of gelatin limit its use as a biomaterial and a number of 
chemical modifications methods have been investigated to improve the mechanical properties 
(Bigi et al. 2001b, Bigi et al. 2004, Zhu et al. 2006). The main chemical crosslinking agent 
used is glutaraldehyde due to its high efficiency of collagenous material stabilization however 




(Bigi et al. 2002, Chiono et al. 2007) have also been reported. During crosslinking of gelatin 
and other collagenous materials with glutaraldehyde, the free amino groups of lysine or 
hydroxylysine amino acid residues of polypeptide chains react with the aldehyde groups of 
glutaraldehyde (Olde Damink et al. 1995).  Glutaraldehyde crosslinked gelatin microspheres 
have been successfully used as microcarriers for the growth and proliferation of fibroblasts 
and endothelial cells (Wissemann and Jacobson 1985), however if gluteraldehyde is released 
into the host due to biodegradation it is toxic (Olde Damink et al. 1995).  
 
1.1.2.2 Synthetic materials 
 Aliphatic polyesters such as polyglycolic acid (PGA), polylactic acid (PLA), their 
copolymers i.e. PLGA and polycaprolactone (PCL) are by far the most widely used synthetic 
polymers for tissue engineering scaffold application. The degradation products (glycolic acid 
and lactic acid) of theses polymers are present in the body and therefore are easily removed 
by natural metabolic pathways and they are both FDA approved and appear in many medical 
in vivo devises. There are hundreds of other synthetic polymers including poly(ethylene 
oxide) (PEO), poly(vinyl alcohol) (PVA), poly(acrylic acid) (PAA) and polypeptides.  
 
1.1.2.2.1 Poly(ε-caprolactone) (PCL) 
Poly(ε-caprolactone) is made up by ring opening polymerization of ε-caprolactone 
(Figure 10) which yields a semicrystaline polymer with a melting point of 59-64°C. The 
homopolymer has a degradation time of approximately two years (Middleton and Tipton 
2000). Copolymers of ε-caprolactone have been synthesised with DL-lactide to decrease the 





Figure 10: Synthesis of poly(ε-caprolactone) 
 
1.1.2.2.2 Poly(lactide-co-glycolide acid) (PLGA) 
 PLGA is synthesized by means of random ring opening co-polymerization of two 
different monomers, the cyclic dimmers (1,4-dioxane-2,5-diones) of glycolic acid and lactic 
acid. The common catalysts used to achieve this polymer are Tin (II) 2-Ethylhexanoate, Tin 
(II) alkoxide or aluminium isopropoxide (C9H21O3Al). During polymerization successive 
monomer units of glycolic acid and lactic acid are linked together to form PLGA by ester 
linkage hence producing an aliphatic polyester (Figure 11). Depending on the ratio of lactide 
to glycolide used for polymerisation, various forms of PLGA can be created, so PLGA 80:20 
would mean that the composition is 80% lactic acid and 20% glycolic acid. All PLGA are 
amorphous (where molecules are not organised in a lattice pattern) and generally have a glass 
transition temperature of approximately 50
o
C. PLGA degrades by hydrolysis of its ester 
linkages in the presence of water. Depending on the ratio of the two groups affects the time 
taken to degrade the polymer. The lower the content of the lactide units, the shorter the time 
required for degradation.  
 





1.2.1 Bioplotter and accuracy 
 
 
Figure 12: View of Bioplotter™ 
 
Before the initial use of the Bioplotter™ (Figure 12), the exact needle tip position was 
measured as all parameters such as layer thickness and initial starting plotting height were 
relative to the exact needle tip position. This was achieved by using the needle sensor which 
was located behind the plotting bath. This measurement was important. The needle tip 
position and length were measured by passing through two light barriers. The one measures 
the position in the x direction and the other sensor measures the tip position in the y and z 






Figure 13: The needle sensor, a) x-position, b) y and z position 
 
The software used to control the Bioplotter was comprised of three individual modules: 
 The Mutronic machine driver 
 The PrimCAM software that processes the data  
 The PrimCNC software that controls the machine 
The Mutronic machine driver forms the basis of the Bioplotter‟s activation system and 
operates in the background with no interference required from the user. The PrimCAM 






Figure 14: PrimCAM, alteration of manufacturing parameters 
 
PrimCNC modules was the main interface for manufacturing the scaffolds, where speed 
and initial plotting height was set and where the manufacturing process could be started and 





Figure 15: PrimCNC screen shot 
 
1.2.1.1 Accuracy of Bioplotter plotted geometries 
The comparison of the inputted data versus the plotted strand was investigated. This was 
achieved by plotting a strand with various speeds and pressures and then capturing images 
using a Nikon E800 and camera and subsequent histomorphometric measurements were 
taken using the computer program BioQuant. The computer information was noted and the 
resulting measurements and distances were compared. 
 
1.2.2 Scaffold Manufacture and in vitro experiments 
For this study, alginate, chitosan and gelatin were chosen as examples of naturally 
derived polymers and the synthetic polymers considered were polycaprolactone (PCL) and 
poly(lactide-co-glycolide) (PLGA). In addition these polymers were chosen as they were 





1.2.2.1 Chitosan scaffold manufacture 
The use of chitosan as a scaffold material for tissue engineering has been reported in the 
literature (Ang et al. 2002, Madihally and Matthew 1999, Zhang and Zhang 2001). The 
authors Ang et al used chitosan in a dissolved form and generated scaffolds by using a 3D 
robotic dispenser, this paper formed the basis of my work regarding chitosan scaffolds. 
Chitosan is normally insoluble in aqueous solutions above pH 7 but in weak acids, chitosan 
becomes fully soluble which permits the chitosan to be extruded. The acidic solution of 
chitosan was then plotted into an alkaline solution of 1% w/v sodium hydroxide mixed in a 
ratio of 7:3 with 100% ethanol, which precipitates out the chitosan forming a hydrated 
gelatinous strand of chitosan. 
A computer aided design model (CAD) first was created; this was achieved in Solid 
Works 2003. The initial model generated was a solid block with dimensions of 10 x 10 x 
5mm. The model was then saved in a STL format. This is a format created by 3D systems and 
is used to export and import files by converting the CAD object so that only the surface 
geometry is represented by a set of triangles.  
 
1.2.2.1.1 Bioplotter parameters 
There are several Bioplotter parameters that can be controlled they include the pressure, 
dispensing velocity, the initial dispensing height, the layer thickness and the strand distance. 
For the scaffold production, the chosen values were: 1.20 bar, 120 mm/min, 500μm, 280μm 
and 630μm respectively and plotting was undertaken at room temperature. The needle tip 
(EFD International, UK) was a 25 gauge with internal diameter of 250μm. These initial 
parameters were obtained through trial and error. Firstly the syringe was loaded and a low 
pressure was applied (0.5 bar), the pressure was slowly increased until a slow and regular 
flow was achieved from the tip of the needle. This gave an initial starting point to determine 
the other parameters. The next step was to find the height above the substrate the needle was 
to start plotting, this was critical because if the needle was too low, the strand would be 
compressed and distort the geometry of the layer. On obtaining these two parameters, the 




increasing the speed until a well formed strand was plotted; this was fine tuned by also 
adjusting the pressure. 
 
1.2.2.2 Dispensing material preparation 
Various chitosan solutions were tested from 2% w/v, 3% w/v and 4% w/v, chitosan 
solution concentrations at 4% and above were very viscous and did not completely dissolve 
hence making them unsuitable for extruding. The selected concentration was prepared by 
dissolving 3% weight/volume chitosan (Sigma UK) in 2% v/v glacial acetic acid (Sigma UK) 
to form a hydrogel which completely dissolved and was sufficiently viscous to enable 
controlled scaffold manufacture. The dissolved hydrogel was then placed on mixing rollers 
and left to dissolve overnight at room temperature. 
 
1.2.2.2.1 Dispensing medium preparation 
The chitosan scaffolds were created by extruding a viscous chitosan solution into a bath 
mixture of sodium hydroxide (NaOH) solution and ethanol to yield a gel like precipitate. The 
concentration of NaOH determines the rate at which the gelation occurs. Three millilitres of 
chitosan solution was poured into a 30 centimetre cubed (cc) polypropylene barrel (EFD, 
UK) with a 25 Gauge (internal diameter 0.25mm) stainless steel tip (EFD, UK). The 
dispensing medium was made up of various concentrations (0.8 w/v – 1.5% w/v) of sodium 
hydroxide (Sigma, UK) but always maintaining a ratio of 7:3 with 100% ethanol (Fisher 
Scientific) and the choice of ratios were based on the work performed by Ang et al. The 
optimal concentration of NaOH was found to be 1% w/v. 
 
1.2.2.2.2 Post-process 
After the scaffold had been manufactured, it was gently removed from the bath and 
immersed in 100%, 70% and 50% ethanol for 5 minutes with a wash in distilled water after 




was to immerse the scaffold in 2% w/v pentasodium tripolyphosphate (PTT) for 10 minutes 
which further cross-links the chitosan (Anal et al. 2006, Dyer et al. 2002), with a final wash 
in distilled water for 30 minutes. The scaffold was then placed at -20°C for 8 hours to solidify 
the solvent and then the scaffold was freeze dried for 1 day at -60°C to remove the residual 
solvent through solid-liquid phase separation (Shu and Zhu 2002). 
 
1.2.2.2.3 In vitro chitosan scaffolds experiment using MG63 an osteoblast cell line 
The purpose of this experiment was to determine whether manufactured chitosan 
scaffolds with and without calcium phosphate incorporated in the chitosan mix were 
biocompatible and could support MG63 cells which are an osteosarcoma cell line (Sakai et al. 
2006). 
Chitosan scaffolds were manufactured as previously mentioned however two chitosan 
mixtures were created, the first was 3% w/v chitosan dissolved in 2% v/v acetic acid and the 
second chitosan mixture was a 3% w/v chitosan dissolved in 2% v/v acetic acid with 0.2% 
w/v calcium phosphate powder added. Calcium phosphate powder was added to attempt to 
introduce some mechanical strength to the plotted scaffolds. 
Two chitosan scaffolds with added calcium phosphate and two chitosan scaffolds without 
calcium phosphate were cut into four using a scalpel (Morton-Swann, UK) into 10mm x 
10mm squares and autoclaved. All subsequent manipulations were carried out under sterile 
conditions. The 16 (8 chitosan scaffolds with calcium phosphate and 8 without calcium 
phosphate) scaffolds were then placed in a 24 well plate and hydrated in growth media for 15 
minutes. The growth medium used was made with Dulbecco‟s modified eagle‟s medium 
(Sigma, UK) supplemented with 10% fetal calf serum (Gibco-Invitrogen, UK) which supplies 
the cells with nutrients to promote growth, 1% penicillin/streptomycin (Gibco-Invitrogen, 
UK) which acts as an antibiotic and 1% L-Glutamine (Gibco-Invitrogen, UK) which is the 
cells energy source and reduces protein degradation in cells. During the hydration of the 
chitosan scaffolds, the flasks containing the cells were washed thrice with PBS, washed with 




cells. After approximately 5 minutes the cells were detached from the surface of the flask and 
the trypsin was then neutralised with 9ml of growth media to stop the effect of the enzyme. 
The MG63 cells were then transferred to a universal tube and a cell count was performed 
using a haemocytometer. The cells were then centrifuged at 2000 rpm at 4°C for 5 minutes to 
obtain a cell pellet and the media was then carefully removed. The cells were then re-
suspended in growth media to obtain a final cell concentration of 4.2x10
6
 cells/ml. The cells 
were statically seeded at a concentration of 250,000 cells/scaffold. This involved pipetting the 
cells directly onto the scaffold and allowing the cells to adhere to the scaffold for four hours. 
The wells were then filled with 500μl of growth media and left for seven days with media 
changes every 2 days. 
 
1.2.2.2.4 Analysis 
At the end of the experiment, the scaffolds were removed and fixed for 10 minutes using 
4% w/v paraformaldehyde (PFA) dissolved in phosphate buffer solution (PBS) for 10 
minutes. The fixed scaffolds were then stained with 4‟-6-Diamidino-2-phenylindole (DAPI) 
which is a fluorescent stain that binds strongly to deoxyribonucleic acid (DNA). DAPI can 
pass through an intact cell membrane and can be used to stain live and fixed cells and 
fluoresces bright blue. 
 
1.2.2.3 Alginate scaffold manufacture 
As has been stated in section 1.1.2.1., alginate has been used as a biomaterial and has 
properties that make it good for scaffold manufacture using the Bioplotter (Khalil et al. 
2005b). For scaffold manufacture, the alginate was first dissolved in sterile 0.9% w/v saline 
solution and then extruded into a 0.09% w/v calcium chloride solution that precipitates out 
the alginate creating a hydrogel scaffold. These basic principles were used and adapted from 




1.2.2.3.1 Bioplotter parameters 
For alginate, the manufacturing parameters found to yield the best scaffolds were, 
extruding pressure set at 1 bar, speed of plotting at 100 mm/min, layer thickness at 230μm 
and the strand distance set at 1.2 mm. The needle to extrude was a 27 gauge with internal 
diameter of 200 μm (EFD, UK). These initial parameters were obtained through iterative 
work. Firstly the syringe was loaded and a low pressure was applied (0.5 bar), the pressure 
was slowly increased until a slow and regular flow was achieved from the tip of the needle. 
This gave an initial starting point to determine the other parameters. The next step was to find 
the height above the substrate the needle was to start plotting, this was critical because if the 
needle was too low, the strand would be compressed and distort the geometry of the layer. On 
obtaining these two parameters, the speed of the plot was determined by starting with a low 
speed (60 mm/s) and gradually increasing the speed until a well formed strand was plotted; 
this was fine tuned by also adjusting the pressure. 
 
1.2.2.3.2 Dispensing material preparation 
Various concentrations of alginate were made, ranging between 1%, 2%, 3%, 4%, 5% 
and 6% w/v. These solutions of alginate (Sigma, UK) were made up at room temperature by 
dissolving in sterile 0.9% w/v saline water. To enhance dissolution, the solution was placed 
in an orbital shaker for three hours until completely dissolved. The resulting solution was 
then autoclaved to sterilise it. 
 
1.2.2.3.3 Dispensing solution preparation 
The dispensing solution precipitates out the alginate in the form of a viscous gel. It was 
made by dissolving calcium chloride (CaCl2) (Sigma, UK) in sterile distilled water. The 
concentration of calcium chloride required for gelation was 0.09% w/v but numerous other 




2%, 3%, 4% and 5% w/v. The dissolved solution was then filter sterilized using a 0.22μm 
filter (Millipore, UK). 
 
1.2.2.3.4 Post-process 
After the scaffold was manufactured, it required a further step to cross-link the alginate 
fully this was achieved by removing the dispensing solution from the bath and replacing it 
with a 1% w/v calcium chloride solution until the scaffold was submerged. This more 
concentrated solution further cross-links the alginate. The scaffold was left immersed at room 
temperature for thirty minutes and then removed and washed twice in sterile 5% w/v 
phosphate buffer saline (PBS) to remove any residual calcium chloride. 
 
1.2.2.3.5 Alginate bead and marrow stromal cells (MSC) experiment 
Alginate was made up at concentrations of 2% w/v, 3% w/v (Sigma UK). A 5 % w/v 
stock solution of alginate was made and then diluted down to the required concentration, so 
ratios of 1:1.5, 1:0.67 with sterile 0.9% w/v saline water were used to create a final 
concentration of 3% w/v and 2% w/v alginate solutions. 
 
1.2.2.3.5.1 Cell collection and culture 
Marrow stromal cells (MSC), which contain a sub population of mesenchymal stem cells 
(Kuznetsov et al. 1997), were harvested from the femoral head tissue that was obtained, with 
written informed consent and with the approval of the local ethical committee, from patients 
undergoing elective arthroplasty. All subsequent manipulations were carried out under sterile 
conditions. The trabecular bone and marrow from inside the femoral head was removed and 
placed in 5ml of growth media. The growth medium used was made with Dulbecco‟s 
modified eagle‟s medium (Gibco, UK) supplemented with 10% fetal calf serum (Autogen, 




penicillin/streptomycin (Gibco-Invitrogen, UK) which acts as an antibiotic and 1% L-
Glutamine (Gibco-Invitrogen, UK) which is the cells energy source and reduces protein 
degradation in cells. The media and trabecular bone mix were then shaken by hand for 1 
minute in order to dislodge the MSCs. The media containing cells was then carefully 
decanted to avoid the presence of bone fragments and placed in a tissue culture treated T25 
flask (25cm
2
 represents the surface area of the flask) (Corning, UK). The media and cells 
were left for four days and after that period the cells that had attached to the plastic culture 
flask were cultured. The media was then removed and the cells washed with PBS before 
being fed with cell culture media. Once the cells in the flask were 80% confluent, the cells 
were passaged into a T75 flasks. This was accomplished by first removing the media which 
was transferred into another T25 flask so that a second harvest could be obtained. The cells 
were washed thrice with PBS and washed with 1ml of trypsin followed by incubation in 1 ml 
of trypsin. After approximately 5 minutes the cells were detached from the surface of the 
flask and the trypsin was then neutralised with 9ml of growth media to stop the effect of the 
enzyme. The cells were then transferred to a universal tube and centrifuged to obtain a cell 
pellet and the media was then carefully removed. 12ml of cell culture media was added to the 
cell pellet and the cell suspension was then transferred to a T75 flask. The cells were grown 
for approximately four weeks until cell were approximately 80% confluent (See appendix A).  
Alginate beads were created using a blunt 19 gauge needle. Firstly a known volume of 
alginate solution was loaded into a syringe, in this case 400μl and as many beads were 
created as possible. With this fixed volume, twenty beads were produced which then enabled 
the volume of one bead to be calculated. For the experiment a total of 10 million cells were 
required but it was not possible to obtain this number from a single patient therefore the cells 
were pooled together from two patients. The aim of the experiment was to determine the 
effects of different concentrations of alginate different calcium chloride concentrations for 
gelling of beads on cell survival. Prior to starting the experiment, the following was prepared: 
Alginate types required for experiment: 
 2% Sigma Alginate (w/v in sterile 0.9% w/v saline water) 




Calcium Chloride solutions required for experiment: 
 1% w/v CaCl2 
 0.09% w/v CaCl2 
For this experiment, the alginate solutions that were used were: 2% and 3% w/v 
dissolved in 0.9% saline solution. The beads were formed in the 0.09% w/v CaCl2 and left for 
10 min then the CaCl2 was removed and replaced by 1% CaCl2 and left for 5 min at room 
temperature.  
 
Alginate bead production: 
Firstly the alginate solutions and the two (1% and 0.09% w/v) calcium chloride solutions 
were made up and filter sterilised using a 0.22μm filter (Millipore, UK). Once the cells in the 
flask were 80% confluent, they were prepared by removing them from the flask. This was 
accomplished by first removing the media. The cells were washed thrice with PBS and 
washed with 1ml of trypsin followed by 1 ml of trypsin added to the cells. After 
approximately 5 minutes the cells were detached from the surface of the flask and the trypsin 
was then neutralised with 9ml of growth media to stop the effect of the enzyme. The cells 
were then transferred to two universal tubes and a cell count was performed using a 
haemocytometer. The cells were then centrifuged at 2000 rpm at 4°C for 5 min to obtain a 
cell pellet and the media was then carefully removed. The cells were then re-suspended in 
0.2ml of growth media and an appropriate volume of 2% and 3% alginate mixture was added 
so that the final cell density was 2 x 10
6
 cells/ml. 
The cell suspension was then carefully pipetted into a barrel of a 1 ml syringe fitted with 
a 19 gauge needle. The alginate/cell mixture was then placed drop-wise into the 0.09% w/v or 
calcium chloride solutions to create beads. Ten wells with calcium chloride were available 
this permitted one bead in each well to be created before the second and third bead was 
added. The beads were then left in the 0.09% w/v for 10 minutes at room temperature. After 
the time had elapsed the calcium chloride was carefully removed as not to damage the beads 




room temperature. The calcium chloride was then carefully removed and washed twice with 
5% PBS and finally 500μl of growth media was added to each well and was changed every 2 
days for 21 days. Complete cell culture media consisted of Dulbecco‟s modified Eagle 
Medium (DMEM) supplemented with 10% Foetal calf serum (FCS) (Autogen, Bioclear), 
penicillin (50IU/ml), streptomycin (50μg/ml), l-glutamine (2mM). For this experiment, five 
time points were created, day 0 (T0), day 2 (T2), day 7 (T7), day 14 (T14) and day 21 (T21). At 
each time point, 6 alginate beads were removed from the 2% alginate group and 6 beads were 
removed from the 3% alginate group. On removal, 3 of the beads from each group were 
stained for 5 minutes with 4‟-6-Diamidino-2-phenylindole (DAPI) which is a fluorescent 
stain that binds strongly to deoxyribonucleic acid (DNA) and stained with Propidium iodide 
(PI), which stains DNA but cannot penetrate an intact cell membrane therefore only marking 
necrotic and late apoptotic cells and un-affecting the viable ones. The beads were then 
examined using a fluorescent microscope (Nikon, Eclipse E800) and the number of DAPI 
stained and PI stained cells counted. The other three remaining beads were prepared for 
sectioning (further details in following paragraph). 
 
1.2.2.3.6 Fixing and sectioning of alginate beads for analysis 
The remaining 3 beads from the 2% w/v alginate group and the remaining beads from the 
3% alginate group were washed in PBS and then left in 1 ml of fixing solution made up of 
250µl of 80% gluteraldehyde, 750µl of 0.1M sodium cacodylate and 1µl of 1M calcium 
chloride for 3 hours. The beads were then removed and incubated in 1ml of 20% w/v sucrose 
dissolved in sterile water and 1 µl of 1 M calcium chloride for 24 hours. The beads were then 
immersed in polyvinyl alcohol (PVA) and snap frozen in a hexane chilled bath and then 
stored at -80°C.  The samples were then mounted on bronze chucks and sectioned using a 
cryotome; sections were cut at 10µm thickness onto tape to facilitate the removal of the 
section from the cryostat blade. Sections obtained using the cryostat method were poor as the 





Plastic-resin sections were obtained using a Technovit 9100 (Heraeus Kulzer GmbH, 
Germany) process. The samples were embedded in a methyl methacrylate plastic. This 
required a destabilised Technovit 9100 basic solution which was prepared by pouring the 
stabilised Technovit 9100 basic solution into a chromatography column with 50g of 
aluminium oxide (Al2O3) (Sigma, UK) and allowed to flow slowly through it. When the 
Technovit 9100 destabilised solution had been prepared, it was stored in a dark glass bottle at 
4ºC to prolong the life of the solution, for full protocol see appendix A.  
 
1.2.2.4 Gelatin scaffold manufacture 
Gelatin (Sigma, UK) was dissolved in sterile distilled water at various concentrations 
ranging from 10%, 20%, 30%, 40%, 50% and 60% w/v. The solution was stirred and heated 
for approximately 10 minutes at 50°C until the gelatin had completely dissolved. The liquid 
solution was then transferred to a glass syringe that was compatible with the Bioplotter™. 
The syringe was placed in a heating jacket that was mounted on the Bioplotter™ and was set 
at 45°C to maintain the liquid state of the gelatin. A 25 gauge needle tip (EFD, UK) was 
fastened to the syringe via a luer lock and the extrusion of the liquid was ready to begin. 
 
1.2.2.4.1 Gelatin scaffold Bioplotter parameters 
For 20% w/v gelatin solution, the plotting speed was 250 mm/min, pressure 1bar and a 
layer thickness of 210μm. For greater concentrations of gelatin solution, the pressure was 
increased. During the manufacture of gelatin scaffolds, the tip of the needle was sometimes 
blocked which inhibited the flow of the plotting medium. This occurred because of the 
cooling of the gelatin and hence its solidification while still inside the needle. This problem 
was overcome by heating the needle tip by „resistance wire heating‟: a known length of 
enamel coated copper wire (RS, UK) of diameter 132μm, standard wire gauge (SWG) 39, 
was wrapped round the needle tip and a current was passed through which heated up the wire 




measured using an ohmmeter. The electric power was then calculated using the following 
formula:  
 
where I denotes current in amps (A) and R denotes resistance in ohms (Ω). 
A graph (Figure 16) was obtained of electric power versus released temperature which 
was measured using a thermocouple; the experiment was carried out at room temperature. 
























Figure 16: Temperature generated by changes in power 
 
1.2.2.4.2 Gelatin cross-linking and cell toxicity 
Gelatin scaffolds were difficult to create by cooling of the polymer alone, so cross-
linking of the gelatin was attempted. Gluteraldehyde and the enzyme transglutaminase were 
considered. Two concentrations of gluteraldehyde were made, 0.25% v/v and 2.5% v/v (Yang 
and Ou 2005) and the two transglutaminase concentrations used were 5U/g and 50U/g 
(Fuchsbauer et al. 1996). These solutions were assessed to determine which was more 
effective in cross-linking gelatin and which concentration was less toxic to the cells. 




extruding it through a heated needle tip into a bath of cross-linking agent with the plotting 
speed 250 mm/min, pressure 1bar and the layer thickness of 210μm. 
All subsequent manipulations were carried out under sterile conditions. The 20% w/v 
gelatin solution was added to 12 wells of a 24 well plate with each of the four cross-linking 
agents added to three of the wells. The plate was incubated at 37ºC for 5 hours then washed 
thrice in PBS and the MG63s, an osteosarcoma cell line (Sakai et al. 2006), were statically 
seeded onto the gelatin. The concentration of cells was 24,000 cells/ml. Each well received 
0.5ml of cell suspension (i.e. 12,000 cells suspended in growth media). The culture media 
was changed every two days for six days with growth media.  
After seven days, the cells were fixed with 4% paraformaldehyde (PFA) for 10 minutes 
and stained with DAPI (1μg/ml) and propidium iodide (PI) (1μg/ml). 
 
1.2.2.5 Poly (lactic-co-glycolic acid) scaffold manufacture 
Unless otherwise indicated, all reagents were purchased from Sigma, UK 
1.2.2.5.1 Dispensing material and solution preparation 
Poly (lactic-co-glycolic acid) (PLGA) in a 75:25 ratio of lactide to glycolide was 
dissolved in various solvents including acetone, chloroform and glacial acetic acid. This 
technique of processing the PLGA and manufacturing scaffolds was adopted as previous 
attempts of creating scaffolds via heat extrusion, namely gelatine scaffolds, proved difficult 
and would require modifications to the Bioplotter™ that would need to be approved by the 
Health and Safety department. The solvent and precipitation method has been described in 
the literature (Kulkarni et al. 1966, Nelson et al. 2003). It is a safer manufacturing method 
with no Bioplotter™ modifications required. The concentration of PLGA used to 
manufacture scaffolds was 30% w/v dissolved in acetic acid however 10% w/v and 20% w/v 
concentrations in different solvents were also tested. The PLGA solution was in a sealed 
universal (Corning, UK) and left overnight in a heated orbital shaker with the temperature set 




A number of different solutions were used to precipitate the PLGA from the solvent 
which included isopropanol (C3H8O), ethanol (C2H6O) and industrial methylated spirit (IMS) 
which is typically 95% ethanol mixed with 5% wood naphtha. 
 
1.2.2.5.2 Bioplotter parameters, plotting techniques and post-processing 
The initial test involving PLGA was inspired by the work undertaken by Nelson et al  
where fibres of PLGA were manufactured by a wet-spinning technique which creates a 
structure with random deposition of fibres (Nelson et al. 2003). 
Scaffolds involving PLGA were created by dissolving the polymer in solvents that 
included chloroform and acetic acid to create a solution. The dissolved polymer was extruded 
in a coagulation bath that consisted of several different liquids to determine which one 
performed best. The tested liquids were isopropyl alcohol and industrial methylated spirit 
(IMS). Due to the price of PLGA a lot of techniques learnt from the manufacture of the 
polycaprolactone scaffold were transferred and used to manufacture the PLGA scaffolds. 
After some iterative work, it was deduced that the most adequate solvent for dissolving the 
PLGA was acetic acid and the best liquid to precipitation the PLGA was IMS.  
Once the 30% w/v PLGA solution had completely dissolved IMS, it was transferred to a 
50ml syringe which was fitted with a 25 gauge blunt needle (EFD, UK). The syringe was 
then placed in the Bioplotter™. The plotting parameters were set as follows: pressure of 0.27 
bar, layer thickness 0.15mm, strand thickness 0.6mm with a 0.3mm offset, the plotting speed 
was set at 163 mm/min. The scaffolds were plotted on a polycarbonate substrate to which the 
precipitated polymer was able to adhere to. The size and dimensions of the scaffolds could be 
controlled and were generally manufactured as 20mm x 20mm blocks.  
On completion of the scaffold, the polycarbonate substrate with the adhered scaffold was 
removed from the bath containing the precipitating solvent. The scaffolds were carefully 
peeled off the substrate and washed to remove the solvents by immersing in sterile distilled 
water for an hour and repeating the washing step with fresh distilled water. The scaffolds 




The PLGA scaffolds were then examined using a scanning electron microscope (SEM) to 
investigate the characteristics of the scaffold. An SEM is a type of electron microscope 
capable of producing high definition images of sample surfaces. The SEM electrons are 
emitted thermionically from a tungsten or lanthanum hexaboride (LaB6) cathode and are 
accelerated towards an anode. The electron beam is focused by a condenser lens into a very 
fine spot sized 1nm to 5nm. The beam then passes through an objective lens which deflects 
the beam in a raster fashion over a rectangular surface of the sample. Electrons are emitted 
through the scattering of the beam which is detected to form an image. Thus the scaffolds 
were examined under the SEM in order to obtain high definition images of the scaffold 
surfaces, the bonding of the layers and the scaffold geometry  
 
1.2.2.5.3 PLGA scaffold degradation experiment 
The aim of the degradation experiment was to determine whether manufactured PLGA 
scaffolds in 5% PBS would show a sign of degradation within 21 days. 
The PLGA scaffolds manufactured were double layered with offset and created in small 
20mm by 20 mm sheets and 2 mm high which were cut into smaller scaffolds 4mm by 4mm 
using a surgical scalpel (Morton-Swann, UK). The scaffolds were then placed into individual 
bijous with 2.5 ml of 5% w/v PBS. The bijous were placed in an incubator at 37°C for 21 
days with five of the scaffolds being removed at T0, T1, T3, T6, T9, T15 and T21. The scaffolds 
were weighed using a weighting scale with an accuracy of 0.1mg (ADAM, model AFA-
120LC, UK) and the data recorded to determine if there was a change in mass which would 
indicate degradation. 
 
1.2.2.5.4 PLGA scaffold and in vitro MSC experiment 
Before marrow stromal cells that contained a sub population of mesenchymal stem cells 
(Kuznetsov et al. 1997) were seeded on the PLGA scaffold, it was decided that a coating 




increase the cell adhesion potential of scaffolds have been widely used, either in the form of 
hydroxyapatite (Ciapetti et al. 2003, Tencer et al. 1987), polylactic acid (Tencer et al. 1988) 
or gelatin (Zhu et al. 2003). Gelatin was used due to its availability and the reported success 
in the literature as a coating agent (Pankajakshan et al. 2007, Shen et al. 2007).  
An experiment was devised to determine the concentration of gelatin that would best 
improve the adhesion of cells to the PLGA scaffold. The gelatin (Sigma, UK) was made up in 
a universal flask (Corning, UK) to 0.1% and 0.2% w/v in sterile distilled water and allowed 
20 minutes to completely dissolve in an orbital shaker (Stuart SI50, UK) at 35ºC. All 
subsequent manipulations were carried out under sterile conditions. Once dissolved, the two 
different gelatin solutions were filter sterilised using a 0.22μm filter (Millipore, UK) and 
200μl of each gelatin solution was pipetted into 8 wells of an ultra-low binding 24 well plate 
(Corning, UK) for 15 minutes in a tissue culture hood (Figure 17). These multiwell plates 
have a covalently attached hydrogen layer on the surface of the plastic which is non-toxic, 
biologically inert and effectively inhibits cell attachment therefore the coating that counter 
acts the low binding effect will be the coating with the greatest cellular attachment potential. 
During the coating of the wells, the cells were prepared as previously mentioned in paragraph 
1.2.2.3 and a cell suspension of 6,000 cells per well was created i.e. 12,000 cells/ml. 
 
Figure 17: Gelatin coating of ultra-low tissue culture well 
 
The gelatin solutions were then removed using a pipette and allowed to dry for 5 minutes 




wells and placed into an incubator at 37ºC with 5% carbon dioxide (CO2). After 24 hours, the 
media was removed using a pipette and the cells fixed for 5 minutes using 4% w/v 
paraformaldehyde dissolved in PBS. The cells were then stained with 4‟-6-Diamidino-2-
phenylindole (DAPI) which is a fluorescent stain that binds strongly to deoxyribonucleic acid 
(DNA) and fluoresces bright blue. The wells were then examined using a fluorescent 
microscope (Nikon, Eclipse E800) and the number of cells counted. The cell number was 
recorded and a graph plotted to determine the gelatin concentration that enabled the greatest 
number of cell attachment. 
On obtaining the results of the gelatin coating, the aim of the following experiment was 
to determine whether cells seeded on the plotted PLGA scaffolds and PCL scaffolds (see 
section 1.2.2.6) are capable of adherence and survival. For this experiment, four PLGA and 
four PCL scaffolds were created two layers high and marrow stem cells were used that 
contained a mesenchymal stem cell population. MSC were cultured as previously mentioned 
in paragraph 1.2.2.3. On completion of the scaffolds, they were washed thrice in distilled 
water and then coated in 0.2% gelatin solution. The coating was achieved by allowing the 
scaffolds to soak in the gelatin solution for 30 minutes. During the coating of the scaffolds 
the cells were removed from their flasks using the enzyme trypsin and a cell concentration of 
24,000 cells / ml was made up. After 30 minutes, the scaffolds were removed and placed on 
some sterile gauze to absorb any excess gelatin solution then placed into a 24 well plate. 
500µl of the cells suspension was then gently pipetted on the scaffolds i.e. 12,000 cells / 
scaffold, and a further 4 empty wells were filled with the cell suspension which acted as 
control groups. The plate was then placed in an incubator at 37ºC and left for 24h.  
After 24h, the scaffolds were removed and flash frozen using hexane at -80°C, the plates 
were then drained of media by placing on an absorbent paper towel and placed in a -80°C 
freezer. DNA assay was then performed on the plates to quantify the number of cells present 







1.2.2.5.4.1 DNA assay 
The assay used was based on a combination of an existing in house protocol and work 
done by Rago et al (Rago et al. 1990). Firstly the standard DNA curve was created by serial 
dilutions of the stock herring testis DNA (200µg / ml) solution were made in water. 200µl of 
the stock was pipetted into three wells of a 96 well plate then 100µl was removed and 
pipetted out into the following well with 100µl of water added. This process was then 
repeated until a final concentration of 3.125µl / ml was achieved. Then a solution of Hoechst 
33258 was made up by diluting the stock at a concentration 1µg / µl, 1:5000 in 100mM NaCl 
and 10 mM Tris pH 7, which gave a final Hoechst 33258 concentration of 200ng / ml. The 
plates that were stored at -80°C were removed and 100 µl of distilled water was added to the 
wells and the plates were incubated at 37°C for 30 minutes. The plates were then frozen at -
80°C for 1 hour and thawed until reaching room temperature, this freeze thaw step was 
performed so that the cells burst and release their DNA. The 100 µl of DNA solution was 
removed and pipetted into the 96 well plate (Corning, UK) with the standard curve. Then 100 
µl of the Hoechst 33258 solution was added to each of the wells (the serial dilution and the 
burst cell‟s DNA). The plate was shaken to evenly distribute the mixtures and the 
fluorescence was then measured on an automated 96 well plate reader (Cytofluor multiwall 
reader, Series 4000). The plate reader excited at wavelength (λ) 350 nm and measured 
emission at λ 455 nm. The values obtained were then normalised by subtracting the values 
obtained from a solution made as described without DNA present.  
 
1.2.2.6 Polycaprolactone scaffold manufacture 
Unless indicated otherwise, all reagents were purchased from Sigma, UK. 
1.2.2.6.1 Dispensing material and solution preparation 
Polycaprolactone (PCL) with three different „number average molecular weights‟ (Mn) of 
10000, 42500 and 80000 was used in scaffold manufacture. This was so that scaffolds could 




determined. The first attempt using this polymer was to melt the polymer in a heated syringe; 
the PCL was then extruded to plot the scaffold. Due to the problematic temperature control in 
the syringe delivery needle, this was not successful and therefore the solvent-precipitate 
technique was evaluated. The various molecular weights of PCL were dissolved to obtain a 
20% and 30% w/v solution in different solvents such as chloroform (CHCl3), acetone 
(CH3COCH3) and glacial acetic acid (CH3COOH3). The dissolved polymer was then extruded 
into a bath that would precipitate out PCL. The content of the precipitation bath was a solvent 
in which the PCL was insoluble but in which the dissolving solvent was fully miscible. The 
miscible solvents tested were isopropyl alcohol, methanol, ethanol, water, glycerine, 
industrial methylated spirit (IMS).The PCL solutions were produced in a sealed universal that 
was placed in an orbital shaker at 35ºC for 12 hours. Once the polymer had completely 
dissolved, it was left for 1 hour to cool down to room temperature and it was transferred to a 
syringe fitted with a 25 gauge (internal diameter 0.25mm) blunt needle. 
 
1.2.2.6.2 Bioplotter parameters and manufacturing techniques 
The Bioplotter is controlled by a computer programme called PrimCam (Primus Data, 
Switzerland) and the combination of these two items constitute technology that can undertake 
computer aided manufacturing (CAM). In this programme, plotting parameters such as the 
layer thickness, strand distance, height at the start of plotting, speed of plotting and the 
plotting geometry i.e. double or single strand, can be controlled and set. Other parameters 
such as strand thickness which depends on the needle gauge and the pressure were controlled 
manually. The programme permitted the user to alter the speed and the pressure while the 
scaffold was being created thus enabling fine tuning.  
After a considerable amount of iterative work, the following parameters were regarded as 
the most appropriate: PCL with Mn 42,500 was dissolved in glacial acetic acid to create a 
30% w/v solution, the pressure used for extrusion was 0.71 bar, the plotting speed 120 
mm/min, the layer thickness 0.14 mm, the strand distance 0.6 mm with a 0.3 mm offset. The 
scaffolds were plotted on a polycarbonate substrate that was coated with a thin layer of 




On completion, the substrate with the scaffold attached to it, was removed and the 
scaffold was peeled off with care. The scaffold was then transferred to a universal tube with 
sterile distilled water and left for 15 minutes, this was repeated thrice however with the final 
wash, the scaffold was left in the water for 1 hour to remove as much of the solvent as 
possible before it was transferred to refrigeration at -20ºC. 
 
1.2.2.6.3 Mechanical testing of scaffolds 
Eight different scaffold geometries were created using the Bioplotter™ with all the 
plotting parameters the same in order to eliminate any discontinuities. The scaffold 
geometries manufactured included: 
Double strand offset (DSO) (Figure 18) 
Double strand offset with a 45º rotation (DSO45) (Figure 19) 
Double strand no offset (DSNO) 
Double strand no offset with a 45º rotation (DSNO45) 
Single strand offset (SSO) 
Single strand offset with a 45º rotation (SSO45) 
Single strand no offset (SSNO) 
Single strand no offset with a 45º rotation (SSNO45) 
 
The scaffolds were cut into blocks of approximately 5 x 5 x 5 mm and compressed using 
a mechanical compression machine (Dartec, UK). The scaffold blocks were measured with 
callipers to ensure the exact measurements were obtained. A 10kN load cell was used and 3 
scaffolds of the same geometry were tested until failure. Stress versus strain curves were 
plotted for each scaffold and the Young‟s modulus derived from the gradient of the graph. A 




scaffold in the mechanical testing machine. Aluminium was selected as it was an easy 
material to manufacture with and was tough enough to compress polycaprolactone scaffolds 
without yielding. 
 






Figure 19: Double Strand with Offset and 45º rotation 
 
 




1.2.2.6.4 In vitro assessment of polycaprolactone scaffolds with marrow stromal cells 
The aim of this experiment was to determine whether in static conditions MSCs seeded 
on manufactured polycaprolactone scaffolds in osteogenic differentiation media were capable 
differentiating into osteoblasts and creating calcium deposits. 
Before the marrow stromal cells could be seeded on the polycaprolactone scaffolds, the 
latter had to undergo several preparation steps. PCL scaffolds were removed from the -20ºC 
freezer and thawed by immersing in sterile distilled water for 40 minutes at room 
temperature. All subsequent manipulations were carried out under sterile conditions. The 
scaffolds were then transferred to a sterile tissue culture hood and six smaller scaffolds were 
then cored out using a 5 mm diameter biopsy punch (Miltex, Ø 5 mm) and placed in 100% 
industrial methylated spirit (IMS) (Sigma, UK) for 15 minutes to sterilise the scaffold. The 
scaffolds were then removed and washed thrice in sterile distilled water to remove any excess 
IMS. Scaffolds were then transferred, for 30 minutes, to a sterile universal containing 
previously prepared 0.2% w/v gelatin (Sigma, UK) which was dissolved in distilled water 
and filter sterilised using a 0.22 μm filter (Millipore, UK) to allow the coating process of the 
PCL scaffolds to occur. During the coating process, T75 flasks (Corning, UK) containing the 
marrow stromal cells were removed from the incubator and the media from the flasks 
aspirated using a pipette. The cells were then washed for 5 seconds with 1 ml of the enzyme 
trypsin which is used to detach cells from the flask. Another millilitre of trypsin was added to 
the flask for 5 minutes, the flask was occasionally tapped to encourage cell detachment. The 
trypsin was then neutralised using 9 ml of growth media to the flask. The growth media 
consisted of Dulbecco‟s Modified Eagle Medium (DMEM) (Gibco, UK) supplemented with 
10% Foetal Calf Serum (FCS) (Autogen, Bioclear), L-Glutamine (2mM), penicillin (50 
IU/ml) and streptomycin (50 μg/ml). Ten micro-litres on the cell suspension was then 
removed and pipetted onto a haemocytometer to determine the cell number. Growth media 
was added to the cell suspension to obtain a final cell concentration of 4.2 million cells/ml. 
After 30 minutes, the scaffolds were removed from the 0.2% w/v gelatin and placed on some 
sterile gauze to absorb any excess gelatin solution and placed using sterile forceps into a large 
cell culture dish (Corning, 150 mm x 25 mm). The PCL scaffolds were then seeded with 60μl 




every 30 minutes for 4 hours to obtain a uniform cell distribution throughout the scaffold and 
then 45ml of growth media was added to the cell culture dish until the scaffolds were 
submerged. The culture dish was then placed in an incubator at 37ºC and left overnight. The 
three scaffolds seeded with cells and the three un-seeded scaffolds were then transferred to an 
ultra-low binding 48 well plate (Corning, UK) to encourage the cells to remain on the 
scaffold and 500 μl of growth media was added to each well containing a scaffold and the 
plate was then returned to an incubator at 37ºC for 3 days. Osteogenic differentiation media 
was then added to the three scaffolds seeded with MSCs and three scaffolds with no cells. 
The osteogenic differentiation media was made with growth media supplemented with β-
glycerophosphate (Sigma, UK) (10mM/l), l-ascorbic acid-2- phosphate (Sigma, UK) 
(50μM/l) and dexamethasone (0.1μM/l). The media was then changed every two days for two 
weeks.  
At the end of the experiment, the scaffolds were fixed with 4% w/v paraformaldehyde 
and cut in half with a scalpel (Swann-Morton). Half of the scaffold was then stained with 
DAPI to determine whether cells were present and the other half was sectioned by dipping in 
OCT embedding matrix (Raymond A Lamb) before being flash frozen in super cooled 
hexane at -80ºC.  The samples were then placed in bijous and labelled and refrigerated and 
stored at -80ºC.  
The embedded samples were then mounted on a bronze chuck and cryostat sectioned 
with sections 10μm thick. The section was cut onto tape to facilitate the removal of the 
section from the cryostat blade and to maximise the integrity and quality of the section. The 
sections were then stained with DAPI which binds with cellular DNA and stained using the 
Von Kossa technique which involves fixing the samples with 4% PFA (Sigma, UK) then 
washed thrice in distilled water followed by incubation under a strong light at room 
temperature in 5% silver nitrate (AgNO3) for 1 hour. The sample was then washed 
thoroughly in water and incubated in 5% sodium thiosulphate (Na2S2O3) for 5 minutes to 
neutralise the remaining excess silver nitrate.  The Von Kossa technique stains calcium 
deposits dark brown that can be viewed using a microscope. The stained sections were then 
viewed and images captured with a DXM1200 camera mounted on a Nikon microscope 




1.2.2.6.5 In vivo assessment of polycaprolactone scaffolds 
The aim of this experiment was to determine whether implanted polycaprolactone 
scaffolds seeded with marrow stromal cells were capable of aiding bone growth of a critical 
sized circular incision in a mouse skull.  
The in vivo experiment was undertaken by a team of scientists within the musculoskeletal 
tissue engineering collaboration (MTEC). The experiment was designed and analysed by Dr 
Aimee Martin and the veterinary work performed by Dr J. Tremoleda and their help is kindly 
acknowledged. All animals were maintained under the guidelines by institutional Animal 
Care and Ethical Committee at the University of Edinburgh, and the surgical procedures were 
all performed in accordance to specification approved under a UK Home Office license (PP 
L60/3396). 
Thin PCL scaffolds were manufactured using the single strand offset (SSO) geometry. 
The scaffolds were 500μm thick and were manufactured using the same parameters as 
previously described. The scaffolds were then cored out with a 3mm biopsy punch (Miltex, Ø 
3mm) and sterilised in IMS and washed thrice in sterile distilled water. From this point on, 
the experiment was undertaken by Dr Aimee Martin and the scaffolds were then coated using 
a proprietary technology developed by Dr Aimee Martin. The scaffolds were then seeded 
with hMSC and the cells were allowed to proliferate for 2 days before implanting. 
On delivery of the 6 – 8 week old NOD/SCID male mice, the animals were given a week 
to acclimatise to the animal house. On the day of the experiment, the animals were 
anaesthetised using an injectable anaesthesia which was made up of Ketamine (Vetalar) and 
medetomidine (Domitor). The dose used was 75mg/kg Ketamine and 1mg/kg of 
medetomidine. After a two minute wait, so that one could be certain that the anaesthetic has 
taken effect, the hair was removed from the top of the head. The animal was then transferred 
into a hood with a warming pad at approximately 32ºC and the skin around the surgical site 
was disinfected and analgesia (Vetergesic) was injected subcutaneously at a dose of 
0.05mg/kg prior to surgery. A single skin cut was performed from the area behind the eyes to 
the back of the head exposing the skull. A 3mm diameter trephine attached to a micro-drill 




irrigation to prevent damage to the sectioned bone. On completion of the incision, the bone 
flap was carefully removed with forceps to avoid any bleeding. The scaffold with cells and 
the scaffold alone was then implanted and then sealed with fibrin glue (Tisseel®, Baxter 
healthcare Ltd). The wound was stitched with prolene 6/0 sutures and protected from animal 
bites with superglue. The animal was maintained during anaesthesia in 2 l/min O2 this could 
be achieved by placing the nozzle close to the animals head. The animal was then injected 
with 0.9% warm saline and the eyes were then treated with Lacrimogel. After 10 minutes, 
0.1ml of reversible anaesthesia Atipamezole (Antisedan) was injected subcutaneously while 
constantly maintaining the animal on the warming pad. Once the animal started to regain 
consciousness, it was placed back into its cage with the warming pad. After the three month 
implantation period, the animals were euthanized and the calvarial area collected using a 
micro-saw. Cryosections were then obtained of the calvarial defects and stained using the 
Von Kossa technique which involves fixing the samples with 4% PFA (Sigma, UK) then 
washed thrice in distilled water followed by incubation under a strong light at room 
temperature in 5% silver nitrate (AgNO3) for 1 hour. The sections were then washed 
thoroughly in water and incubated in 5% sodium thiosulphate (Na2S2O3) for 5 minutes to 
neutralise the remaining excess silver nitrate.  The Von Kossa technique stains calcium 
deposits dark brown that can be viewed using a microscope. The sections were then stained 
with DAPI (1μg/ml) which binds strongly with DNA. The stained sections were then viewed 
and images captured with a DXM1200 camera mounted on a Nikon microscope (Eclipse 
E800) using a 10x/0.30 ∞/1.2 magnification lens. 
 
1.2.3 Statistical analysis 
All statistical analysis was performed using quantative data analysis with SPSS release 
16 for Windows. Data was checked for normal distribution by applying the Kolmogorov-
Smirnov test. In cases where the randomly selected data were shown to have normal 
(Gaussian) distribution, i.e. where 95% of the data fell within plus or minus 1.96 standard 
deviations from the mean, parametric statistical tests such as two-tailed Analysis of Variance 




statistical significance between the groups. When the p value of the ANOVA test was p<0.05, 
the use of the Tukey-Kramer post-hoc test allowed comparison of more than two means at 
once without introducing the type I error associated with multiple t-tests (Fielding and Gilbert 




















1.3.1 Bioplotter accuracy of plotted geometries 
The accuracy of the Bioplotter™ was determined by extruding four layers of the 
polycaprolactone polymer dissolved in acetic acid. The aim of the experiment was to observe 
the accuracy of the Bioplotter™. The parameter that was controlled by the Bioplotter™ was 
the strand distance, which was the distance from the centre of a strand to the centre of the 
neighbouring strand on the same layer. 
Briefly the pressure and the speed were fixed with alterations only made to the CAM 
program to change the distance between the centres of the parallel strands (strand distance) 
on the same plotted layer. Four arbitrary strand distances were chosen 500, 600, 700 and 
800µm. The strand distance was measured using a histomorphometry program (BioQuant) 
which enables measurements of microscope images to be measured accurately (Table 1). A 
graph was plotted of measured strand distances versus inputted strand distances in both the x- 
and y- directions (Figure 21) with pictures to show the results (Figure 22-25).  
As can be seen from the two graphs below (Figure 21), statistical significance was 
observed between each strand distance in both the x- and y- directions. It can also be 
observed that the standard error was small which indicates that the strand distance does not 
differ much with respect to the mean. The measured strand distances were on average 2% 
lower compared to the inputted strand distance. This was because when the polycaprolactone 
strand was extruded, it contracted in both the x- and y- directions. It can also be observed that 











Figure 21: Inputted versus extruded strand distance, in the x-direction (top graph) and in 
















x-direc y-direc x-direc y-direc x-direc y-direc x-direc y-direc 
 
493.97 493.27 582.95 592.43 697.3 698.87 786.52 791.47 
 
494.38 508.97 594.16 602.24 703.37 678.64 795.77 798.19 
 
489.88 504.5 604.07 603.17 693.76 689.66 794.18 795.95 
 
485.39 495.51 589.68 591.01 674.16 692.44 777.53 779.08 
 
474.16 491.02 578.47 587.44 687.64 690.57 777.53 804.92 
 
494.38 504.48 586.13 593.25 687.64 697.3 795.5 794.64 
 
492.13 477.57 578.47 596.16 698.87 686.09 780 784.75 
 
485.39 479.82 603.13 593.25 692.13 692.82 764.04 800.44 
 
501.65 488.8 585.2 591.01 694.38 697.3 793.66 807.17 
Aver 490.00 494.00 589.14 594.44 692.14 691.52 784.97 795.18 
Stand. 
error 
2.60 3.64 3.17 1.75 2.81 2.12 3.66 3.02 
Table 1: Inputted versus plotted strand distance 
 
A Nikon Eclipse E800 upright microscope was used to gather pictures of the scaffolds. 
Some examples of the pictures can be seen in figures 22 - 25. Histomorphometry was then 






Figure 22: Scaffold with 500 µm strand distance, x10 magnification 
 
 






Figure 24: Scaffold with 700 µm strand distance, x10 magnification 
 
 





1.3.2 Chitosan scaffold 
1.3.2.1 Chitosan scaffold manufacture and Bioplotter parameters 
Briefly, 3% w/v chitosan solution was created by dissolving in 2% acetic acid. The 
plotting medium was made with a 1% w/v NaOH and ethanol in a 7:3 ratio. The needle used 
to plot the chitosan solution was a 25 gauge (250 µm internal diameter) (EFD, UK). An 
initial arbitrary pressure was chosen by having the syringe in an idle position and the pressure 
increased until a flow of chitosan was observed, this pressure was 1.60 bar. The plotting 
speed was set at 100 mm/min and the strand distance 500 µm. The result of this combination 
of parameters can be observed in figure 26. 
As can be observed from figure 26, a poor scaffold was created as all that can be 
observed was a pool of chitosan; this was due to the pressure being too high and the plotting 
speed too low. 
 
Figure 26: Attempt at creating a chitosan scaffold 
  
The following scaffold was manufactured by increasing the plotting speed to 120 
mm/min, this was performed to try and eliminate the pooling of the chitosan and the result of 






Figure 27: Chitosan scaffold with increased plotting speed to 120 mm/min 
 
The increased plotting speed positively affected the scaffold manufacture as it can be 
observed that at the bottom of figure 27 a reduction of the pooling effect was witnessed and 
strands can be seen. 
The following attempt consisted of further reducing the pressure to 1.40 bar to minimise 
the pooling effect further, in doing so, the plotting speed was also reduced to 114 mm/min so 
that during extrusion the plotted strand would not break an hence create a continuous strand, 
the results of these changes can be seen in figure 28. During the manufacture and as the first 
layer was plotted successfully, it was decided that a second layer would be created and the 






Figure 28: Attempt at two chitosan layers, pressure 1.4 bar and speed 114 mm/min, a) 
first layer, b) start of second layer. 
 
It was observed that the first layer was successfully plotted but the second was poorly 
plotted (Figure 28b). This was due to the layer thickness being set too high and as the second 
layer was being extruded, the strands did not attach to the foundation layer and were dragged 
along creating a pool of liquid of non gelatinous chitosan. 
The layer thickness was then lowered to 250μm and a five layer scaffold was created.On 
completion, the scaffold was allowed to cure completely in the bath for a further ten minutes. 
The scaffold was then removed and washed in 70% v/v, 50% v/v and 100% ethanol for five 
minutes in each. The scaffolds were then divided into two groups with one group being 
untreated and the other group treated with pentasodium tripolyphosphate (TPP) for ten 
minutes to further cross-link the chitosan (Anal et al. 2006, Dyer et al. 2002, Shu and Zhu 
2002). The scaffolds were then given a final wash with distilled water and then refrigerated at 
-20ºC for at 8 hours so that the scaffold was completely frozen. The frozen chitosan scaffold 
was then removed and lyophilised for 24 hours. The resultant scaffolds treated with TPP and 
not treated and with offset and without, can be seen in figures 29 – 31. From these images it 




pores clearly visible (Figure 29 and 30) compared to the non-TPP treated chitosan scaffold 
(Figure 31).  
 
Figure 29: Chitosan scaffold treated with PTT, no strand offset 
 
 






Figure 31: Chitosan scaffold not treated with PPT 
 
1.3.2.2 Chitosan scaffold and cells in vitro 
Briefly two different types of scaffolds were created i.e. with 0.2% w/v calcium 
phosphate powder and without and were prepared for static seeding with MG63 an 
osteoblast-like cells line. The scaffolds were plasma sterilised and then cut using a scalpel 
into smaller 10mm x 10mm scaffolds. The cut down scaffolds were then placed into a 24 well 
non tissue culture plastic plate and re-hydrated with growth media for 15 minutes. The media 
was removed and a cell suspension of 250,000 cells/ml was pipetted onto the scaffold and left 
in an incubator at 37ºC for 4 hours before 500µl of growth media was added. The scaffolds 
were left for 7 days with media changes every 2 days. At the end of the experiment, the 
media was removed and the scaffolds were stained with DAPI to determine whether the cells 
were still present on the scaffolds after 7 days, this can be seen in the following figures 




It can be observed from figures 32 and 33 that after the 7 day period, cells were still 
present on the scaffold which is shown by the blue (DAPI) stained cell nuclei. This 
demonstrated that the two types of chitosan scaffolds were capable of accommodating the 
MG63 osteoblast-like cell line. The staining performed on the chitosan scaffolds without cells 
(Figure 34) demonstrated that the staining obtained in the previous figures were stained cell 
nuclei. The presence of cells was a positive outcome and demonstrated the biocompatibility 
of the chitosan scaffold which was also reported by Ang et al (Ang et al. 2002) however the 
scaffolds lacked any mechanical strength after the 7 day period which made it impossible to 
move or transfer them which rendered chitosan scaffolds useless as load bearing tissue 
engineering scaffolds.  
 








Figure 33: Chitosan scaffold with calcium phosphate seeded with MG63, Normal light 
(left), DAPI stained (right) 
 
 






1.3.3 Alginate scaffold 
1.3.3.1 Alginate scaffold manufacture and Bioplotter parameters 
Briefly, 3% w/v alginate solution was made by dissolving the alginate in sterile 0.9% w/v 
saline water sterile distilled water. The solution was left to dissolve and then transferred to a 
syringe barrel. An iterative process was used where a low pressure was chosen (0.7 bar) and 
gradually increased until a flow of solution was observed from the blunt needle, the selected 
pressure was 1.4 bar. The manufacture of the first layer was then attempted by starting with a 
low plotting speed (60 mm/min) and then gradually increasing it until a distinguishable and 
defined strand was created. 
As can be seen from figure 35, the pressure was too high and in combination with a low 
plotting speed a non uniform scaffold was created that closely resembled a pool of alginate. 
The following attempt involved reducing the pressure to 1 bar and changing the plotting 
speed to 100 mm/min. The layer thickness was set to 230µm and the strand distance set to 1.2 
mm. The resultant scaffold can be observed in figure 36. 
 
 






Figure 36: Alginate scaffold, plotted at 1 bar and plotting speed 100 mm/min 
 
1.3.3.2 Alginate beads and marrow stromal cells 
Briefly, MSCs were introduced in the alginate solution and beads were created. The 
beads were then stained with DAPI which stains cell nuclei and PI which stains dead or leaky 
cells, an example of this can be seen in figure 37. All the beads were stained and a cell count 
was performed to determine the number of live cells per field of the 2% w/v alginate and the 
3% w/v alginate (Figure 38). A table with the number of live cells in the two different 
alginate concentrations can be observed in table 2 and a graph representing this data was then 





Figure 37: Alginate scaffold embedded with MSC and stained with DAPI (blue) to 
demonstrate all cell nuclei and PI (red) to demonstrate dead cells 
 
 
Percentage of Live cells (MSC) 
 
Day 0 Day 2 Day 7 Day 14 Day 21 
2% Alginate 99.2 89.4 82.1 78.6 66.7 
Standard error 0.752 0.850 0.562 1.922 2.452 
3% Alginate 93.3 87.5 83.0 75.6 64.1 
Standard error 2.348 6.915 4.188 6.687 7.512 
Table 2: Percentage of live cells in alginate scaffold 
 
It can be observed from figure 38 that in the 2% w/v alginate beads, statistical 
significance was observed between day 0 and day 2, day 7, day 14 and day 21. This means 
that there was a significant drop of live cells at each time point compared to day 0 however in 
the 3% w/v alginate beads, no statistical significance was observed between any of the time 




the 21 days which would imply that the 3% w/v alginate beads were more biocompatible than 
the 2% w/v alginate. 
 
 
Figure 38: Average percentage of live cells over a 21 days period in 2% w/v Sigma 
alginate (top graph) and 3% w/v Sigma alginate (lower graph). Results are expressed as the 





1.3.4 Gelatin scaffold 
1.3.4.1 Gelatin scaffold and Bioplotter parameters 
Briefly, various gelatin concentrations were experimented with, ranging from 10% w/v to 
60% w/v. The 10% w/v - 20% w/v gelatin needed to be heated in order to dissolve them 
completely. The higher concentrations, 30%-60% w/v gelatin, never completely dissolved 
even with heating and so were discarded. The 20% w/v gelatin solution was used as it 
completely dissolved when heated and once in a dissolved state, was viscous enough so that 
flow rate was controllable. During the initial scaffold manufacture, the needle tip was not 
heated and due to this the gelatin would solidify inside the needle and block the flow. This 
problem was dealt with by using an in house wire heater coiled round the needle tip to keep 
the gelatin liquid (figure 39) however this had some limitations as the exact temperature was 
not measured and was only controlled by referring to the temperature vs power graph (Figure 
16). As the wire needed to be coiled all the way down the needle tip, the gelatin was 
occasionally deposited directly onto the wire which solidified the gelatin and disrupted the 
flow of the liquid gelatin being extruded. This was avoided by moving the wire and exposing 
approximately 500μm of needle tip which improved the flow of the liquid gelatin. This 
enabled one to create the first layer of the scaffold however when a second layer was 
extruded on top, it would collapse into the channels created by the previous layer (figure 40). 
This could be avoided by introducing a liquid with a relative density similar to that of the 
gelatin being extruded to provide support for the strand. It was also decided that a cross 
linking agent could be added to further strengthen the gelatin which would provide increased 
mechanical strength. From the literature it was determined that  gluteraldehyde (Yang and Ou 







Figure 39: In house manufactured wire heater for blunt needle 
 
 
Figure 40: Cross-sectional representation of plotted strand collapsing between previously 
plotted layer 
 
1.3.4.2 Gelatin cross-linking and cells 
Briefly, as described in paragraph 1.2.2.4., the two cross-linking agents were made up to 
two different concentrations to determine which on was the least toxic to cells. The two 
gluteraldehyde concentrations were 0.25% and 2.5% and the two transglutaminase 
concentrations were 5U/g and 50U/g. The gelatin was added to the wells and then cross-
linked with the appropriate cross-linking agent. After 7 days the cells were fixed with 




DNA. DAPI can pass through an intact cell membrane and can be used to stain live and fixed 
cells and fluoresces bright blue.  In each field the number of cells was recorded by counting 
the total number of cells which were stained with DAPI (Figure 41). 
As can be seen from figure 41, no statistical significance was observed between the two 
different concentrations of transglutaminase however statistical significance was observed 
between the 5U transglutaminase and both the gluteraldehyde groups.  
An attempt was then made to manufacture gelatin scaffold into a bath of 5U 
transglutaminase however, the desired supporting effect of the solution was not observed 
during strand extrusion. Cross-linking of the gelatin strands was observed however this 
occurred after 2-3 minutes which was too lengthy as the manufacture of the second layer had 
already commenced.  
 





1.3.5 Poly (lactide-co-glycolic acid) (PLGA) scaffold 
1.3.5.1 PLGA scaffold manufacture and Bioplotter parameters 
Briefly, PLGA was dissolved in chloroform to a 20% w/v concentration and extruded 
into a coagulation bath of isopropyl alcohol. Numerous different plotting speeds and 
pressures were attempted ranging from 150 mm/min to 300 mm/min and 0.2 to 0.6 bar 
however after several iterations the plotting speed and plotting pressure that yielded the best 
results were 250 mm/min and 0.22 bar respectively. These parameters were chosen as the 
plotting medium was non-viscous and hence in order to create adequate strands a high 
plotting speed and low pressure were required (Figure 42). This yielded a satisfactory first 
layer but subsequent layers did not plot correctly as the PLGA did not solidify fast enough 
and hence the strand collapsed into the gaps before solidifying. The next step was to increase 
the concentration of the PLGA to 30% in order to increase the viscosity and therefore retains 
the strand morphology which would enable the manufacture of a second layer without 
collapsing into the gaps between strands. However, this was unsuccessful as the increased 
viscosity required and increased plotting speed that then meant the first layer was completed 
more rapidly and therefore did not have time to completely solidify. During scaffold 
manufacturing it was observed that the chemical reaction between the PLGA dissolved in 
chloroform with the isopropyl solvent coagulation bath were not a satisfactory combination 
and hence would not be appropriate for scaffold manufacture. 
 





As the previously mentioned combination of solvent and coagulation bath had limited 
success, PLGA was dissolved in acetic acid to a 20% w/v solution and extruding into 
different coagulation reagents. Firstly isopropyl was used to precipitate the PLGA but this 
yielded a similar result as with the PLGA dissolved in chloroform. Industrial methylated 
spirit (IMS) was then employed which generated promising results as the strands would not 
collapse due to the increased precipitation rate of the PLGA. The scaffolds which maintained 
their geometry and did not experience layer collapse were generated with a plotting pressure 
of 0.05bar and a plotting speed of 202 mm/min and were obtained after substantial iterative 
work and the results can be seen in figure 43.  
 
Figure 43: 20% PLGA scaffolds, a) and b) manufactured with the same plotting pressure 
of 0.05bar and plotting speed of 202 mm/min and four layers high, however a) was plotted on 
a polycarbonate substrate with no Vaseline™ and b) was with a polycarbonate substrate with 
a thin film of Vaseline™ to aid removal of the PLGA scaffold 
 
Once an appropriate plotting speed, pressure, solvent and extruding medium was 




performed to further increase the viscosity of the extruded solution which would render the 
extrusion process more controllable and also to have comparable solution concentrations with 
the polycaprolactone scaffolds. The increased viscosity created problems as a new plotting 
speed and pressure were required as scaffold manufacture using the same plotting parameters 
as the lower concentration yielded inadequate results (Figure 44). After several adjustments 
scaffolds which maintained their layer structure and the geometry were created and can be 
observed in figure 45. After the completion of the scaffolds, they were carefully removed 
from the substrate which was thinly covered with Vaseline™ which aided in its removal and 
immersed in water for 30 minutes to remove any solvent from the scaffold. The scaffolds 
were then placed into a small Petri dish for storage and kept refrigerated at -20ºC until 
required for experiments.   
 






Figure 45: PLGA manufactured to 2mm in height and no collapse of created layers. 
Extruding pressure: 0.27 bar, plotting speed: 163 mm/min 
 
Images of the scaffolds were then taken using the scanning electron microscope (SEM) to 
determine the scaffold geometry (Figure 46). From the SEM images (Figure 46 a) and b)) it 
can be observed that there is good geometry with even spacing between strands and that the 
layers maintain their structure and do not collapse. Figure 46b, also shows small anomalies 
between the perpendicular layers which appear to look like small bubbles which may have 






Figure 46: SEM image of PLGA scaffold 
 
1.3.5.2 PLGA scaffold degradation 
Briefly, PLGA scaffolds were created as mentioned in 1.3.5. and then cut with a scalpel 
(Morton-Swann, UK) to smaller scaffolds with dimensions approximately 4mm x 4mm. 
Thirty five scaffolds were cut so that at the seven different time points (T0, T1, T3, T6, T9, T15 
and T21), five scaffolds were removed and weighed to determine if there was any weight loss 
which would indicate degradation. The table below (Table 3) shows the weights of the 







Weight of scaffold (mg) 
  





Day 0 6.2 6.3 5.8 7.1 6.5 6.38 0.21 
Day 1 5.8 6.1 5.8 6.3 6.1 6.02 0.10 
Day 3 6.0 5.3 5.4 5.9 6.2 5.76 0.17 
Day 6 5.8 5.8 6.0 5.0 6.2 5.76 0.20 
Day 9 6.3 5.9 5.4 6.0 6.2 5.96 0.16 
Day 15 5.5 6.1 5.3 6.8 5.9 5.92 0.26 
Day 21 5.4 6.6 6.9 6.8 5.9 6.32 0.29 
Table 3: Weights of PLGA scaffolds at various time points 
 
 






1.3.5.3 Gelatin coating to enhance cellular attachment to scaffold 
Briefly, an ultra-low binding tissue culture plate was coated with 2 different gelatin 
concentrations (0.1% w/v and 0.2%w/v) in order to determine which coating would increase 
the adhesion of marrow stromal stem cell to the manufactured scaffolds. The wells were then 
examined and the number of cells per field counted which yielded figure 48. Images were 
digitally stored and representative images can be observed in figure 49. 
As can be seen from figure 48, there was a significant difference between the number of 
cells attached to the low-binding tissue culture plate coated with 0.2% w/v gelatin and the 
other two treatments. It can also be seen that there was a significant difference between the 
0.1% w/v gelatin and the non coated plastic. This demonstrates that in coating the low-
binding tissue culture wells with gelatin, significantly increased the number of cells that 
attached to the plastic.  This experiment demonstrated that the 0.2% w/v gelatin coating 
significantly increase cell adhesion and therefore would be used to coat scaffolds prior to 
seeding with cells. 
 
 






Figure 49: Representative images of DAPI stained MSC with different gelatin coatings, 
a) DAPI stained MSCs with no gelatin coating, b) bright field image of MSCs with no gelatin 
coating, c) DAPI stained MSCs with 0.1% gelatin coating, d) bright field image of MSCs 
with 0.1% gelatin coating, e)DAPI stained MSCs with 0.2% gelatin coating, f) bright field 




1.3.5.4 PLGA and PCL with marrow stromal cells 
All data points represented in the standard curve represent the average of 3 wells. The 
standard curve was created from serial dilutions of DNA from herring testis which 
demonstrated a linear relationship between concentration of DNA and fluorescence and 
yielded a linear equation (Figure 50). Using the linear equation obtained from the standard 
curve, measurements of the adhered cell cultures seeded onto the scaffolds and the wells were 
performed using the fluorescence values. This calculation yielded the relationship between 
the cell numbers. Florescence results obtained from the measurements of cultures containing 
the scaffolds were then compared to the known cell number curve which allowed the cell 
number to be determined (Figure 51). 
It can be observed that at the end of the experiment, there were fewer cells in the wells 
where the PCL scaffold was present compared to the wells with the PLGA scaffolds. This 
was because there were a greater number of cells that attached to the PCL scaffold rather the 
PLGA scaffolds. 
 







Figure 51: Cell assay for MSCs seeded on PLGA and PCL scaffolds 
 
1.3.6 Polycaprolactone scaffold 
1.3.6.1 Polycaprolactone scaffold manufacture and Bioplotter parameters 
Briefly, polycaprolactone scaffolds were created by dissolving the polymer in a solvent. 
Various solvents were available hence several needed to be tested to determine which 
performed best. The pure solvents tested were: chloroform, dichloromethane, acetone and 
acetic acid. The dissolved polymer (25 and 30% w/v were tested) was then extruded into a 
bath that would precipitate out PCL. The content of the precipitation bath was a solvent in 
which the PCL was insoluble but in which the dissolving solvent was fully miscible. The 
miscible solvents tested were isopropyl alcohol, methanol, ethanol, water, glycerine, 
industrial methylated spirit (IMS).  
Various concentrations were tested starting at 20% w/v and increasing the concentration 
so that the PCL stayed soluble at room temperature, with different concentrations being 
achieved with different solvents, the highest successful concentration occurred at 30% w/v 




The first test was performed using chloroform as the solvent and polycaprolactone (Mn 
80,000) as the polymer. The PCL was dissolved to a 30% w/v concentration and extruded 
into isopropyl alcohol onto a glass slide, the results of these combinations can be seen in 
figure 52 accompanied by table 4. The inputted scaffold dimensions were 15mm x 15mm but 











a 2.81 170 0.08 6 layers 
b 3.15 150 0.08 5 layers 
c 3.15 105 0.10 8 layers 
d 3.15 115 0.08 
8 layers, 0.3 mm 
offset 
e 3.15 110 0.08 
4 layers, 0.3 mm 
offset 
f 3.20 115 0.08 
12 layers, 0.3 mm 
offset 






Figure 52: First test with 30% PCL Mn 80,000 dissolved in chloroform and extruded in 
isopropyl alcohol 
 
The next set of scaffolds were plotted using a 25% concentration of PCL, the lower 




not have time to solidify and eliminate the regions where structure was lost, results can be 
seen in figure 53 and table 5. 
 













a 3.53 125 0.1 
10 layers, Isopropyl was added while 
plotting and stirred, strand distance 0.6 
mm 
b 3.10 115 0.1 
3 layers, peeled off at side, Isopropyl 
added + stirring, strand distance 0.6 
mm 
c 3.53 125 0.12 
5 layers, Isopropyl added + stirring, 
strand distance 0.5 mm 
d 3.55 125 0.15 
5 layers, 2 drops of Isopropyl added 
during every layer + stirring, strand 
distance 0.5 mm, left in Isopropyl for 
3 min after finished plotting 
e 3.57 125 0.15 
5 layers, 1 drop of Isopropyl added 
whilst plotting on scaffold, strand 
distance 0.5 mm 
f 2.84 125 0.18 
4 layers, on completion left to cure in 
water, 0.3 mm i/d needle 
Table 5: Scaffold manufacturing parameters for figure 53 
 
As can be observed from figure 53, the created scaffolds were still lacking accurate 
strand deposition and a defined geometry. It was then decided to test a different molecular 
number (Mn 42,500) of polycaprolactone to determine if this change would improve the 



















a 3.0 100 0.13 
4 layers, did not fully solidify in 
middle, started peeling of substrate 
and ripped 
b 3.1 115 0.13 
5 layers, centre and top right 
corner loss of strand definition, 
peeling off substrate at tope left 
corner 
c 3.1 115 0.15 
6 layers, top right and centre of 
scaffold fused together no strand 
definition 
d 3.1 115 0.15 
4 layers, 8x8 scaffold, no scaffold 
definition 
e 3.1 121 0.15 
4 layers, 18x18 scaffold, better 
definition, peeled off at corner 
Table 6: Scaffold parameters for figure 54 
 
From these attempts, the main problems were that the extruded strands did not solidify 
fast enough and therefore fused with the previous layer which resulted in the zones where 
there is no strand definition (Figure 54 b, c, d). The other problem was that the scaffolds did 
not adhere to the substrate and peeled off which meant that the scaffold could not be 
manufactured to more than 5 or 6 layers. It was decided to solve the accuracy of scaffold 
manufacture by using different solvents and precipitation baths. Adherence of the scaffold 




For the following tests, a 20% PCL (Mn 80,000) was dissolved in acetone and plotted in 
various precipitation baths, the results and parameters can be seen in figure 55 and table 7 
respectively. 
 

















a 0.6 116 0.1 
12 layers, plotted in 100% ethanol, 
Petri dish coated with Vaseline, 
washed in water on completion 
b 0.6 116 0.1 
4 layers, plotted in methanol, Petri 
dish coated with Vaseline 
c 0.6 116 0.1 
1 layer, plotted in glycerine, no strand 
definition 
d 0.62 116 0.1 
2 layers, plotted in ethanol, Petri dish 
coated with too much Vaseline hence 
peeling of scaffold 
Table 7: Scaffold manufacturing parameters and notes for figure 55 
 
After numerous iterations using acetone as the solvent, it was decided that a different 
solvent for the PCL should be tested as the combination of acetone and the various different 
coagulation baths were not going to yield a satisfactory scaffold.  
Acetic acid was then used as the solvent for PCL polymer with the same reagents as 
previously described in the coagulation baths. The initial test was performed with 20% w/v 
PCL (Mn 10,000) dissolved in acetic acid and extruded in isopropyl (Figure 56a), table 8 
contains additional notes. This produced inaccurate strand deposition and therefore IMS was 
tested as the coagulation agent (Figure 56b). It can be seen from the image that the geometry 
of the deposited strand was more accurate but once the four layers were completed, and the 






Figure 56: 20% w/v PCL (Mn 10,000) dissolved in acetic acid and extruded in a) 










a 0.22 130 0.15 
First layer successfully 
plotted, second layer 
unsuccessful. Extruded in 
Isopropyl alcohol. Very 
brittle 
b 0.36 130 0.13 4 layer, total height of 
0.56mm. Extruded in IMS 
c 0.6 100 0.13 
Attempt to remove 
scaffold from substrate. 
Too brittle 
Table 8: Scaffold manufacturing parameters for 2% w/v PCL dissolved in acetic acid, 




The next test involved the highest average molecular number weight of PCL (Mn 80,000). 
The polymer was dissolved in acetic acid at a concentration of 20% w/v and extruded in 
isopropyl, methanol and 80% ethanol. Results can be observed in figure 57 and table 9 
supplies additional notes.  
For figure 57, it can be seen that the new tested solvent acetic acid, improved the strand 
geometry and therefore scaffold manufacture. This demonstrated that acetic acid was the 
solvent that future scaffold manufacturing processes should employ. However the reagents 
used to solidify the PCL were unsatisfactory. In figure 57e) and f), the manufactured 
scaffolds are well created and no layer collapse or un-solidified strands were observed 
however the removal of the scaffolds from the substrate proved to be difficult. The 
Vaseline™ coating on the substrate had no effect in easing the adhesion of the scaffold to the 
substrate and therefore damage to the scaffold was caused on removal. Due to this IMS was 




















a 0.7 106 0.13 
1 layer, plotted in water in a glass slide, 
peeled off 
b 0.7 100 0.13 1 layer, plotted in isopropyl alcohol on a 
glass slide, did not stick to glass 
c 0.6 100 0.13 
4 layers, plotted in isopropyl alcohol 
directly onto Petri dish, fused to Petri dish 
and could not take off scaffold 
d 0.6 113 0.13 5 layers, plotted in 80% ethanol, washed in 
water after completion of scaffold 
e 0.6 116 0.14 
8 layers, plotted in methanol, PCL solidified 
quickly 
f 0.6 116 0.14 
Scaffold e) to demonstrate thickness of 
1.04 mm 
Table 9: Scaffold manufacturing parameters and additional notes for figure 57 
 
The PCL concentration was then increased to 30% w/v which made the extrusion process 
even more controllable and the type of PCL changed to Mn 42,500. The pressure was then 
increased to 0.71bar and the plotting speed to 120 mm/min, the layer thickness was set at 
0.14 mm, the strand distance 0.6 mm with an offset of 0.3 mm. These plotting parameters 
created the scaffolds that were then used for all the experiments involving PCL scaffolds. The 





Figure 58: a) PCL scaffold, b) view from the top, c) side view 
 
Once PCL scaffolds were created they were then scanned using an SEM and images 
taken (Figure 59). It can be observed that the layers do not collapse and that there seems to be 
satisfactory fusion between layers. The surface of the PCL has a slightly rough appearance 





Figure 59: SEM images of PCL scaffolds, a) Double and single layer scaffold, b) Close-
up of double layer, c) junction of two layers 
 
Summary of results for scaffold manufacturing and cell type 
 Chitosan Alginate Gelatin PLGA PCL 
Concentration 3% w/v 3%, 2% w/v 20% w/v 30% w/v 30% 
Dissolved in 2% v/v acetic 0.9% saline Water Acetic acid Acetic acid 
Extruded in 1% w/v NaOH 
+ ethanol 
0.09% CaCl2 Air IMS IMS 
Cell type used MG63 MG63 MG63 MG63, MSC MG63, MSC 
Zetos™ 
bioreactor 
No No No No Yes 






1.3.6.2 Mechanical testing of Polycaprolactone scaffolds 
As can be seen from figure 60, the DSNO had the highest Young‟s modulus and was 
significantly different compared to the DSNO45 and the DSO45 scaffolds. This result was 
expected as the Double Stranded No Offset (DSNO) creates „columns‟ throughout the 
scaffold which bears the load and therefore rendered the scaffold mechanically stronger in the 
longitudinal direction which in turn increases the Young‟s modulus. It can also be observed 
that the scaffolds without the 45º rotation of the layer had lower Young‟s modulii than 
scaffolds with a 45º rotation of the layer. 
 
 
Figure 60: Young's modulus of double stranded manufactured polycaprolactone scaffolds 
of different geometries 
 
In figure 61, it can be observed that the Single Stranded No Offset (SSNO) had the 
largest Young‟s Modulus for the same reasons as mentioned for the double stranded 








Figure 61: Young's modulus of single stranded manufactured polycaprolactone scaffolds 
with different scaffold geometries 
 
1.3.6.3 In vitro assessment of polycaprolactone scaffolds and marrow stromal cells 
As can be observed from figure 62a, Von Kossa staining can clearly be seen which would 
indicate that under static conditions and in osteogenic differentiation media, MSC are capable 
of producing calcium deposits. It can also be seen from figure 62b, that cells have been also 
stained with DAPI which would indicate that some cells were present at the end of the 
experiment. Figure 62c and 62d, demonstrate that the calcium deposits stained in figure 62a 
are in fact created by the cells and are not some product of other factors i.e. the gelatin coated 
PCL scaffold chemically reacting with the osteogenic differentiation media and 





Figure 62: Representative images taken at x20 of MSCs seeded on PCL scaffolds in 
osteogenic differentiation media stained with a) Von Kossa and b) with DAPI. PCL scaffold 
not seeded with cells in osteogenic differentiation media stained with c) Von Kossa and d) 
with DAPI 
 
1.3.6.4 In vivo assessment of polycaprolactone scaffolds 
As can be seen in figure 63, the scaffolds that were implanted in the calvarial defect and 
seeded with marrow stromal cells produced calcium deposits which can be seen from the Von 
Kossa stain visible as brown in figure 63a. The stained calcium was in direct contact with the 
PCL scaffold visible as the circular shapes. In Figure 63b it can be observed that at the end of 




month experiment in vivo, no toxic by-product was leached out of the scaffold. This could 
entail that further in vivo work could take place. 
 
 
Figure 63: Representative images of polycaprolactone scaffold filling in calvarial defect, 












1.4.1 Bioplotter accuracy of plotted geometries 
Data presented in chapter 1.3.1 demonstrated that the extruded strands created by the 
Bioplotter are slightly smaller than the inputted values with an average of 2% difference. This 
shrinkage was likely due to the contraction of the polycaprolactone on solidification. Another 
factor which may have contributed to the discrepancy of the measurements and the inputted 
data may have been the measurements of distances using the histomorph programme. The 
measurements were obtained manually which involved some inaccuracies when measuring 
the distance between the centre of one strand and the centre of the other. This measuring 
inaccuracy could be avoided it the histomorphometry programme had an option of creating a 
straight line between two points. Furthermore, as the plotted strands were three dimensional, 
obtaining clear and focused pictures on the microscope sometimes proved difficult and may 
have influenced the quality of the measurements. For these reasons, numerous readings were 
taken to try and eliminate these possible errors that would affect the measurements of the 
strand distance and therefore the estimate of the plotting accuracy.  
In work performed by other groups where scaffolds were manufactured using a fibre 
deposition technique similar to the Bioplotter™, accuracy of the extruded strand dimension 
was also investigated (Malda et al. 2005, Moroni et al. 2005, Woodfield et al. 2004). 
Woodfield et al reported manufacturing scaffolds with theoretical strand distances of 500µm, 
1000µm and 2000µm which was the inputted value in the computer aided manufacture 
(CAM) programme. There was no noted discrepancy between the extruded and inputted 
values (Woodfield et al. 2004). Work performed by Moroni et al and Malda et al also 
reported high accuracy of the distances between the extruded strands (Malda et al. 2005, 
Moroni et al. 2005). The plotted material poly(ethylene glycol) terephthalate – poly(butelene 
glycol) terephphalate) (PEGT/PBT) co-polymer used by Woodfield et at and Malda et al, was 
not reported to experience shrinkage during extrusion  as the polymer used for extrusion was 
heated and extruded in a viscous liquid form (Malda et al. 2005, Woodfield et al. 2004). In 
the reported experiments the plotting was not performed in a liquid with the scaffolds 




work undertaken by Nelson et al where the dissolved polymer PLGA was extruded in a 
coagulation bath to precipitate out the polymer, reports of reduced cross-sectional area were 
reported (Nelson et al. 2003). 
 
1.4.2 Chitosan scaffolds 
1.4.2.1 Chitosan scaffold manufacture 
As can be seen from chapter 1.3.2, chitosan scaffolds were successfully created after a 
considerable number of trials and after achieving a balance between the extruding pressure 
and the plotting speed and obtaining a correct concentration of the dispensing material and 
the dispensing medium.  
Three chitosan concentrations were tested, 2% w/v, 3% w/v and 4% w/v dissolved in 2% 
v/v acetic acid. The 4% w/v concentration of chitosan was too high and the chitosan did not 
completely dissolve which made it inadequate for extrusion. The remaining two 
concentrations both completely dissolved and hence were suitable for extrusion but the 3% 
w/v being more viscous was chosen as it was easier to control the flow of the dissolved 
chitosan during extrusion. The successful use of 3% w/v chitosan concentration is in 
agreement with the work done by Ang et al as it was the same concentration used (Ang et al. 
2002).  
The dispensing medium used to neutralise and hence create a gelatinous precipitate of 
chitosan was made up using a mixture of sodium hydroxide (NaOH) and pure ethanol mixed 
in a ratio of 7:3. Through a series of smaller tests, the concentration of sodium hydroxide 
required to yield an effective scaffold was found to be 1% w/v. Higher concentrations such as 
2% w/v and 1.5% w/v were tested but they precipitated the chitosan out of solution too 
quickly and too effectively not allowing subsequent layers to adhere to the already deposited 
chitosan layer. Lower concentrations of 0.5% w/v and 0.75% w/v were also tested however 
they produced the opposite effect of the higher concentrations and did not solidifying fast 
enough resulting in a distorted and non-uniform scaffold. These observations were also 




however was within a range of 0.75 % w/v and 1.5 % w/v (Ang et al. 2002). These findings 
reinforced the results generated by the experiments discussed in this thesis. The only other 
paper that has reported this chitosan manufacturing technique was Ng et al who seeded the 
scaffolds with human dermal fibroblasts (Ng et al. 2004a), however this was part of the same 
team as Ang et al. 
The final parameters used to create a scaffold with a 250 µm needle were dispensing 
pressure of 1.20 bar, dispensing speed 120 mm/min, initial dispensing height of 500 µm, 
layer thickness of 280 µm and strand distance of 630 µm. The parameters used by Ang et al 
were dispensing pressure 3 bar, dispensing speed 360 mm/min and initial dispensing height 
of 200 µm but these differences were expected as the extruding needle used by Ang et al was 
a 30 gauge needle which represents a 150 µm internal diameter. The finer needle tip explains 
the reason for the need of a higher extruding pressure which directly influences the 
dispensing speed. Due to the finer strand being extruded, the starting height was also lower.  
Several papers reported in the literature manufactured chitosan beads cross-linked with 
TPP also reported that this cross-linking agent was more effective in retaining the shape of 
the bead upon manufacture (Durkut et al. 2006, Shu and Zhu 2002, Zhang et al. 2002). In the 
work produced by Shu and Zhu, it was reported that the TPP treated beads exhibited 
increased mechanical strength compared to the other cross-linked beads after being 
lyophilised. This was observed in the manufactured chitosan scaffolds however was not 
investigated further as the scaffolds would not be used dry but in a wet state. It was 
discovered from the in vitro work (see paragraph 1.3.2.2.) that chitosan scaffolds cross-linked 
with TPP in cell culture media lost all mechanical strength after 14 days and therefore would 
render them useless as load bearing scaffolds. In the literature involving chitosan crosslinked 
with TPP, no reference to the mechanical strength was reported once the chitosan had been in 
a wet state furthermore the main application of the chitosan treated with TPP was as a drug 
delivery system (Dung et al. 2007, Shu and Zhu 2002, Vodna et al. 2007). This would imply 
that scaffolds manufactured using chitosan treated with TPP are not capable of being 
manufactured into load bearing structures, however there have been studies where chitosan 




(Zhang and Zhang 2001), gelatin (Liu et al. 2004, Xia et al. 2004) and poly(vinyl alcohol) 
(Park and Kim 2006) to increase the mechanical properties of the structure. 
 
1.4.2.2 In vitro chitosan scaffold and MG63 cells  
The MG63 cells were seeded statically at a density of 250,000 cells per scaffold. As can 
be seen from chapter 1.3.2., cell adhesion to the scaffold was observed as shown by the DAPI 
stained nuclei. This indicated that there was potential for cells survival on the chitosan 
scaffold and therefore possible cell differentiation. Several studies by other groups have also 
demonstrated that cells are capable of adhesion (Ang et al. 2002, Di Martino et al. 2005) and 
proliferation on chitosan (Nettles et al. 2002, Xia et al. 2004). Cell attachment was reported 
by Ang et al who had seeded human osteoblasts onto the manufactured chitosan scaffolds and 
observed the presence and adhesion of cells after four weeks on the scaffold using a scanning 
electron microscope. However interestingly in the study undertaken by Ng et al, very few 
dermal fibroblasts cells were present at the end of the 3 week experiment (Ng et al. 2004b).  
The demonstration of cellular adhesion to the scaffold was a positive outcome however 
after seven days, when an attempt was made to transfer the scaffold to a Petri dish for 
staining; the chitosan scaffold fell apart and had lost all of its structural strength that was 
present at the start of the experiment. Even the scaffolds that were treated with pentasodium 
tripolyphosphate also lacked any structural strength. The scaffolds were then stained in the 
wells after removal of the cell culture media. This ruled out any future work with chitosan as 
a scaffold material to create a load bearing structure using the scaffold manufacturing method 
described in chapter 1.2.2. 
 
1.4.3 Alginate scaffolds 
1.4.3.1 Alginate scaffold manufacture 
As can be seen from chapter 1.3.3., alginate was successfully used to manufacture a 




2005) and is to the author‟s knowledge, the only paper where alginate has been extruded to 
produce a 3D scaffold. The sodium alginate was dissolved using sterile distilled water in 
several different concentrations from 2% w/v, 3% w/v and 4% w/v however the 3% w/v 
alginate solution was used for scaffold manufacture as it was more viscous and therefore 
would render the extrusion process more controllable. The same concentration was used by 
Khalil et al for alginate scaffold manufacture (Khalil et al. 2005). The optimal dispensing 
solution was created by testing various calcium chloride concentrations that ranged from 
0.09% w/v to 5% w/v by attempting to plot a scaffold. Higher concentrations i.e. 2% w/v to 
5% w/v solidified the alginate too quickly and also had a secondary effect where the 
solidified strand would float to the surface of the bath however this was not reported by the 
work performed by Khalil et al. The calcium chloride concentration was then lowered to 
0.09% w/v and 1% w/v to observe the consequences that this would have on the solidification 
rate and the floating effect of the strands. Reducing the calcium chloride concentration helped 
in several ways to reduce the solidification rate and enabled a second layer to be plotted and 
also delayed the floating effect, which also allowed a second layer to be plotted but when a 
third layer was plotted, the scaffold again detached from the substrate and floated to the 
surface. This problem was investigated further by attempting to anchor the strands to the 
substrate by changing the material of the substrate. Several materials were tested including 
Petri dish plastic, a glass slide, aluminium and polycarbonate but these attempts were 
unsuccessful. The substrates were then coated with Vaseline™ which would roughen the 
surface and aid strand adherence but this did not improve anchorage of the initial strand. The 
problem was finally overcome by developing a plotting technique that was named the 
„shallow bath‟ technique. This process involved having the plotted strand solidifying at the 
surface of the bath and when the layer was finished and the next was to be created, a few 
drops of calcium chloride were added so that this layer was being solidified at the surface. 
This technique was then repeated for every new layer. The three different alginate 
concentrations were successfully plotted into scaffolds using the „shallow bath‟ technique. 
After several intermediate experiments, the concentration of calcium chloride used was 
0.09% w/v as it would solidify the strands slow enough to enable the layers to fuse and also 




Once the scaffolds were completed, they were transferred to a 1% w/v calcium chloride bath 
for further solidification. 
In the study performed by Khalil et al and the scaffold manufacturing parameters 
reported in section 1.2.2.3, several similarities were observed. The alginate concentration 
used for extrusion (3% w/v alginate aqueous solution) and the needle internal diameter 
(200μm) were the same, however the calcium chloride concentration used to cross-link the 
alginate was 5% w/v (Khalil et al. 2005) compared to 0.09% w/v reported in 1.2.2.3. This 
large difference in calcium chloride concentrations suggests that the chemical composition of 
the alginate used in the study performed by Khalil et al was different to the alginate supplied 
by Sigma, UK.  
 
1.4.3.2 Alginate beads and marrow stromal cells 
Alginate beads were created that contained marrow stromal cells. The cells present in the 
scaffolds were stained with DAPI and PI and a cell count was performed to determine 
whether there is a difference between 2% w/v and 3% w/v alginate. From section 1.3.3 it was 
observed that in the 2% w/v alginate beads, statistical significance was observed between day 
0 and day 2, day 7, day 14 and day 21. This implied that there was a significant drop of live 
cells at each time point compared to day 0 however in the 3% w/v alginate beads, no 
statistical significance was observed between any of the time points. This result suggests that 
the number of live cells does not statistically decrease during the 21 days which would imply 
that the cells encapsulated in the 3% w/v alginate beads had a better survival rate than in the 
2% w/v alginate. This was supported by other work in the literature where 3% w/v alginate 
was used. In work performed by Khalil et al where human fibroblast cells were encapsulated 
and extruded in the alginate, cell survival was reported to be at 85% after 7 days 
encapsulation (Khalil et al. 2005). This concentration was also used in work performed by 
Wang et al, where murine bone marrow cells survived after 12 days encapsulation (Wang et 
al. 2003b). However the main difference was that the alginate used in both reported cases was 
an ultra pure form supplied by ProNova Biomedical. In other work reported in the literature, 




2% w/v and 3% w/v had similar properties when cells were encapsulated with 85% cell 
viability at the end of the experiment compared with 70% cell viability in the 5% w/v alginate 
(Wang et al. 2003a). In other studies, 2% w/v alginate concentration was used  and a good 
cell survival was reported (Kong et al. 2003, Simmons et al. 2004) however the alginate 
underwent an irradiation step to reduce the molecular weight and the alginate used was of a 
purer grade. The alginate beads were not sectioned due to technical reasons. 
 
1.4.4 Gelatin scaffold 
1.4.4.1 Gelatin scaffold manufacture 
Gelatin scaffolds were not successfully manufactured by extrusion due to several factors. 
Firstly gelatin was dissolved in sterile distilled water at various concentrations ranging from 
10% w/v to 60% w/v. At concentrations between 30% w/v and 60% w/v the gelatin never 
completely dissolved rendering it inadequate for extrusion. Concentrations below that range 
did eventually dissolve when heated but when allowed to reach room temperature, the gelatin 
would solidify. This meant that the gelatin needed to be heated using the syringe heating 
jacket to keep the gelatin in a liquid state which occurred at around 40ºC. Once the gelatin 
reached its liquid state a dispensing needle was fastened via a luer lock to the syringe body 
and the gelatin was ready to extrude. The 10% w/v and 15% w/v concentrations were heated 
to their melting points however the gelatin solution became very liquid and therefore exited 
the needle tip without any pressure being used. The concentration was increased to 20% w/v 
gelatin which was viscous enough not to exit the syringe under its own weight and hence was 
viscous enough to be controlled while plotting. During the extrusion of the gelatin strand, the 
gelatin as it was being forced out of the needle tip would cool down and solidify in the needle 
which blocked the flow of the extruding material. This was dealt with by producing a wire 
heater around the needle tip (see chapter 3.4.1). This helped with the fluidity of the gelatin 
but created other problems that involved the liquid gelatin solution on extrusion being in 
direct contact with the heating wire which evaporated the water leaving solid gelatin that 
disrupted the flow. Various attempts were tested to minimise this effect by raising the needle 




extrusion was then disregarded as a viable method of manufacturing a gelatin scaffold and to 
the author‟s knowledge, no scaffolds have been created by extrusion of heated gelatin in the 
literature, however other gelatin scaffold fabrication methods were observed. The two mainly 
discussed techniques for gelatin scaffold manufacture in the literature were electrospinning 
(Thomas et al. 2007, Venugopal et al. 2008) and gelatin sponges (Hong et al. 2005, Kang et 
al. 2006, Rohanizadeh et al. 2008) however, scaffolds manufactured using the electrospinning 
technique used a polymer-gelatin blend, such as polycaprolactone (Chong et al. 2007, 
Venugopal et al. 2008), polyglyconate (Thomas et al. 2007), poly(lactide-co-glycolide) (Li et 
al. 2006) to increase the mechanical properties. In work performed by Hong et al and 
Rohanizadeh et al, the gelatin sponges used were commercial products (Gelfoam) and not 
manufactured by the groups however in Kang et al, gelatin scaffolds were manufactured 
using the particle leaching technique (Kang et al. 2006). This demonstrates that in order to 
manufacture gelatin scaffolds, electrospinning or particle leaching technique could be used 
however heated gelatin extrusion technique was unsuccessful. 
The next technique considered was to extrude a lower concentration of liquid gelatin into 
a cross-linking solution such as glutaraldehyde or transglutaminase (McDermott et al. 2004). 
This was first attempted by manufacturing gelatin scaffold into a bath of 5U transglutaminase 
however, the desired supporting effect of the solution was not observed during strand 
extrusion. Cross-linking of the gelatin strands was observed however this started occurred 
after 4 minutes  (Bertoni et al. 2006) which was too lengthy as the manufacture of the second 
layer had already commenced. Glutaraldehyde was also considered however this was deemed 
toxic to cells (Khor 1997) and due to its toxic nature considerable improvements to the 
Bioplotter™ would be required  and a fume extractor for the gluteraldehyde fumes would 
need to be installed. 
 
1.4.4.2 Gelatin cross-linking and cells 
Data presented in section 1.3.4.2, demonstrated that significantly more cells were present 
on the transglutaminase cross-linked gelatin compared to the gluteraldehyde crosslinked 




 The different effects between the two cross-linking agents was also reported in a study 
investigating the cellular effects of transglutaminase and gluteraldehyde (Bertoni et al. 2006, 
Chau et al. 2005, Yung et al. 2007). This result was not surprising as gluteraldehyde is a 
fixative and toxic to cells in high concentration (Bertoni et al. 2006). It can also be observed 
that the gelatin treated with transglutaminase had a higher cell count than the non cross-
linked control group this may have been associated with a higher proliferation rate during the 
experiment. Work undertaken by Chau et al demonstrated that human osteoblasts seeded on 
transglutaminase treated gelatin had an increased rate of proliferation compared to non-
treated gelatin. From these results, it can be concluded that 5U transglutaminase was a less 
toxic cross-linking agent as statistical significance was observed between the 5U 
transglutaminase group and the two concentrations of gluteraldehyde and the control. 
However work produced by Ito et al, compared three different concentrations of 
transglutaminase (0.5U, 1U and 2U) and reported that 1U transglutaminase was the optimum 
concentration to cross-link 5% w/v gelatin to increase fibroblast proliferation (Ito et al. 2003).  
 
1.4.5 Poly (lactide-co-glycolic) acid (PLGA) scaffolds 
1.4.5.1 PLGA scaffold manufacture 
PLGA scaffolds were successfully created by dissolving the polymer in glacial acetic 
acid and creating a 30% w/v solution and extruding it in a bath of industrial methylated spirit 
(IMS). Several different solvents were used to dissolve the PLGA including chloroform 
(Nelson et al. 2003), acetone (Williamson and Coombes 2004) and acetic acid (Blanco-Prieto 
et al. 2000, Godbee et al. 2004, Notin et al. 2006) and coagulation baths were also tested as 
can be seen in chapter 1.3.5. In work presented by Nelson et al, fibres were created using a 
wet spinning technique where PLGA was dissolved in chloroform at a concentration of 20% 
w/v and extruded into a tube containing the coagulation agent isopropyl. When scaffolds 
were manufactured using the same solvent and coagulation bath, strands were created which 
was also obtained in Nelson et al however when attempts were made to extrude a second 
layer, the latter collapsed into the gaps of the initial layer. In view of this, PLGA was then 




structurally sound scaffolds. The SEM pictures also demonstrated that the created scaffold 
had good geometry, it also showed that there was good fusion between layers and that the 
surface of the PLGA scaffold strands were smooth which was also observed by Nelson et al 
even though a different solvent and coagulation bath reagent was used (Nelson et al. 2003).  
The degradation of PLGA scaffolds as seen in chapter 1.3.5 conformed with other work 
in the literature (Chen et al. 2004, Lu et al. 2000). The experiment performed in this thesis 
lasted 3 weeks however in previous studies degradation of PLGA was not observed until 
week 10 (Chen et al. 2004, Lu et al. 2000). This explains why no significant decrease in 
weight was observed during the three week long experiment. An issue with the experiment 
was that when the scaffolds were cut down to size, the smaller scaffolds were not identical. 
This explains why the mean weight of the scaffolds at day 21 where greater that at any other 
time point except day 0. 
This experiment showed that there was no degradation during the 21day experiment and 
in order to witness degradation, the experiment would have to last a minimum of 10 weeks as 
was reported in the literature. 
 
1.4.5.2 PLGA and marrow stromal cells 
As seen in paragraph 1.3.5.4, the standard curve generated by using DNA from herring 
testis yielding a linear curve which was what previous literature suggested (Rago et al. 1990). 
Freezing cell cultures after incubation yielded a linear relationship between fluorescence and 
cell number. The freeze – thaw technique did not require any mixing as the cells are lysed 
and created a crude cellular homogenate (Schirmer et al. 2004). The processing time was 
minimal and the reactions did not require any dangerous reagents. The tissue culture plates 
were stored in -80ºC and therefore experiments can be batched and analysis performed 
simultaneously eliminating any inaccuracies that may occur between experiment analyses 
(Rago et al. 1990). The cell adhesion and viability comparison of the two scaffold materials 
yielded different results. From the DNA assay, the number of cells that remained attached to 




mean that more cells were attached to the PCL scaffold compared to the PLGA scaffold. This 
was an interesting and positive outcome regarding the cell adhesion to polycaprolactone 
coated with gelatin. In work performed by Chastain et al where the osteogenic potential of 
PLGA and PCL was compared, marrow stromal cells seeded on PLGA scaffolds were 
reported to significantly upregulate osteocalcin gene expression levels (noncollagenous 
protein found in bone and dentin and secreted by osteoblasts) and in contrast osteocalcin was 
markedly downregulated in the PCL scaffold (Chastain et al. 2006), however no significant 
difference was observed on the number of cells that attached to the two different scaffold 
materials. This could be due to the manufacturing process of the scaffolds which involved a 
particle leaching technique which creates randomly distributed pores which may have trapped 
the cells during seeding and therefore not recorded a difference of cell number and the two 
types of polymers. 
  
1.4.6 Polycaprolactone scaffolds 
1.4.6.1 Polycaprolactone scaffold manufacture 
As with PLGA various solvents and coagulation baths were tested to determine which 
combination produced the most geometrically sound scaffolds. It was concluded that the best 
results were obtained by dissolving the PCL in acetic acid (Sarasam and Madihally 2005) in 
order to yield a concentration of 30% w/v. The dissolved polymer was then extruded in a bath 
of IMS to precipitate out the PCL. These parameters were concluded after a lot of iterative 
work as can be seen in section 1.3.6. 
The first test involving polycaprolactone (PCL) was performed by dissolving the polymer 
(Mn 80,000) in chloroform and extruding it into isopropyl alcohol (Nelson et al. 2003). The 
initial results were promising as strands were created and this showed that this technique had 
potential. After numerous attempts where changes were made to the polymer average 
molecular number weight, concentration and with changes to the pressure and plotting speed 
it was concluded that this combination of solvents would not yield a satisfactory scaffold 




however scaffolds manufactured with this solvent were not created correctly as the geometry 
of the strands was distorted. It was also discovered that the polymers precipitated out after 
several hours and created a white cloud in the stock solution. This was unsatisfactory as 
during extrusion, the precipitate would affect the plotting parameters and would alter the 
concentration of the plotting solution. 
After numerous attempts the most successful results were obtained with acetic acid 
(Sarasam and Madihally 2005) and IMS. As can be seen from figure 58, structurally the 
scaffold displayed no collapse of the any layers and there was clear fusion of layers (Figure 
59) which was reinforced by the SEM images. Figure 59c shows that the surface is rough 
which might be an advantage for cell adhesion which was mentioned in the literature 
regarding polycaprolactone scaffolds (Ciapetti et al. 2003). Alternative manufacturing 
methods for polycaprolactone scaffolds have been reported in the literature, these included 
electrospinning (Khil et al. 2005, Ma et al. 2005, Thomas et al. 2006), particle leaching (Hou 
et al. 2003), selective laser sintering (Tan et al. 2005a, Williams et al. 2005) and fused 
deposition modelling (Ramanath et al. 2008, Shor et al. 2007, Zein et al. 2002) however 
electrospinning and particle leaching yields random scaffold geometries and pore size cannot 
be controlled in contrast selective laser sintering and fused deposition modelling created well 
defined scaffold geometries with user defined scaffold parameters (Hutmacher 2001). 
 
1.4.6.2 Mechanical testing of manufactured polycaprolactone scaffolds 
As can be seen from the results section 1.3.6.2, the double stranded (DSNO) with a 
Young‟s modulus of 3.2 ± 0.22 MPa and the single stranded with no offset (SSNO) with a 
Young‟s modulus of 2.0 ± 0.12 MPa had the highest Young‟s modulus in their respective 
groups (Moroni et al. 2006, Zein et al. 2002). This was expected as both the scaffolds with 
„no offset‟ created „columns‟ throughout the scaffold which bore the load and therefore 
rendered the scaffold mechanically stronger in the longitudinal direction which in turn 
increased the Young‟s modulus. It was also observed that the double stranded scaffolds with 
offset and with the 45º rotation of the layer (DSO45) had the lowest Young‟s modulus in that 




rotation of the layer (SSO45) where it had the second highest Young‟s modulus value. This 
result is due to the scaffold being double or single stranded. In the double stranded scaffolds 
(DSO45) because there are two layers extruded on top of each other this effectively creates a 
taller strand and therefore a taller layer, this then implies that there are less changes in layer 
direction, i.e. from 0º to 45º to 90º etc… which meant that when the scaffold was compressed 
in a vertical direction, naturally the scaffold will also rotate and because there were less 
changes in layer direction, this weakens the scaffold which lowers the Young‟s modulus 
(Moroni et al. 2006). However in the single stranded scaffold (SSO45), these changes in layer 
direction occur at every layer rendering the scaffold more resistant to rotations of the layers 
and therefore when compressed the Young‟s modulus remained higher.  
It was also observed that the double stranded with offset (DSO) had the second highest 
Young‟s modulus however the single stranded offset (SSO) had the lowest in its group. This 
can be explained as in the double stranded scaffold with offset (DSO) the double layer 
strengthens the scaffold however in the single stranded with offset (SSO) the single layer in 
weak when compressed which in turn reduces the Young‟s modulus. 
The Young‟s modulus obtained from the mechanical testing of the various scaffolds gave 
in some cases similar results to what exists in the literature. In work performed by Shao et al, 
particle leaching was used to obtain a porous polycaprolactone scaffold which yielded a 
scaffold with a Young‟s modulus of 0.81 MPa (Shao et al. 2006a). These scaffolds involved 
dissolving the polymer in a solvent and adding the particles to be leached out and were 
intended for the regeneration of cartilage. In work published by Thomas et al, the 
electrospinning technique was used to generate scaffolds with a Young‟s modulus of between 
6.12 MPa and 11.93 MPa (Thomas et al. 2006). In work published by Zein et al and 
Hutmacher et al, fused deposition modelling was used to create scaffolds which involved 
heated polycaprolactone and extruding it layer by layer into a 3D scaffold. The mechanical 
properties of the single strand no offset scaffold (SSNO) was reported to be 69.2 ± 3.6 MPa 
and when a rotational layer was introduced, the Young‟s modulus was reduced to 47.1 ± 1.9 
MPa (Zein et al. 2002). In work presented by Shor et al, fused deposition was also used and 
single stranded scaffolds manufactured with Young‟s modulus of 30 MPa and it was also 




modulus to 76 MPa (Shor et al. 2007). In the published work by Thomas et al and Shao et al, 
the PCL was dissolved in a solvent in order to manufacture 3D scaffolds which mechanically 
alter the properties of the PCL therefore reducing the Young‟s modulus of the scaffolds. This 
result was observed in the work presented in this thesis. In comparison work by Zein et al, 
Hutmacher et al and Shor et al, the PCL was heated and extruded in a molten state which did 
not alter the mechanical properties. This was also observed and results can be seen in chapter 
2. It has also been reported that the Young‟s modulus of trabecular bone from human 
mandibles ranged from 3.5 to 125 MPa (Misch et al. 1999) therefore from the mechanical 
characterization, it can be concluded that the PCL scaffolds have the potential to be applied in 
tissue engineering of bone and cartilage.  
 
1.4.6.3 In vitro assessment of polycaprolactone scaffolds and marrow stromal cells 
As can be observed from section 1.3.6.3., Von Kossa staining was clearly seen to be 
present on the section of the scaffold. This demonstrates that MSCs are capable of forming 
calcium deposits under static conditions and in osteogenic differentiation media. The section 
stained with DAPI also demonstrates that cells were present at the end of the experiment. 
Similar results showing good biocompatibility of PCL in combination with human cells have 
been observed by other groups (Marra et al. 1999, Mondrinos et al. 2006). Osteoblastic 
differentiation of MSCs seeded on a PCL scaffolds was observed after 15 days (Endres et al. 
2003). In another group electrospun PCL scaffolds seeded with MSCs mineralized and extra 
cellular matrix was observed after 4 weeks (Shin et al. 2004). In work presented by Darling 
and Sun, it was reported that PCL scaffolds manufactured by precision extrusion deposition 
supported the proliferation of cultured rat cardiomyoblasts, however no detailed analysis of 
cellular metabolism and proliferation were not provided (Darling and Sun 2004). Hutmacher 
et al used primary human fibroblasts and human osteoprogenitor cells to demonstrate the 
biocompatibility of PCL scaffolds however the capacity of these scaffolds to induce bone 
formation was not addressed (Hutmacher et al. 2001b). Marra et al concluded from their two-




growth (Marra et al. 1999). It can be conclude from the data that PCL scaffolds demonstrated 
good biocompatibility for hard tissue formation when seeded with MSC. 
 
1.4.6.4 In vivo assessment of polycaprolactone scaffold 
As can be observed from section 1.3.6.4., the scaffolds implanted into the calvarial defect 
showed deposits of mineralized residues, as shown by the Von Kossa stain which further 
confirmed that the 3D environment was conducive to osteogenesis which has also been 
observed in other studies (Schantz et al. 2003). The scaffolds provided a suitable environment 
for the MSC to differentiate into osteoblasts in the absence of differentiation medium as in 
the in vitro experiment. A similar enhanced osteoblast differentiation was observed in 
polymer scaffolds (Ishaug et al. 1997). Previous reports showing that PCL scaffolds 
fabricated using various manufacturing processes displayed good biocompatibility in vivo. 
Williams et al, used selective laser sintering (SLS) to manufacture PCL scaffolds that were 
seeded with human fibroblasts genetically modified to express bone morphogenic protein-7 
(BMP-7) and implanted into subcutaneous pockets of immunocompromised mice. These 
scaffolds supported the development of new bone over a period of 4 weeks as demonstrated 
by μCT detection of mineralized tissue (Williams et al. 2005). Experiments involving PCL 
scaffolds have been reported in the literature where models of human phalanges and small 
joints were seeded with bovine periosteum cells and implanted in nude mice (Landis et al. 
2005). In the 15 month long study performed by Landis et al, bone formation was observed 
and no toxic effect of the PCL scaffold was reported. In vivo repair of osteochondral defects 
have also been reported in the literature (Shao et al. 2006b, Swieszkowski et al. 2007) with 
positive results. Shao et al demonstrated that a hybrid PCL scaffold/cell construct could 
promote functional and structural repair of a critical size osteochondral defect in the first 3 
months. It can be conclude from the current work, that the PCL scaffold demonstrated 







A scaffold manufacturing technique using the Bioplotter™ was investigated and 
successfully applied in this research to produce novel 3D scaffolds with fully interconnected 
channel networks and highly controllable geometry. Several different materials including 
chitosan, alginate, poly(lactide-co-glycolide) (PLGA) and polycaprolactone (PCL) were 
effectively manufactured into scaffolds by a computer controlled extrusion and deposition 
method. Scaffolds were made of layers of aligned microfilaments within a geometrical 3D 
structure. Analysis of the mechanical properties of the PCL scaffolds contributed to a better 
understanding of the nature of the different designs. The mechanical properties were found to 
generally depend on the layer pattern which was in agreement with theoretical concepts on 
structural properties. The efficacy of scaffold manufacturing technique has been proven by 























Chapter 2.  













Mechanical strain is an important consideration when trying to induce cell differentiation 
and it would be very useful to control and measure strain in scaffolds. This would enable the 
optimum scaffold geometry and material to be determined. Several techniques exist to 
measure strain, the most common is the strain gauge which relies on a small metal foil pattern 
which is attached securely to the surface of the material to be measured, when deformation 
occurs, the resistance of the metal foil changes and hence strains can be measured. This 
technique has been used on numerous occasions to determine the strains generated during, 
bone remodelling (Szivek and Magee 1989), loading of the temporomandibular joint 
(Throckmorton and Dechow 1994), in vivo axial strain of a human femur (Aamodt et al. 
1997) and tibia (Funk and Crandall 2006). However due to the size of the strain gauge which 
is approximately 10mm x 10mm, it is not a suitable method for measuring strains generated 
in scaffolds.  
Another method used for measuring strain is the laser speckle interferometry. This 
technique relies on the interferometric properties of coherent light (laser) to measure the 
direction and extent of deformations occurring in an object when a force is applied to it and 
has been used to measure strain in mandibular joints, long bones and the skull (Horta et al. 
2003, Kragt et al. 1982, Roman et al. 1999, Sanghavi et al. 2004, Zaslansky et al. 2005). This 
technique is highly sensitive and is able to measure small deformations (Verrue et al. 2001). 
Unfortunately due to the inherent nature of the technique, strains generated inside the scaffold 
could not be measured as the laser beam could not reach the scaffold strands situated at the 
centre. 
However, finite element method (FEM), which has been successfully applied to the 
mechanical study of stresses and strains in engineering, renders it possible to transpose the 
technique to a biomechanical situation. An important advantage of this technique is the 
ability to determine the strains and stresses that occur inside a scaffold during loading and 
simulate various loading situations once an adequate finite element model is created. FEM 
has been used to determine the mechanical properties of library of various scaffolds (micro-




et al. 2005). Young‟s modulus of porous calcium phosphate scaffolds (Lacroix et al. 2006) 
and an extruded hot melt polycaprolactone scaffold (Fang et al. 2005) were reported. Finite 
element analysis has also been reported to determine the stresses and strains in an in vivo 
cyclically compressed poly (lactide-co-lactide) scaffold (Duty et al. 2007). 
 
2.1.1 Basic concept and background of the finite element method 
Finite element analysis (FEA) is a computer based numerical technique while finite 
element method (FEM) is considered as the methodology by which the analysis is converted 
into a set of simultaneous equations. 
The finite element method of analysis is a very powerful and modern computational tool 
as it is non-destructive analytical method that yields very useful insights into structures. The 
method has been used globally during the past 50 years to solve very complex engineering 
problems, particularly in the structural engineering (Sarkani et al. 2000, Thevendran et al. 
1999, Yang et al. 2000), automotive (Alaylioglu and Ali 1978, Rao and Muthuveerappan 
1993) and aircraft industry (Giglio 1999). It has now gained wide acceptance in many other 
disciplines such as thermal analysis (Jaafar et al. 2007), fluid mechanics (del Coz Diaz et al. 
2007), electromagnetic (Garcia-Castillo et al. 2005), biomechanical analyses (Huiskes and 
Chao 1983, Kolston and Ashmore 1996, Korioth and Versluis 1997a) and physical 
anthropology (Ryan and Rietbergen 2005). The basic idea of the finite element method is to 
solve a complex problem by simplifying it. Because the actual problem is simplified and 
assumptions are made, only an approximate solution is created however this can be refined 
by using more computation effort.  
Although the name finite element method has only recently been utilised, the concept has 
been used for several centuries. Ancient mathematicians found the circumference of a circle 
by approximating it as a polygon (Figure 64). By considering the polygon S 
(u)
 one can obtain 
an upper bound and by considering S 
(l)
 one can obtain the lower bound of the circle 
circumference S. As the number of sides of the polygon increase, the approximate value 




An approach similar to finite element method which involves the use of continuous functions 
defined over triangular regions was first suggested by Courant in 1943 in applied literature of 
mathematics (Courant 1943). The finite element method that is known today, was presented 
by Turner et al in 1956 in which the application of simple finite elements for the analysis of 
aircraft structure was suggested (Turner et al. 1956). This work was widely considered as one 
of the key contributions in the development of finite element method. With the invention of 
the computer, a rapid way of performing the numerous calculations involved in the finite 
element analysis (FEA) was developed, making the method practically viable.  
 
Figure 64: Lower and upper bounds to circumference of a circle 
 
With the continuous development and increased processing power of computers, the 
application of the finite element method also progressed at a rapid rate. The finite element 
method started being presented as a solution to stress analysis problems (Przemieniecki 1968) 






Figure 65: Triangular element with three nodes 
 
2.1.2 Finite element method 
The fundamental idea behind the finite element method is to divide the body, structure or 
region that requires analysing into a vast number of finite elements. These elements may be 
one, two or three dimensional. A widely used two dimensional element is the triangle (Figure 
65). When a two-dimensional (2D) structure is divided into hundreds or even thousands of 
these non-overlapping triangles it can be observed that all planar geometries can be divided 
into finite elements. The particular element has three nodes (a, b, c) placed at the vertices of 
the triangle (Figure 65). 
For illustration, figure 66a shows an irregular shaped plate which will be divided and 
represented with the use of finite elements (figure 66b).  
 





If the stress distribution for the above plate was required, the field variable of interest is 
the stress however because there are an infinite number of points in the plate there also are an 
infinite number of stresses to be measured. This problem can therefore be said to have an 
infinite number of degrees of freedom. Instead of requiring that the stress be determined at 
every point in the plate which is an unreasonable option, let the stress be determined at a 
finite number of points. The points used are the interconnected joints of the triangular 
elements known as nodes or nodal points. The nodes lie on the element boundary where 
adjacent elements are connected. It should also be noted that the curved boundaries are 
approximated by the several triangular elements (Figure 66b). The finite element method will 
only provide the stresses of the plate at the nodal points. Knowledge of the stresses at the 
nodal point (nodal stresses) will permit one to determine the general stresses within the 
region. 
In order to obtain a solution of a more general problem by the finite element method 
where different field variables such as displacement, temperature, velocity or pressure are 
involved, the process involved always follows a step by step method. The procedure can be 
divided in six steps: 
 Discretization of the model, i.e. replacing an infinite dimensional linear problem with 
a finite dimensional version  
 Selection of a proper interpolation model 
 Derivation of element stiffness matrix and load vectors 
 Assembly of an element equation to obtain the overall equilibrium 
 Solution of the unknown nodal variables 
 Computation of the element strains and stresses  
These will be discussed in the following section. 
 
2.1.2.1 Discretization 
The discretization of the body into finite elements is the first step in the finite element 




having a finite number of degrees of freedom. The shapes, sizes, number and configuration of 
the elements have to be selected carefully so that the original body is simulated as closely as 
possible. 
 
2.1.2.1.1 Basic element shapes 
For any given model, a certain amount of judgement needs to be used when selecting the 
appropriate elements for discretization. The choice of the type of element is dictated by the 
geometry of the model and the number of special coordinates required to describe the system 
i.e. whether the model is in one-, two- or three-dimensions, with some of the most commonly 
used elements shown in figure 67, 68 and 69. 
  
 
Figure 67: a) One-dimensional element, b) schematic representation of a) 
 
When the geometry of the model, material properties or other parameters such as stress, 
displacement, pressure or temperature can be modelled in terms of only one spatial 
coordinate, the one-dimensional element can be used (Figure 67). Although the element has a 






Figure 68: Two-dimensional finite elements, a) triangular element, 
b) quadrilateral (rectangular) element 
 
In certain models, the cross-sectional area of the element vary along the length and when 
the configuration and other parameters (i.e. stress, displacement, pressure and temperature) of 
the model can be described in two independent spatial coordinates, a two-dimensional 
element is required (Figure 68). The basic element useful for two dimensional analysis is the 
triangular element (Figure 68a), although the quadrilateral element (or its special forms, i.e. 
rectangle (Figure 68b), and parallelogram) can be obtained by combining two or four 
triangular elements, in some cases the use of the quadrilateral (in particular rectangular) 
elements proves to be advantageous when modelling rectangular models. If the geometry, 
material properties and other parameters of the model can be described in three independent 
spatial coordinates, the three-dimensional elements can be used. The basic three-dimensional 
element, analogous to the triangular elements in the two-dimensional case is the tetrahedron 
element (Figure 69a), whereas in some cases, the rectangular prism provides an advantageous 






Figure 69: Three-dimensional finite elements, a) tetrahedron, b) rectangular prism 
 
 
Figure 70: Three-dimensional solid elements for idealization of short beam, a) original 





2.1.2.1.2 Size of elements 
The size of elements needs to be selected carefully as it will have a direct influence on 
the convergence of the solution. If the size of the element is small, the final solution would be 
expected to be more accurate, however the smaller elements are this will have a direct impact 
on the length of time required to solve the problem (Clough 1969). 
 
2.1.2.1.3 Location of nodes 
If the model has no abrupt changes in geometry and material properties, the model can be 
divided into equal sub-divisions and hence the spacing of the nodes can be uniform (Figure 
71a). If discontinuities are present, nodes need to be introduced at these discontinuities 
(Figure 71b). 
 
Figure 71: Location of nodes, a) uniform spacing, b) discontinuity in geometry 
 
2.1.2.1.4 Number of elements 
The number of elements chosen for idealization is related to the accuracy required and 
the size of elements involved. An increased number of elements generally yield more 
accurate results however for any given problem there will be a certain number of elements 
beyond which the accuracy cannot be considerably improved, a graphical representation of 





Figure 72: Effect of varying the number of elements on solution with no considerable 
improvement beyond N 
 
2.1.2.2 Interpolation model selection 
The idea of the finite element method is to obtain an approximation to a complicated 
problem by dividing the region of interest into finite elements and approximating the solution 
over each sub-region by a simple function. The nodal points of the elements offer strategic 
points for writing mathematical functions to describe the shape of the distribution of the 
unknown quantity over the domain of the elements, therefore an important and necessary step 
is the choice of a simple function for the solution in each element. The functions used to 
represent the behaviour within the elements are known as interpolation functions or 
approximating functions. A number of mathematical functions such as polynomials and 
trigonometric series can be used for this purpose, especially polynomials due to the simplicity 
of simplification and the ease of performing differentiation and integration. The accuracy of 
the result can be improved by increasing the order of the polynomial (Figure 73) therefore 
theoretically a polynomial of infinite order corresponds to the exact solution but in practice, 
polynomials of finite order are used. Although trigonometric functions possess some of the 
polynomial properties, they are seldom used in finite element analysis as these functions are 
difficult to manipulate mathematically in complex models (Krahula and Polhemus 1968). The 





Where  denotes the unknown and where , denote the values of the 
unknowns at the nodal points and  are the interpolation functions.  
 
Figure 73: Polynomial approximations 
 
For example in the case of a planar deformation problem where there are only two 
displacements at each node, the line element (Figure 67) with two end nodes will have u1 and 
u2 as degrees of freedom or unknowns, for the triangular element (Figure 68a), there will be 
six degrees of freedom or unknowns, u1, u2, u3, … , u6. A degree of freedom can be defined as 





2.1.2.3 Derivation of element stiffness matrix and load vectors 
By applying known laws and principles, equations can be obtained that govern the 
behaviour of the element. The equations are obtained in general terms and therefore can be 
used for all elements in the discretized model. A number of possibilities exist for the 
derivation of element equations, with the three most common being the direct approach, the 
energy approach and the weighted residual approach. 
 
2.1.2.3.1 The direct approach 
In this method, direct physical reasoning is used to determine the element properties, i.e. 
the characteristic matrices and vectors, in terms of the relevant variables. Although this 
method is limited to simple types of elements, it demonstrates the physical interpretation of 
the finite element method. The following example will illustrate this method. 
A stepped bar (Figure 74) with various different steps which are assumed to have 
different lengths (l), areas of cross section (A) and Young‟s modulii (E) will be considered. It 
can be deduced that the way to discretize this system is by considering each step as an 
element; the system will therefore consist of three elements and four nodes (Figure 74b). 
 
Figure 74: Stepped bar under axial load, a) Physical system, b) Finite element 




The element equations are required in this case to determine the force-displacement 
equations of the steps. In order to derive these equations, the element is isolated (Figure 74c) 
into a typical element e, where a force (F) and a displacement (u) is defined at each end of the 
two nodes in the positive direction of the x-axis. The unknown variable in this example is the 




where  is called the stiffness or characteristic matrix,  is the vector of nodal 
displacements and  is the vector of nodal forces of the element. The element stiffness matrix 
can be derived from the basic definition of the stiffness coefficient and no assumed 
interpolation polynomials are required. In structural mechanics, the stiffness influence 
coefficient kij is defined as the force required at node i, in the direction of ui, to create a unit 
displacement at node j (uj = 1) while other nodes are restrained (Martin 1966). This definition 
can be used to generate the matrix . When a unit displacement is applied at node 1 and 











So if change in length = 1 
 
So for figure 74d, the induced force k11 is equal to  at node 1 and the reaction force 
k21 at node 2 is equal to . Similarly values of k22 and k12 can be obtained by giving a 
unit displacement to node 2 and restraining node 1 which will result in  and   






2.1.2.3.2 The minimum potential energy approach 
The principle of minimum total potential energy may be stated as follows: out of all the 
possible displacement fields that satisfy the geometric boundary conditions, the one that also 
satisfies the equations of static equilibrium results in the minimum total potential energy of 
the structure or body (Love 1944), which was then rigorously proved by Sokolnikoff 
(Sokolnikoff 1956). The total potential energy (𝛱) is defined to be the sum of the two 
different types of potential energy, i.e. the internal strain energy or the internal potential 
energy (Ui) and the external potential energy (Ue) generated by the external forces acting on 
the system or: 
 
However for conservative force systems, the loss in external potential energy during 
loading is equal to the work done (We) on the system by the external forces so , so 
the previous equation becomes: 
 
When the principles of minimum potential energy is applied, it is required that 𝛱 be at a 
minimum for stable equilibrium. In order to minimize 𝛱, the first variation or derivative of 








2.1.2.3.3 The weighted residual approach 
The weighted residual method is a powerful technique that can be used to obtain 
approximate solutions to linear and nonlinear equations. A number of weighted residual 
methods can be employed but four particular functions are most often used (Argyris 1960, 
Crandall 1956, Desai and Abel 1972, Finlayson 1972). The four most popular weighted 
residual methods are referred to as:  
 Point collocation method  
 Subdomain collocation method 
 Least squares method 
 Galerkin method 
Before describing the four methods, a general structure around which the various 
methods are developed will be presented. 
 
2.1.2.3.3.1 General concepts 
A single governing equation with only one independent variable will be used to illustrate 
the general concept. Let the governing equation be represented by: 
 
where T represents the function sought that is a function of x only. D represents the domain 
of the region governed by the previous equation. In addition, the boundary conditions can be 







where V1 and V2 include only the parts of the domain D that are on the boundary (Figure 75). 
 
Figure 75: Schematic representation of a one-dimensional problem domain D with two 
boundaries V1 and V2 
 
An approximation of the solution to the equations can be obtained by an approximate 
function T’ where 
 
which has one or more constant unknown parameters a1, a2, … , an and which satisfies the 
boundary conditions at V1 and V2. The prime ( ) denotes an approximate solution and not a 
derivative. The functions Ni (x) are referred to as the trial functions. If the approximate 
solution  is substituted back into it will not necessarily satisfy the equation 






where the notation indicates the residual R is a function of x and the parameters . 
The exact solution is obtained when the residual R is zero for all the points in the domain D. 
The weighted residual approach requires that the parameters  be determined 
by satisfying: 
 
where the functions wi (x) are the n arbitrary weighting functions (Stasa 1985). 
 
2.1.2.3.3.2 Point collocation method 
In the point collocation method, the residual R is set to zero at n points in the domain D, 
the weighting function wi (x) are denoted as  and defined such that  
 
 
The collocation points, the xi‟s, are selected arbitrarily to cover the domain D uniformly. 
The  indicates the Dirac delta function and is not the variational operator (Rao 1989). 





This procedure yields n simultaneous algebraic equations in n unknowns which are the 
constant parameters . Once these are determined the approximate solution is 
given by equation  
 
and the problem is approximately solved. 
 
2.1.2.3.3.3 Subdomain collocation method 
In the Subdomain collocation method, the weighting functions are chosen to be unity 
over a portion of the domain and zero elsewhere. Therefore mathematically the weighting 








where D1 is a portion of the domain not included in D2, D3, … , Dn, this can be represented 
graphically for n = 3 (Figure 76).  
 
Figure 76: Subdomains and weighting functions for the subdomain collocation weighted 
residual method 
 
2.1.2.3.3.4 Least squares method 
In this method, the integral I of the weighted square of the residual over the domain is 





The problem is reduced to the determination of the parameters  such that the 
values of the integral I is minimized. Therefore the partial derivative of I must be obtained 
with respect to a1 and set to zero, then with respect to a2 and set to zero and so forth. This can 





where D includes the entire domain. As the limits on the integral are not a function of the 
unknowns , the order of the integration and the differentiation may be 
interchanged. Carrying out the differentiation and dividing by the constant factor 2 and not 








So in order to determine the weighting functions, it is necessary to compare the above 





That can be summarized as:  
 
Therefore the least-squares weighted-residual method requires the solutions of the n 
equations given by equation 1 for the n unknowns parameters  where the wi 






2.1.2.3.3.5 Galerkin method 
In the Galerkin weighted-residual method, the trial functions Ni(x) are used as the 
weighting functions or: 
 
So for the Galerkin method, equation 1 becomes: 
 
Because only one trial function being present for each unknown parameter, the above 
equation gives n equations that when solved, yield the values of the unknown 
parameters . The values obtained for the unknown parameters 
depend on the trial function initially selected. This weighted-residual method is 
the most commonly used for finite element applications (Desai and Kundu 2001). 
 
2.1.2.4 Assembly of an element equation to obtain the overall equilibrium 
2.1.2.4.1 Assembly of element equation 
Once the element matrices and the element vectors are found, the next step is to construct 
the overall or system equations. The process used for constructing the system equations from 
the element characteristics is the same regardless of the type of problem and the number and 
type of elements.  
The method of assembling the element matrices and vectors is based on the need of 
compatibility at the element nodes. This means that at the nodes where the elements are 
connected, the values of the unknown nodal degrees of freedom are the same for all the 




which can be rotations, curvatures or other spatial derivatives of translations. When the 
generalized displacements are matched at the common node, the nodal stiffnesses and nodal 
loads of each of the shared elements are added to yield the net stiffness and net load at that 
node which will lead to equations describing the behaviour of an element, which are 
commonly expressed as 
 
where is the vector of element nodal forces, [k] is the global stiffness matrix which is 
constructed from the stiffness matrices of each element, and  is the vector of nodal 
displacements (Korioth and Versluis 1997b). It is the nodal displacements which are solved 
given a set of nodal forces, constraints and global stiffness matrix. 
 
2.1.2.4.2 Boundary conditions 
As indicated above, after assembling the global stiffness matrix  and the vector of 
element nodal forces, the overall system equations of the entire domain can be expressed as: 
 
however these equations cannot be solved as the loaded body is free to undergo unlimited 
rigid body motion unless some boundary conditions are imposed to support the body in space 
and hence in equilibrium under the loads.  
A boundary condition expresses a prescribed value of displacement on a part of the 
boundary of the structure and establishes how the body is supported in space. After the 
introduction of these boundary conditions, the structure is capable of withstanding applied 
forces. Without boundary conditions the structure is free to undergo an unlimited rigid body 




Three types of boundary conditions exist which are described as, displacements, 
gradients of unknowns or both. They are also called first or Dirichlet boundary conditions 
(displacements), second or Neumann boundary conditions and third or mixed boundary 
conditions (gradients).  
For instance, if a column is supported such that the axial displacement at the base is 
specified, this represents the first condition; if the base is fixed such that the gradient is 
specified, it is the second condition; if the base is completely fixed this constitutes the mixed 
condition.  
 
2.1.2.5 Solution of the unknown nodal variables  
The finite element analysis of any problem results in a system of matrix equations and 
after the incorporation of the boundary conditions in the assembled system of equations, the 
final matrix equations are obtained. The methods available for solving the final matrix 
equations can be divided into two types: direct and iterative. The direct methods will yield the 
exact solution in the absence of round-off and other errors. The errors arising from round-off 
and truncation may lead to poor and maybe useless results. The basic method used for direct 
solutions is the Gaussian elimination but even with this method, there are several varieties 
depending on the computer programme used to calculate and hence yield the results (Rao 
1989).  
Iterative methods are those which start with an initial approximation and by applying a 
suitable algorithm, lead to a better approximation. When the process converges, it can be 
expected that the approximate solution obtained will be improved. The main advantages of 
the iterative methods are the simplicity and uniformity of the calculations to be performed, 
that make them suitable for use on computers and their minimal insensitivity to the 





2.1.2.6 Computation of the element stains and stresses 
For the displacement formulation, nodal displacements are the primary unknowns as they 
must be computed first and then the secondary quantities (strains, stresses, moments, shear 
forces etc.) can be obtained by using the known relations between displacement and the 
desired secondary unknown. 
 
2.1.3 Concepts in elasticity 
Stress is defined as force per unit area and strain as elongation per unit length. A linear 
elastic material behaves in such a way that when loaded and subsequently unloaded, the 
stress-strain relationship is linear (Figure 77). The elastic limit of a material is reached when 
permanent deformation occurs.  
 
Figure 77: Stress-strain curve for a linear elastic material 
2.1.3.1 Stress 
Consider a loaded body in static equilibrium with external forces F1, F2, etc, which are 
transmitted through the body in a complex manner. An infinitesimally small volume element 
positioned at a point in a global in a global x y z-coordinate (Figure 78). There are six faces to 
the cube and on each face there is a normal and two shear stresses that act. The two subscripts 
are identical for the normal stresses whereas they are different for the shear stresses which 




classification used follows the subsequent convention. The first subscript is associated with 
the outward normal to the plane over which the stress acts, and the second subscript is 
associated with the direction of the stress. Positive faces are defined to have outward normals 
in the same direction as the coordinate axes and the negative faces have the outward normals 
in the opposite direction to the coordinate axes. In figure 78a the three visible faces are 
positive and the three hidden faces are negative.  
 
Figure 78: a) External forces acting on a body and infinitesimal volume element with 
normal and shear stresses in three-dimensions, b) in two-dimensions 
 
With the concept of positive and negative faces clarified, the convention adopted for 
normal and shear stresses are considered positive if directed in the positive coordinate 
direction on a positive face and are also considered positive if directed in the negative 
coordinate direction on a negative face. Otherwise, the stresses are considered to be negative 
which ensures that positive normal stresses are tensile whereas negative normal stresses are 






Strain in a body generally varies from one point to another under load. An illustration of 
strain can be observed in figure 79 where a square element whose sides are of unit length is 
subjected (Figure 79a) to some external load which results in the element deforming such that 
the sides of the element are no longer perpendicular (Figure 79b). The normal strains εxx and 
εyy are defined in figure 79b as: 
 
based on the fact that the sides of the square element are of unity length before deformation. 
The normal and shear strains are all shown as positive, therefore the shear strain εxy is 
positive when the angle BOA is smaller than π/2. Strain is dimensionless but it is usually 
reported in units of millimetre/millimetre (mm/mm) or as microstrain (µε) which is 10-6 
strain. 
 
Figure 79: Definition of normal and shear strains, a) unstrained element with sides of unit 





2.1.3.3 Strain – displacement relations 
In stress analysis, the Lagrangian point of view is usually adopted in that a point in the 
body is followed as it moves due to deformation induced by the loading. An arbitrary point 
undergoes displacements in the x, y and z directions, which are denoted as u, v and w. The 
strains and displacements are not independent but are related for small deformations in two-
dimensional problems as: 
 
and in three-dimensional problems as: 
 
 
The two equations for 2D and 3D problems are known as the strain-displacement relation 
but it should be noted that these equations hold only for small deformation and will not work 
for stress analysis involving large deformations.  
 
2.1.3.4 Hooke’s law 
For Hooke‟s law to be appropriately used, the deformations must not result in strains that 
would cause the material to exceed the proportional limit and that the material remains within 
the elastic limits. In its most simple form, Hooke‟s law states that the normal stress (σ) is 







where E is known as Young‟s modulus, the elastic modulus or the modulus of elasticity 
which is a measure of stiffness of a material i.e. how much a material deforms under axial 
load (Figure 80). Since strain is dimensionless, the Young‟s modulus has units the same as 




Figure 80: Representation of dimensions required for obtaining Young's modulus (E) 
 
2.1.3.5 Poisson’s ratio 
Poisson‟s ratio (ν) is a measure of the ability of a material to resist change of volume and 
change of shape and is defined as the lateral strain divided by the axial strain (Figure 81) 







Figure 81: Illustration of Poisson's ratio, solid square represents object before axial strain 


















Before an analysis can take place, the scaffolds were first drawn using a CAD 
programme that represented the real manufactured structures. The scaffolds were then 
transferred to the FEA program and the material properties were assigned. The boundary 
conditions were then put in place and the analysis carried out which yielded information 
regarding the surface strain distribution throughout the scaffolds. 
 
2.2.1 Model creation 
Creation of a realistic model requires the geometry of the structure to be inputted into a 
computer program. Several techniques exist to accomplish this and they include an automated 
and a manual method. One automated approach involves converting laser scans of the desired 
object into a wire frame model that is then converted into an FE model. This method 
generates a high-resolution representation of the outer surface of the object but cannot give 
information on the internal geometry. Computer tomography (CT) scan voxels (3D pixels) 
can be transformed into an FE model with high resolution but also requires some complex 
issues in finding the appropriate threshold algorithms to define the boundaries through the 
structure accurately (Fajardo et al. 2002).  
 Manual methods include obtaining images (e.g., MRI, CT and photos) and manually 
digitizing them into a computer aided design (CAD) model or alternatively creating a 
structure using CAD software that can then be converted into an FE model. This latter 
technique was used for generating a CAD model from the manufactured PCL scaffolds. On 
creating the PCL scaffold (as mentioned in earlier chapter), images were taken using an 
Olympus microscope at 20 times magnification that would provide information regarding the 
scaffold dimensions, strand diameters, distance between strands and between layers. These 
images were then observed using a histomorphometric program (BioQuant) that permitted the 
average layer thickness, strand distance and strand thickness to be obtained and hence used to 





Figure 82: Dimensions measured and used to create CAD model 
 
2.2.2 Generated Computer Aided Design models 
CAD models were created for the FEA analysis. The dimensions of the computer 
generated scaffolds were obtained from the histomorphometric measurements made on the 
plotted scaffolds. Solid Works 2003 was the CAD program used to generate the computer 
models of the scaffolds. The general method for creating the virtual scaffold models was 
started by drawing a single strand (Figure 83a) with arbitrary length which was then copied to 
form the first layer (Figure 83b). The second layer which was perpendicular the first layer 
was initiated by drawing a strand (Figure 83c) which was then copied to generate the second 
layer (Figure 83d). These two layers were then joined so forming a single object which was 
then copied and stacked to give height to the scaffold of 5.062 mm (Figure 83e). The scaffold 














Eight different scaffolds with different layer orientation and strands per layer were 
created which represented the manufactured scaffolds that could be created using the 
Bioplotter™ (Figure 84 and 85), these included: 
 Single strand no offset (SSNO) (Figure 84a)  
 Single strand with offset (SSO) (Figure 84b) 
 Single strand no offset with 45° rotation (SSNO45) (Figure 84c) 
 Single strand with offset and 45° rotation (SSO45) (Figure 84d) 
 Double strand no offset (DSNO) (Figure 85a) 
 Double strand with offset (DSO) (Figure 85b) 
 Double strand no offset with 45° rotation (DSNO45) (Figure 85c) 







Figure 84: CAD models of single stranded scaffolds, a) no offset, b) with offset, c) no 







Figure 85: CAD models of Double Stranded scaffolds, a) No offset, b) with offset, c) No 





2.2.3 Assessing the Young’s modulus of Polycaprolactone 
Before the CAD models were transferred to the FEA program, material properties of the 
polycaprolactone were required so that the results generated by the analysis were realistic. 
The first method used to obtain the Young‟s modulus of polycaprolactone of molecular 
number 10000, 42000 and 80000, was to melt pellets of the material in a test tube and allow it 
cool and hence solidify. The test tube was then broken, leaving a solid cylinder of PCL. The 
cylinder was then cut using a low speed circular saw (Buehler, Isomet) to smaller cylinders 
that were 10 mm high. The samples were then tested in compression using a mechanical 
tester (Zwick-Roel, UK) with a 10kN load cell (GTM, Germany) at a compression rate of 
1mm/min. A graph of the compressive stress against strain was then plotted and the Young‟s 
modulus obtained by calculating the gradient of the linear portion of the graph (Figure 90). 
The mechanical properties of polycaprolactone were determined by creating three 
different cylinders with three different molecular numbers and obtaining the Young‟s 
modulus by compressive testing. From the graph of stress against strain, it can be observed 
that the gradient of PCL Mn 10,000 is steeper which indicates a greater young‟s modulus 
however the graph also shows that the ultimate compressive strength is lower which indicates 
a brittle substance as the graph rapidly decreases as the strain is increased. The other two 
molecular numbers of polycaprolactone (Mn 42,500 and Mn 80,000) have a slightly flatter 
gradient and the ultimate compressive strength is not reached (Figure 90). Values of the 
Young‟s modulus obtained this way were correct (Table 10) but did not represent the 
Young‟s modulus of the polycaprolactone that was precipitated out while making the 
scaffolds. Therefore another measurement needed to be collected that more closely matched 
the mechanical properties of the extruded polycaprolactone. Strands of 30% w/v 
polycaprolactone with Mn 42,500 were extruded and processed the same way as one would a 
scaffold. Strands were kept wet and were fastened securely into a mechanical testing rig by 
using adhesive tape and were marked to determine whether slippage of the stand occurred 
and then the length of the strand was recorded. The strand was then subjected to a tensile 
strain with the force and displacement recorded. A graph was then plotted (Figure 91) and the 
Young‟s modulus calculated (Table 12). From these graphs, it can be seen that the linear part 




were lower than the initial test because when the strand is dissolved, extruded and 
precipitated, the mechanical properties of the structure are weakened. 
The second method involved PCL (Mn 42,000) that was dissolved in glacial acetic acid. 
This was then extruded into a bath of IMS (Sigma, UK). The resultant strands were cut and 
the lengths and diameters measured using Verniers callipers. The strands were tested in 
tension using a mechanical tester (Dartec, UK) with a 10N load cell. A smaller load cell was 
used as this provided more accurate measurements due to its increased sensitivity. A graph 
was then plotted of tensile stress against strain and the gradient calculated of the linear part to 
yield the Young‟s modulus. 
 
2.2.4 Finite element analysis assessment of scaffold geometries 
The finite element programme used was ABAQUS version 6.5. The CAD models were 
saved in standard ACIS text (SAT) format which is a format that can be imported into the 
ABAQUS program. When the scaffold part is imported it has to be given material properties 
such as the Young‟s modulus and the Poisson‟s ratio. The Young‟s modulus of the PCL was 
obtained from a previous experiment which is described in paragraph 2.3. The Poisson‟s ratio 
selected for the PCL was 0.3 as cited in the literature (Fang et al. 2005).  
The model was then assigned three boundary conditions; the first represented a flat 
surface at the bottom of the scaffold which prevented any displacement in the direction of the 
applied force (Figure 86a). The second boundary condition was set as a displacement which 
corresponded to the desired global strain at the top of the scaffold therefore to obtain 3000με, 
the required displacement was 0.0152 mm which acted as the applied force (Figure 87). The 
third was a fixed anchor point which prevented lateral movement of the virtual scaffold 
(Figure 86b). The models were then meshed (Figure 88) with a global seed value of 0.11, 
which represents the size of the meshing elements and with all the required steps completed, 





Figure 86: Boundary conditions on the bottom surface of scaffold, a) Stops the scaffold 
moving in the direction of compression, b) Fixed point (highlighted in red) 
 
 





In order for the strain distribution throughout the scaffold to be determined, a programme 
was written in Python programming language (to achieve this, help rendered by Dr A. 
Phillips is kindly acknowledged). 
Once the analysis was completed, the data was represented graphically with different 
colours representing different strains (Figure 89).  
 



















2.3.1 Young’s modulus of polycaprolactone 
Briefly, the mechanical properties of polycaprolactone were determined by creating three 
different cylinders with three different molecular numbers and obtaining the Young‟s 
modulus using compressive testing. From the graph of stress against strain (Figure 90), it can 
be observed that the gradient of PCL Mn 10,000 is steeper which indicates a greater Young‟s 
modulus however the graph also shows that the ultimate compressive strength is lower which 
indicates a brittle substance as the graph rapidly decreases as the strain is increased. The other 
two molecular numbers of polycaprolactone (Mn 42,500 and Mn 80,000) have a slightly more 
horizontal gradient and the ultimate compressive strength is not reached. Values of the 
Young‟s modulus obtained this way were correct (Hutmacher et al. 2001b, Mondrinos et al. 
2006, Wang et al. 2004) but did not represent the Young‟s modulus of the polycaprolactone 
that was precipitated out while making the scaffolds. Therefore another measurement needed 
to be collected that more closely matched the mechanical properties of the extruded 
polycaprolactone. Strands of 30% w/v polycaprolactone with Mn 42,500 were extruded and 
processed the same way as one would a scaffold. Strands were kept wet and were fastened 
into a mechanical testing rig with the length of the strand recorded. The strand was then 
subjected to a tensile strain with the force and displacement recorded. A graph was then 
plotted and the Young‟s modulus calculated. From figure 91, it can be seen that the linear 
part of all three graphs coincide and the resulting Young‟s modulus are similar. These 
properties were lower than the initial test because when the strand is dissolved, extruded and 











Figure 90: Stress versus Strain graph of three different number average molecular 
weights of melted and solidified polycaprolactone 
 
From figure 90, the Young‟s Modulus of the individual number average molecular 
weights of polycaprolactone was calculated by determining the gradient of the linear part of 












PCL Mn 10,000 306 
PCL Mn 42,000 226 
PCL Mn 80,000 206 
Table 11: Young's Modulus of three different number average molecular weights of PCL 
 
Three PCL strands (Mn 42,000) were tested in tension and the lengths and diameters 
recorded (Table 11) to enable calculations of the Young‟s modulus by determining the 











Strand 1 25.00 0.145 0.017 
Strand 2 19.67 0.145 0.017 
Strand 3 18.13 0.145 0.017 
Table 12: Dimensions of polycaprolactone strands 
 
The results of the tensile experiment yielded a stress against strain graph (Figure 91) 












Strand 1 36.57 
Strand 2 52.39 
Strand 3 49.18 
Average 46.05 
Table 13: Young's modulus of extruded strands of PCL Mn 42,000 
 
2.3.2 Young’s modulus of scaffold through FEA analysis 
The Young‟s modulus of the scaffold was determined by firstly inputting the Young‟s 




finite element analysis was firstly performed by using the material properties of the 
polycaprolactone that was melted and solidified and then the extruded polycaprolactone 
properties were used. The reaction force at the bottom boundary condition was obtained, this 
then represented the actual force being exerted on the top surface and hence the Young‟s 




For the melted and solidified PCL (Table 10 and Figure 90) and the extruded and 
precipitated PCL (Table 12 and Figure 91) the Young‟s modulus was calculated by knowing 
the height (L), area (A) and displacement (ΔL) which were 5.062 mm, 25 mm
2
 and 0.0152 
mm respectively. The reaction forces given in table 13 were obtained by subjecting the FEA 

















Young's modulus of scaffold 
(MPa) 
DSNO 1.750 23.31 
DSO 1.264 16.84 
DSNO45 1.489 19.84 
DSO45 1.480 19.72 
SSNO 1.655 22.05 
SSO 0.470 6.26 
SSNO45 0.824 10.98 
SSO45 1.032 13.77 
Table 14: Young's Modulus of various scaffold geometries using the material properties 















Figure 92: Representation of Young's Modulus of different scaffold geometries using 














Table 15: Young's Modulus of various scaffold geometries using the material properties 






Figure 93: Young's modulus of scaffolds using the properties of the extruded PCL 
 
From the results obtained from the two different material properties of PCL, it can be 
observed that the Young‟s modulii obtained with the melted and then solidified PCL 
properties are approximately 7 times higher. An interesting observation is that the trend of the 
scaffolds Young‟s modulii with the two different initial PCL properties remains similar. In 
figure 92 and 93, the DSNO scaffold geometry has the highest and the SSO scaffold 
geometry has the smallest Young‟s modulus. 
 
2.3.3 Surface strain distribution throughout scaffolds 
In order to assess the surface strain distribution i.e. the surface strain distributed 
throughout the entire scaffolds, at a physiologically relevant surface strains of 3000 µstrain 




scaffold strained between 2000 and 4000 µstrain was determined.  The finite element analysis 
was performed using the Young‟s Modulus obtained from the extruded PCL (Mn 42,000) as 
described in paragraph 2.3. Two global strains of 3000 and 5000 µstrain were chosen to 
compress the scaffold, as these strains are generated in the Zetos™ bioreactor during 
mechanical stimulating (Mann et al. 2006) (See chapter 3 for more detail). 
 
 
Figure 94: Surface of scaffold strained in compression between 2000 με and 4000 με 
with induced global strain of 3000 με and 5000 με 
 
The two different global strains were analysed and from figure 94, it can be observed that 
in most cases, an increased global strain yielded an increased compressive surface strain. The 
two scaffold geometries where this is not true are the double strand no offset (DSNO) and the 
single strand no offset (SSNO) which can be explained due to the scaffold geometry. These 
two geometries form „columns‟ due to the stacking of the layers as there is no offset or 
rotation of the layers and hence the majority of the compressive surface strain between 
2000με and 4000 με are located at these supporting „columns‟. When the global strain was 




physiological window of 2000με - 4000με was exceeded and therefore reducing the 
percentage surface strain.  
In figure 95, where the surface strain in tension is shown, it can be seen that an increased 
global strain considerably augmented the surface strained in tension. However the dominant 
surface strain in the scaffolds is compressive.  
 
 
Figure 95: Surface of scaffold strained in tension between 2000με and 4000με with an 
induced global strain of 3000με and 5000με 
 
The total strains generated throughout the scaffolds were then investigated (Figure 96), 
which represents the sum of the compressive and tensile strains. This then demonstrates the 























The computer aided design models (CAD) were created by using the histomorphometric 
measurements performed on a polycaprolactone scaffold where various dimensions and 
lengths that would be required to create an accurate CAD model were measured. The main 
values required were the strand diameter, the height between strands and the distance 
between strands. The values were measured on six different locations on the scaffold so that 
an average value could be used that would more appropriately represent the dimensions of the 
required measurements and also to minimise the measuring errors that might have been 
introduced during the histomorphometric measurements. These errors occurred because the 
distances were measured by hand as the software BioQuant did not have the option to 
measure distances between two points using a pre-programmed straight line but the line had 
to be generated by hand which induced an error. Histomorphometry has not been reported in 
the literature for measuring scaffold geometry but is commonly used to determine distances 
between cells and areas of bone (Eriksen et al. 1989, Nafe and Schlote 2004, Revell 1983). 
Other groups that have done related work have used micro-computer tomography (CT) to 
generate exact CAD models of the generated scaffolds which then underwent FEA (Duty et 
al. 2007, Lacroix et al. 2006, Lin et al. 2004, Su et al. 2006).  
After all the scaffold geometries were created, the files had to be converted to the 
standard ACIS text  (SAT) format so that they could be opened by FEA program ABAQUS. 
Once all the models were converted and transferred, the Young‟s modulus and the Poisson‟s 
ratio had to be assigned. The value chosen for Poisson‟s ratio of polycaprolactone was 0.3 as 
this value was used in the literature (Fang et al. 2005, Sun et al. 2004). 
After assigning the material properties, the models were given boundary conditions and 
meshed. The accuracy of the meshing caused several problems and had to be chosen 
carefully. It was discovered that a very fine mesh (global seeding value 0.07) could not be 
accomplished as the desktop computer (Pentium 4, 2.80GHz, 512 Mb RAM) ran out of 
memory and took a long time to process. This low seeding density was initially chosen as 
another group that performed analyses with the same ABAQUS program used a similar value 




computers which was probably due to using more powerful computers. Slightly lowered 
seeding density were then used (global seed value 0.09) which generated a mesh but when the 
analysis was initiated the computer ran out of memory and the analysis was halted. A global 
seed value of 0.11 was then discovered by iteration to be the lowest that did not crash the 
FEA software and did not affect the accuracy of the results. Hart et al, suggested that the 
precision of a particular FE model through a convergence test in which the model is 
repeatedly calculated with increasingly finer meshes until the magnitude of the chosen test 
area reaches a plateau, converging towards a precise solution of that model (Hart 1990). In 
the past, assessing precision was an important step due to limitations on computer power 
required researchers to determine an appropriate degree of mesh refinement that was 
reasonably precise and minimized computational demand however this has become less of an 
issue with more powerful computers (Richmond et al. 2005). Cook and Avrashi stated that no 
matter how finely a structure was meshed and how precisely the calculations were performed, 
the computed answer may still be wrong (Cook and Avrashi 1992) and that independent 
experimental support was critical to any FEA attempting to model a mechanical problem in a 
realistic manner by direct measurement of strain. However this view of FEA may be slightly 
dated and reports of the accuracy of FEA have been widely reported (Autuori et al. 2006, 
Burgers et al. 2008, Diego et al. 2006, Duty et al. 2007). FEA has been used in many 
biological applications in which individual skeletal elements or joints, such as the proximal 
femur (Beaupré et al. 1990) or skull (Strait et al. 2005) are modelled to better understand how 
the bones involved behave in response to applied loads. Beaupré et al, tested their theory of 
bone remodelling by comparing real bone structure with the results obtained of an FEA 
model that was repeatedly loaded and altered following the rules of the theory. In this way, 
Beaupré et al were able to assess the utility of the remodelling theory and demonstrate that 
similar stress related phenomena might be responsible for bone morphogenesis as well as 
functional adaptation in response to altered mechanical loads (Beaupré et al. 1990). 
Preuschoft and Witzel used FE modelling to test hypotheses about the evolutionary rules that 
govern skull morphology by applying muscle loads to a block with only minimal skull form 
i.e. orbits, dental arcade and location of muscle and compared the resulting stress distribution 
against a real skull form (Preuschoft and Witzel 2005). Li et al, used FE modelling to 




and strain distribution and the deformation of the spine (Li and Wang 2006). These cases 
demonstrate that FE modelling has reached a level of sophistication and accessibility that 
renders it a powerful and useful tool to aid in measuring strain distribution and mechanical 
properties of scaffolds. 
The Young‟s modulus of the scaffolds obtained from the FE analyses where the 
mechanical properties used were that of the melted and solidified PCL were much higher than 
the actual Young‟s modulii of the manufactured and mechanically tested scaffolds (see 
chapter 1). However Wang et al who used PCL to create scaffolds by liquefying the polymer 
to just above its melting point reported a Young‟s modulus approximately 10 times greater 
(Wang et al. 2004) than that obtained in the finite element analyses in this chapter. This could 
be due to the fact that the geometry of the tested scaffolds were different, in Wang et al‟s 
work, the strand distance was 0.41 mm as opposed to 0.6 mm, the layer thickness was 0.254 
mm whereas in this work it was 0.14 mm and the strand thicknesses were the same (0.25 
mm). This then means that the effective distance between strands is 0.16 mm (0.41 - 0.25 = 
0.16) which would considerably increase the overall mechanical properties of the scaffold. In 
work produced by Charles-Harris et al, polylactic acid (PLA) scaffolds were manufactured 
by salt leaching and scanned using a Synchrotron X-ray microtomography which yielded a 
3D image which was then analysed using FEA. The Young‟s modulii ranged between 0.05 
and 0.2 MPa , these lower values of Young‟s modulus were caused by the large pores that 
were present in the scaffolds due to the use of salt particles between 300 and 600 μm 
(Charles-Harris et al. 2007). In FE analyses performed by Lacroix et al, calcium phosphate 
bone cement was compressed and yielded a Young‟s modulus of 41 MPa however due to the 
nature of the scaffold, the random pore orientation and various thicknesses of the internal 
walls, it was reported that parts of the scaffold underwent much higher strains than others and 
were not uniformly distributed (Lacroix et al. 2006) which was not the case in the extruded 
scaffolds. 
The FEA analyses performed with the Young‟s modulus obtained from the extruded 
strands (section 2.3), yielded values of Young‟s modulus similar to the manufactured PCL 
ones (Chapter 1). This would indicate that the extrusion process that the polycaprolactone 




to the mechanical properties could be due to the polymer chain reduction and maybe the 
introduction of bubbles during the extrusion process which would reduce the strength of the 
polymer. These reduced mechanical properties were also observed in the literature where the 
polymer was dissolved in a solvent in order to be manufactured into a scaffold (Charles-
Harris et al. 2007, Shao et al. 2006b).  
Another factor which affected the difference between the Young‟s modulus of the 
manufactured and the computer generated scaffolds was that the scaffolds created in the CAD 
program had no defects and were theoretical ideal representations of the manufactured 
scaffolds. It can be observed from the SEM images (see chapter 1) and figure 59, that the 
strands are not perfect cylinders as was represented in the CAD models and that the strands 
experience a slight amount of sagging, this phenomenon can also be observed in other work 
done by Wang et al and Moroni et al (Moroni et al. 2006, Wang et al. 2004). 
From the results obtained from section 3.3 regarding surface strain distribution 
throughout the scaffold, the two global strain values chosen were 3000 and 5000 με, as these 
were the global strains that the scaffold was subjected to in the Zetos™ bioreactor system. If 
the displacement of the piston which generates the compression in the bioreactor could be 
altered, the global strain could be increased which would then generate more surface strain 
between 2000 and 4000 με throughout the scaffold which would then affect more of the cells 
that were seeded on the scaffold. This increased surface strain would in principle push more 
of the MSCs down the osteoblastic lineage and hence create more bone mineral. In work 
produced by Duty et al, it was reported that the average strains generated in their scaffold 
was 2000με however the proportion of the scaffold surface strained was not mentioned (Duty 
et al. 2007). In the work reported by Lacroix et al who created porous calcium phosphate 
scaffolds, it was observed that 90% of the strain distributed throughout the scaffold was 
lower than 2200με (Lacroix et al. 2006) which is at low end of the effective strain 
experienced in trabecular bone. However the work performed in this chapter suggests a 
greater effective strain distribution throughout the scaffold with approximately 40% of the 






FE analysis has been shown to be a reliable tool to precisely characterize the strain 
distribution and the mechanical properties of the 3D scaffolds. Furthermore the use of 
histomorphometry has made it possible to create a mathematical model that can then be 
analysed using a finite element analysis package and determine the strain profile of the 
scaffold when loaded and its mechanical properties. From the finite element analyses 
performed on the CAD scaffold models; these were represented by the values of the Young‟s 
modulus obtained by mechanically stimulating the manufactured PCL scaffolds which 
provides validation of the FE model of the scaffolds. By obtaining similar results for the 
Young‟s modulus, it can be concluded that the strains distributed throughout the scaffolds are 
also similar as the ratio of the stress and the strain are comparable. This then enables the 
creation of scaffolds with specific surface strain characteristics to be created by first 
modelling them using FEA by varying the scaffold architecture. This prevents using materials 
that will not meet the desired surface strain requirements. Finite element analysis can be used 
to determine various scaffold geometries and establish which scaffold geometry is best suited 





















Chapter 3.  














 century, Julius Wolff suggested that mechanical stress was responsible for 
determining the architecture of bone  but more importantly suggested that mechanical stress 
and the form of bone are related by a mathematical law called Wolff‟s law of transformation 
(Wolff 1892). Although it is accepted that certain aspects of Wolff‟s law are not entirely 
correct i.e. that bone remodelling occurs by a set of mathematical laws, (Bertram and Swartz 
1991, Lovejoy et al. 2003, Pearson and Lieberman 2004), the idea that mechanical stress 
affects bone architecture is well documented in the literature and widely accepted,  (Carter 
1987, Frost 1992, Lanyon et al. 1982, Mosley 2000).  Increased loading of the skeleton has 
been shown to increase bone mass (Bassey and Ramsdale 1994, Jones et al. 1977, Woo et al. 
1981) and retard bone loss in postmenopausal women (Brockie 2006, Krolner et al. 1983, 
Simkin et al. 1987). Conversely a reduction of bone formation (Morey and Baylink 1978, 
Wronski and Morey 1983) and mineral content (Cann and Adachi 1983, Rambaut and 
Johnston 1979, Vico et al. 1987) are associated with the un-loading of the skeleton in 
spaceflight. However during spaceflight, bone loss occurs in a non-uniform manner with the 
distal leg bones experiencing the greatest bone loss (Collet et al. 1997, Vogel and Whittle 
1976). This has been hypothesized to occur due to the lack of normal high frequency heel 
strike activity under microgravity conditions (Goodship et al. 1998).  
Some interpretations of Wolff‟s law have suggested that changes in bone structure are 
brought about by a feedback system that occurs between the local mechanical signals and the 
bone cells which results in changes of bone arrangement. The best accepted theory is the 
„mechanostat‟ hypothesis proposed by Frost (Frost 1983, Frost 1987, Frost 1990). Frost‟s 
mechanostat theory is unique in its distinction between modelling and remodelling processes 
with thresholds for activating lamellar or woven bone formation. Frost describes a window of 
mechanical usage that should be considered as physiological or normal. When local 
mechanical load in bone exceed the upper boundary of the physiological window, bone will 
undergo modelling and adapt its structure to reduce the local strains. If the mechanical loads 
on the bone are very large, the local strains will be pushed into pathological overload which 
causes woven bone formation on the bone surface and conversely if the local strains are low, 





The mechanostat and the mechanisms that make it work are not completely understood 
however there is a requirement for some sort of cellular mechanotransduction (Turner and 
Pavalko 1998), which is the conversion of a biophysical force into a cellular response. In 
bone, the mechanotransduction can be divided into four distinctive phases: 
 Mechanocoupling 
 Biochemical coupling  
 Transmission of signal 
 The implementer cell response 
 
3.1.1.1 Mechanocoupling 
Mechanocoupling is the transduction of a mechanical load applied to the bone into a local 
mechanical signal that is detected by a sensor cell. In bone, the mechanical loads that are 
associated with normal everyday use cause a deformation in the bone known as strain. One 
micro-strain (µε) is equivalent to one micrometer (µm) of deformation per meter. The levels 
of these strains are different depending on the activity and can range between 400 and 3000 
µε (Burr et al. 1996, Milgrom et al. 2000). The typical use of long bones combines 
compressive forces and bending (Bertram and Biewener 1988, Rubin and Lanyon 1982) 
which creates large differences of strain on the bone surface. The peak magnitudes generated 
in bone have been associated with the degree of bone adaptation (Rubin and Lanyon 1985), 
but there are other factors that contribute to the adaptive response. During mechanical loading 
of bone, the bone tissue deforms and creates a pressure difference in the bone‟s canalicular 
system which engenders movement of extracellular fluid transporting nutrients to the 
osteocytes and creates fluid shear stresses on the osteocytes cell membrane (Burger and 
Klein-Nulend 1999, Weinbaum et al. 1994). The shear stresses cause cell deformation and is 
followed by metabolic activity via integrins and the cytoskeleton (Ajubi et al. 1996). The 
osteocytes and the bone lining cells act as the sensors for the local bone strain as they are 




Nulend 1999, Turner and Forwood 1995). Osteocytes and the bone lining cells are stretched 
the same amount as the bone tissue when it is loaded with the mechanical stimulus on the 
osteocytes being biaxial as when the bone is compressed in the longitudinal direction, it 
expands slightly in the perpendicular direction (Duncan and Turner 1995). In addition, the 
strains caused by loading generate extracellular fluid flow across the osteocytes. It is unclear 
which type of stimulus, mechanical stretch or fluid flow has a greater effect on the bone cells. 
It is probable that the latter respond to more than one component of their mechanical 
environment. This is supported by the ability of mechanical strain and fluid flow to promote 
bone cell activity (Ajubi et al. 1996, Burger et al. 1995, Davies et al. 2006, Mann et al. 2006, 
Reich et al. 1990b, Weinbaum et al. 1994). Because in vivo loading is always accompanied 
by fluid flow, bone cells might respond to changes in their strain environment by a combined 
assessment of both fluid flow and physical deformation.  
 
3.1.1.2 Biochemical coupling 
Biochemical coupling is the transduction of a mechanical signal sensed by the cell into a 
biochemical signal which would alter gene expression. The bone cells possess glycoprotein 
integrins that are rigidly adhered, on one side to the bone matrix and on the other to the cell 
cytoskeleton. If there is a disruption in the tension of the extracellularly exposed integrins, a 
signal would be transmitted to the osteocyte nucleus (Duncan and Turner 1995). Stretch- 
activated channels such as the potassium channel or the guanine nucleotide binding proteins 
(G-proteins) located on the cell membrane may be activated by fluid flow. These pathways 
are thought to work together or independently depending on the type of mechanical signal 
received (Turner and Pavalko 1998). 
 
3.1.1.3 Transmission of signal 
There are two possible pathways by which a biochemical signal in the sensor cell is 
transmitted to the implementer cell to increase osteogenic activity after a mechanical 




strain and also act as the implementer cell that increases bone formation. This situation is 
supported by Harter and Burger who observed an increase in the production of expression of 
matrix proteins when osteoblasts-like cells were exposed to a cyclic mechanical stretch 
(Harter et al. 1995). However, active osteoblasts make up only 5% of the bone surface in 
adult humans with bone lining cells making up 94% of the bone surface and osteoclasts 
making up the remaining 1% (Parfitt 1983). Therefore stimulation of active osteoblasts alone 
is not sufficient to generate substantial increases in bone mass. Osteocytes and bone lining 
cells make up in excess of 95% of all cells of the osteoblastic lineage that are attached to the 
bone (Frost 1960, Parfitt 1983), in addition the osteocytes have the ability to communicate 
with other bone cells by using an extensive network of cellular processes connected through 
functional gap junctions (Noble and Reeve 2000, Stains and Civitelli 2005, Taylor et al. 
2007) and are responsive to mechanical stimulus in vivo (Dodds et al. 1993, Pead et al. 1988, 
Skerry et al. 1989). Therefore it is assumed that these cells act as sensors to mechanical 
stimuli but since osteocytes and bone lining cells are nonproliferative and are unable to 
actively form or resorb bone, they must signal to the implementer cells (osteoblasts or 
osteoclasts) before any change in bone structure can be initiated. The most likely 
intermediaries for the transmission of the biochemical signal between the sensor cells and the 
implementer cells are the prostaglandins (Klein-Nulend et al. 1995, Klein-Nulend et al. 1997) 
and nitric oxide (NO) (Johnson et al. 1996, Pitsillides et al. 1995), with both being produced 
when mechanical stimuli was applied to cells in vitro. Blocking the production of 
prostaglandin in vivo with selective inhibitors eliminates mechanically induced bone 
formation (Forwood 1996) and inhibitors of nitric oxide synthases also suppress 
mechanically induced bone formation in rats (Fox et al. 1996, Turner et al. 1996). 
 
3.1.1.4 Implementer cell response 
The response of bone formation to mechanical loads involves the proliferation and 
nonproliferation of the implementer cells or in the case of bone formation, osteoprogenitor 
cells. Within forty eight hours after mechanical loading an early bone formation response is 




preosteoblasts (Turner and Pavalko 1998). Proliferating osteoprogenitor cells are stimulated 
by mechanical loading and differentiate into osteoblasts 72 to 96 hours after mechanical 
stimulus (Turner et al. 1998). 
 
3.1.1.5 Mesenchymal stem cells 
Mesenchymal stem cells (MSC) were first described in bone marrow where they were 
also termed „marrow stromal cells‟ (Friedenstein et al. 1974). However it is now known that 
similar but heterogeneous populations of progenitor cells are also present in many other 
tissues. Mesenchymal stem cells can be isolated from periosteum (De Bari et al. 2006, 
Nakahara et al. 1991), muscle (Sampath et al. 1984), synovium (De Bari et al. 2001), 
synovial fluid (Jones et al. 2004), liver and blood (Campagnoli et al. 2001), umbilical cord 
blood (Erices et al. 2000), and fat (Lee et al. 2004b). The source of the mesenchymal stem 
cells has an influence on phenotype and functional properties which was reported in the study 
carried out by De Bari et al where human mesenchymal stem cells from periosteum have a 
greater capacity to create bone in vitro than do human mesenchymal stem cells from the 
synovial membranes (De Bari et al. 2006).  
Many adult tissues contain population of stem cells that have the capacity for renewal 
after trauma, disease or aging. The adult bone marrow contains mesenchymal stem cells that 
are thought to be multipotent cells. MSCs can replicate as undifferentiated cells and have the 
potential to differentiate to lineages of mesenchymal tissue which includes bone, cartilage, 
fat, tendon, muscle and marrow stromal cells (Dennis and Charbord 2002). The potential use 
of MSCs to treat genetic disorders and for tissue engineering for reconstruction of bone tissue 
has fuelled attempts to isolate and purify MSC populations but this has been difficult. 
Work done by Horwitz et al for the International Society of Cellular Therapy made a 
statement to define theses progenitor cells and termed them „multipotent mesenchymal 
stromal cells‟ and more recently by Dominici et al who also proposed a minimum criteria to 
define human MSC. These cells should firstly be plastic adherent in up to five days when 




must bear some stromal markers (CD73, CD90 and CD105) and be negative for 
haematopoietic marker (CD14 or CD11b, CD34 and CD45) and thirdly the cells must be able 
to differentiate to osteoblasts, adipocytes and chondroblasts under standard in vitro conditions  
(Dominici et al. 2006, Horwitz et al. 2005).  
Commitment of MSCs to tissue-specific cell types is orchestrated by morphogens 
(molecules that play a role in the development of organs), developmental signalling pathways 
and transcriptional regulators that act as „master switches‟ (Figure 97) the main one being 
Wnt, Runx2 and Osterix. The Wnt/β-catenin pathways provides initial developmental cues 
that indirectly enable the initial cascade of gene expression for skeletal development, bone 
formation and osteoblast differentiation (Church and Francis-West 2002, Logan and Nusse 
2004). Wnts play an extensive role in skeletogenisis from embryonic skeletal patterning, 
through fetal skeletal development and remodelling of the adult skeleton which was 
demonstrated by multiple skeletal defects in mice with mutations in Wnts (Kato et al. 2002).  
 
 





Runx2 transcription factor which is also known as CBFA1 (Core Binding Factor 1) is a 
central regulator of bone formation and is essential for osteoblast differentiation, this 
differentiation program also requires other genes such as osterix, which encodes a 
transcription factor genetically „downstream‟ of Runx2 (Karsenty and Wagner 2002). The 
targeted disruption of Runx2 results in a complete lack of bone formation by osteoblasts 
which indicates that Runx2 is essential for endochondral and bone formation (Komori et al. 
1997).  
Osterix (Osx) is a bone morphogenic protein 2 (BMP2) inducing gene which contains a 
deoxyribonucleic acid (DNA) binding domain. In Osx-null mutant mice, no endochondral or 
bone formation occurs (Nakashima et al. 2002). The mesenchymal cells in Osx-null mutant 
mice do not deposit bone matrix and cells in the periosteum and the condensed mesenchyme 
of membranous skeletal elements cannot differentiate into osteoblasts, although these cells 
express normal levels of Runx2. Osx-null osteoblast precursors in the periosteum of the 
membranous bones express chondrocyte markers (Sox9 and Col2a1) which suggests that 
Runx2 expressing preosteoblasts are still bipotential cells and Osx acts downstream of Runx2 
to induce osteoblastic differentiation in the osteochondroprogenitor cells (Nakashima et al. 
2002). 
Committed preosteoblasts are recognised close to the bone surface by their proximity to 
surface osteoblasts and by histochemical detection of alkaline phosphatase enzyme activity 
which is one of the earliest markers of the osteoblast phenotype whereas osteocalcin is a late 
marker that is upregulated only in post-proliferative mature osteoblasts (Aubin 2001). 
 
3.1.2 Mechanical stimulation of bone cells 
Due to the complexity of the in vivo environment, in vitro representations are heavily 
relied on to study the phenomena of cellular response to mechanical stimulation. Such work 
has generally involved cell culture systems with controlled delivery of a substrate strain, fluid 




complexity and precision with varied levels of mechanical input signal with magnitudes 
ranging from 200 με to 100,000 με. 
Early efforts in the field of in vitro mechanostimulus were of a non-quantative nature. 
Pioneering work was performed by Glücksmann in 1939, who used numerous interesting 
biological loading models. One of these involved endosteal cell cultures from embryonic 
chick tibiae which were grown on substrates of explanted intercostal muscle to which pairs of 
neighbouring ribs were left attached (Glucksmann 1939). Over a period of days the endosteal 
cell cultures were compressed as the ribs were drawn together due to degeneration of the 
muscle tissue. Presently multiple in vitro techniques have been used to simulate in vivo strain 
on cultured cells including hypotonic swelling (Chen et al. 2005, Duncan and Hruska 1994), 
longitudinal mechanical stretch (Harell et al. 1977, Jones et al. 1991), biaxial mechanical 
stretch (Brighton et al. 1991, Buckley et al. 1988, Hasegawa et al. 1985), substrate bending 
(Bottlang et al. 1997, Pitsillides et al. 1995), fluid shear (Reich et al. 1990a, Reich and 
Frangos 1991), hydrostatic pressure (van Kampen et al. 1985, Veldhuijzen et al. 1979) and 
compressive loading (Davies et al. 2006, el Haj et al. 1990). These different methods of in 
vitro strain application produce different types of cellular deformation (Figure 98). Variation 
in cell deformation engendered by these methods of applying strain makes it questionable 






Figure 98: Schematic representation of cellular deformation in vitro under different types 
of loading. a) Hypotonic swelling, b) Uniaxial stretch, c) Biaxial stretch, d) Fluid shear,                  
e) Hydrostatic pressure 
 
Considering that bone cells are probably loaded in vivo by mechanical stretch and fluid 
shear, hypotonic swelling and biaxial stretch are probably the least physiologically relevant in 
vitro models as hypotonic swelling does not occur in bone under physiological conditions and 
biaxial stretch does not accurately represent the effects that occur in mineralised bone 
(Duncan and Turner 1995). Hydrostatic pressure rarely occurs in mineralized bone but can be 
observed in certain very specific cases i.e. during endochondral ossification of long bones 
where cartilage increases in size and is replaced by bone (Carter and Wong 1988, Ochoa et al. 
1991). 
 
3.1.2.1 Mechanical stretching systems 
Stretching systems that utilize a controlled uniaxial deformation of substrate have many 




back to the 1980s by work performed by Somjen et al who developed a static loading system 
(Somjen et al. 1980) but developments have been made in control of parameters and the 
accuracy of applied strain. Leung showed the potential for an oscillating load by using a 
motorized plunger-linkage system adapted to stretching rectangular elastin substrates seeded 
with aortic smooth muscle cells (Leung et al. 1977). However the heterogeneity of the strain 
distribution was due to the effects of the end grips and the different physical properties and 
geometric irregularities of the natural elastin. 
 
Figure 99: Uniaxial substrate tension (stretch) 
 
Improvements were made by Ives et al by simplifying the motor system to a spring- 
loaded pulley/cable arrangement and by replacing the natural substrate with a more 
homogeneous and geometrically regular polyetherurethane urea substrate (Ives et al. 1986). 
Individual rectangular wells sealed into a common polycarbonate base sheet have been 
described with the mechanical strain being generated by the base sheet tensioned cyclically 
(Murray and Rushton 1990), but no method was presented to measure the strain distribution 
on the culture surface. Another device employing rectangular wells was described four years 
later where individually cast silicone rubber dishes were gripped by brackets and driven by a 
DC (direct current) motor. Strain distribution for both the axial and transverse (Poisson 
effect) components were measured by optical measurements of grid ruling which led to the 
input strain fields being well quantified (Neidlinger-Wilke et al. 1994). There have been 
some specialized developments of the longitudinal stretch system where microscopic and 




3.1.2.2 Biaxial mechanical stretch 
Biaxial stretch of a substrate can be achieved by pulling a membrane segment in two 
perpendicular directions (Figure 100). This system is not vulnerable to frictional problems 
(discussed further in later examples), but is demanding in terms of hardware implementation 
and only provides biaxial strain at sites located away from the grips (Norton et al. 1995).  
 
Figure 100: Biaxial substrate strain 
 
Another system of achieving biaxial strain was by a vertically pulsating circular ring with 
low friction outer rim which served to stretch a portion of a cell culture membrane (Figure 
101) (Hung and Williams 1994).  
 




3.1.2.3 Substrate bending 
Substrate bending (Figure 102) provides an alternative method for the generation of 
uniaxial longitudinal strains to a culture surface. A four point bending systems have been 
developed to deliver a low strain level which coincides with the strains experienced in bone 
in vivo, typically several hundred to approximately 3000 με (Bottlang et al. 1997). Cast 
silicone rectangular dishes were bent using a four point bending set up by means of an 
electromagnetic actuator and homogeneity of strain was demonstrated optically using 
holographic interferometry as the strain levels were low  (Bottlang et al. 1997). Other four 
point bending systems have been devised using plastic strips onto which osteoblasts-like cells 
and osteocytes were seeded (Pitsillides et al. 1995). Another four point bending system 
created by Jones et al used rectangular culture plates made of polycarbonate or glass 
suspended within a silicone rubber culture well which enabled the study of either 
compressive or tensile strains depending on the sides of the substrate being loaded (Jones et 
al. 1991). In this study, it was reported that strains of over 10,000 με de-differentiated the 
osteoblasts and changed the cell morphology to become fibroblasts-like. 
 
 
Figure 102: Longitudinal substrate bending 
 
3.1.2.4 Fluid shear systems 
Another approach to cell culture mechanostimulus reported in the literature has been by 




influenced by fluid shear including cellular response and mechanoreception (Davies 1995, 
Klein-Nulend et al. 1997). Two main types of apparatus configurations have been reported 
including the cone-and-plate system (Figure 103a) and the parallel flow chamber (Figure 
103b). The cone-and-plate system generates fluid shear by rotation of a cone around its 
central axis which is orientated perpendicularly to a flat plate (Hermann et al. 1997, Mohtai et 
al. 1996, van Grondelle et al. 1984). The other fluid shear system, the parallel plate flow 
chamber, relies on a pressure differential created between two openings at either end of a 
rectangular chamber which generates a laminar flow across the culture surface. This system 
holds many practical benefits including the homogeneity of the shear stimulus, simplicity of 
the equipment, ease of changing of the cell medium, simplicity of access to the culture and 
small volumetric requirement (Brown 2000). 
 
Figure 103: a) Cone and plate chamber, b) Parallel plate flow chamber 
 
3.1.2.5 Hydrostatic pressure 
Hydrostatic pressurization (Figure 104), has been a very frequently used method for 
compression of cells, tissue and explanted cultures (Bagi and Burger 1989, Bourret and 
Rodan 1976, Klein-Nulend et al. 1986, Lippiello et al. 1985, Wu et al. 2007). Both negative 
and positive pressures has also been described (Yousefian et al. 1995). Hydrostatic 




homogeneity of the stimulus, simplicity of configuration multiple loading replicates and ease 
of delivering and generating either static or short dynamic loading inputs. Because there is no 
direct contact from piston there is no concern of cellular compaction and there is no 
dependency on the state of adhesion of the cell culture and the substrate. In order to create the 
hydrostatic pressure, the incubator gas pressures required are high which in turn produces 
increased levels of oxygen and carbon dioxide in the cell medium, which then requires a 
compensatory treatment step involving changing the ratio of CO2 and oxygen (Ozawa et al. 
1990). 
 
Figure 104: Hydrostatic pressure 
 
3.1.2.6 Compressive loading 
This loading technique has been attractive for cartilage and bone stimulation due to its 
similarity to in vivo loading. Pneumatically controlled systems in which small cartilage 
explanted discs were loaded in an unconfined uniaxial compression have been reported 
(Torzilli et al. 1997). Earlier variations have been described where constant or low-cycle 
intermittent loads were manually applied to cartilage explants by means of dead weights 
(Burton-Wurster et al. 1993), or a motorized micrometer and a sensitive load cell were used 
to deliver a precise and controlled load over three orders of magnitude (0.001-1.0 MPa) in 




Axial compression for bone has also been developed. A pneumatically driven culture 
system for the axial compression of 10 mm core biopsies of cancellous bone have been 
developed by el Haj et al, but in addition to the axial compression the system provided 
controlled delivery of nutrient fluid by means of portals in the compression piston (el Haj et 
al. 1990). Other pneumatically driven axial systems that are able to stimulate up to 24 rat 
mandibular condyles explants specimens have been reported (Copray et al. 1985). Similar 
multi-specimen unconfined compression systems were reported using a ring to control axial 
displacement of the specimens, however there was no attempt made to quantify strain 
delivered to the individual specimens but only estimates made of strains ranging between 50 
and 80% (Cheng et al. 1996). Another system was developed by Tanaka with particular 
interest in bone strain (Tanaka 1999). This system used a piezoelectric actuator which was 
driven by a power amplifier as to achieve axial piston displacements. It was capable of 
importing waveforms which could govern the frequency and the generated strains. An in vivo 
technique for mechanically loading cells seeded on a polymer scaffold has been reported by 
Duty et al in which cylindrical scaffolds seeded with rat MSCs were implanted 
subcutaneously in a specially designed chamber which delivered a 30 minute load three times 
a week for two weeks. The chamber assembly was then left for a further 4 weeks to maximise 
the mineral deposition in response to the loading (Duty et al. 2007). 
 
3.1.2.6.1 Zetos bioreactor and mechanical loading system 
A more recent mechanical compression system was developed in 2003 and called the 
Zetos™ system (Figure 105). The Zetos™ is a highly accurate mechanical loading and 
measurement system with a combined diffusion culture/loading chamber which acts as a 
bioreactor. It was specifically designed to study trabecular bone under controlled culture and 
loading conditions for long periods of time. The loading system has been designed to 
function in two main modes. The first is to apply a specific compressive strain to the sample 
and the second is to deliver a specific force to the specimen and record the resulting 




50 Hz with amplitudes over 7000µε. The system allows accurate measurement of numerous 
mechanical properties including Young‟s Modulus (Jones et al. 2003).  
The loading system consists of a frame of six hardened steel bolts with stainless steel end 
caps encased in an aluminium housing. A screw mechanism raises and lowers the load 
sensor; a piezoelectric actuator unit, including strain gauge with the load sensor (Figure 
105a). The screw mechanism can also be used to deliver a small static preload to the sample 
which brings the interfacing surfaces of the machine and the machine/bone interfaces into 
contact (Jones et al. 2003). The piezoelectric actuator (Figure 105b) is controlled by a high 
voltage amplifier whose input is connected to a microcontroller circuit and is capable of 
applying forces of 4500 N, with a maximum expansion of typically 60 µm. Combined with a 
WINDOWS based user interface program, one is able to apply a quantifiable force or 
deformation of the bone core in the culture/loading chamber (Figure 105c). The 
microcontroller and associated electronic system and sensors work independently of the 
computer‟s operating system and are capable of recording both the piezoelectric expansion 
from the strain gauge, and the force from the load cell. The current configuration of the 
loading system is to test bone cores 5mm in height and 10mm in diameter which are housed 
in the culture/loading chambers. 
 Previously discussed bone testing and loading systems used to evaluate and test living 
tissue rely on hydraulics or a variety of levers, cams and screws which are unable to provide 
tightly controlled real-time measurements of force and deformation under dynamic loading 
conditions. A precise and quantifiable loading system is necessary to apply well defined 
mechanical loads that mimic in vivo, loads to samples that can vary in their material and 
structural properties. This is why the Zetos™ was used to mechanically stimulate the 
polycaprolactone scaffolds seeded initially with MG63, an osteoblast-like cell line and then 






Figure 105: Zetos™ bioreactor system, a) force sensor, b) piezoelectric actuator, c) 
culture/loading chamber. (Image adapted from Jones et al. 2003) 
 
Previous work done using the Zetos™ bioreactor has generated encouraging data. 
Explanted ovine, bovine and human cancellous bone cores were cultured in the Zetos™ 
culture/loading chambers to compare the macro and micro-architecture of the three bone 
types so that a source of experimental material could be selected (Davies et al. 2006). In 
another study, the Zetos™ bioreactor was used to maintain osteocyte viability and investigate 
the effects of mechanical loading on osteocyte apoptosis in human trabecular bone (Mann et 





3.2.1 Polycaprolactone scaffold preparation 
Before cells could be seeded on the polycaprolactone (PCL) scaffolds (see paragraph 
1.3.6), the latter had to undergo several steps before they were ready. After the scaffolds had 
been manufactured, they were washed thrice in sterile distilled water and stored in a freezer at 
-20 ºC so that they could be used when required. Before the experiment could start, the 
scaffolds were removed from -20ºC and thawed by immersing in sterile distilled water for 40 
minutes at room temperature. The scaffolds were then cored our using a 5 mm diameter 
biopsy punch and placed in 100% industrial methylated spirit (IMS) for 15 minutes to 
sterilise the scaffold. The scaffolds were then removed and washed three times in sterile 
distilled water in a tissue culture hood which removed any remaining IMS and maintained the 
scaffolds in a sterile environment. The scaffolds then underwent different steps depending on 
the type of experiment. 
 
3.2.2 PCL scaffolds seeded with MG63 in Zetos™ bioreactor 
All manipulations were carried out under sterile conditions. The Zetos™ bioreactor 
system (Figure 106) was originally designed to maintain ex vivo bone cores with the 
application of a controlled cyclic mechanical loading pattern (Davies et al. 2006, Jones et al. 
2003). Instead of bone cores, the PCL scaffolds were placed in the chambers and were 
maintained by the constant perfusion of nutrients and oxygen. The Zetos™ bioreactor 
consists of a set of diffusion chambers in which the scaffolds are placed. These chambers are 
connected via tubing (Tygon, France) to a reservoir of media that supplies the scaffold by the 
use of a perfusion pump with a flow rate of 7 ml/hour. The scaffolds within the chambers 
were mechanically stimulated on a daily basis for the duration of the experiment, using loads 
that engendered a peak strain of 5000 με at a frequency of 1 Hz in a wave pattern 
corresponding to physiological jumping exercise based on studies in bovine bone (Mann et al. 




 The chambers contain a loading piston at the top (Figure 108a) which transmits the load 
to the scaffold however there is no recoil mechanism for the piston, as the intended specimen 
is bone and due to its inherent mechanical properties, naturally recoil the piston. Due to this 
and the nature of the scaffolds, rubber rings (Figure 108c) were manufactured that would fit 
around the scaffold and also fit in the chambers. This would enable the piston to recoil by the 
help of the rubber rings and hence permit the scaffolds to be loaded cyclically. 
 
Figure 106: Zetos™ bioreactor system with chambers, perfusion pump and reservoir of 
media 
 
Scaffolds first were treated as previously mentioned in paragraph 3.2.1, then 10 scaffolds 
were immersed in 0.2% w/v  gelatin for 30 minutes the gelatin was previously filter sterilised 
(see chapter 1) to increase cell adhesion. MG63s were selected as this cell line proliferates 
rapidly which was useful as 6 million cells were required for the experiment. Ultimately the 
experiment was repeated with MSCs however the MG63 cell line provided valuable 
information in determining whether cells on PCL scaffolds in the Zetos™ chambers were 





Figure 107: Physiological mechanical stimulation 
 
During the preparations of the scaffolds, the MG63 cell line was being prepared for 
seeding onto the scaffolds. This was accomplished by first removing the media from the T75 
flask (Corning) followed by three washes with PBS. One millilitre of trypsin, an enzyme that 
is used to detach the cells from the flask, was added to the flask to wash the cells and 
removed after 5 seconds. Another millilitre of trypsin was added to the flask for 5 minutes, 
the flask was tapped occasionally to encourage the cells to detach. The trypsin was then 
neutralised by adding 9ml of growth media to the flask. Ten micro-litres (μl) were removed 
from the cell suspension and deposited on the haemocytometer to determine cell number. The 
scaffolds were placed in two large cell culture Petri dishes (Corning, 150 mm x 25 mm) and 
growth media added to the cell suspension to obtain a cell concentration of 4.2 million 
cells/ml. The scaffolds (10 treated with gelatin and 10 un-treated) were seeded with 250,000 
cells in 60µl. The scaffolds were flipped every 30 minutes for 4 hours so that cells were 
evenly distributed throughout the scaffold, then 45ml of growth media was added to each 
Petri dish until the scaffolds were submerged and they were left over night. The scaffolds 
were then transferred to non tissue culture plastic 48 well plate and 500µl of growth media 
was added to each scaffold and the plate was then left for 3 days. Two coated and 2 non-
coated scaffolds were removed which would be used to represent the start of the experiment 
(T0) and cut in half, with one half flash frozen in super cooled hexane (-80°C) bath and the 
other dipped in OCT embedding matrix (Raymond A Lamb) before flash freezing to be used 
for cryostat sectioning. Four coated and four non coated scaffolds were placed in a 50 ml 
universal tube with 5 ml of Zetos™ growth media, the rest of the scaffolds were placed in the 




culture media. The Zetos™  growth media consisted of 13.38g of powdered DMEM (Gibco, 
UK), 2.38g of HEPES (final concentration 10 mM/l), 1.08g of β-glycerol 2- phosphate 
disodium salt hydrate (BGP) (final concentration 5 mM/l), 1.6ml of 7.5% sodium hydrogen 
carbonate (final concentration 0.14 mM/l) and finally adding 1000ml of ultra pure water. The 
mixture was stirred using a magnetic stirrer and the pH was measured using a pH meter 
(Thermo Orion, model 410) and adjusted to 7.25 - 7.3 by adding dropwise 1M sodium 
hydroxide (NaOH) solution. The media was then filtered through a Nalgene bottle top filter 
(75 mm diameter membrane, 0.2 µm pore size) and separated into 450ml amounts. The media 
was then supplemented with 10% Foetal calf serum (FCS) (Autogen Bioclear), penicillin 
(final concentration 50IU/ml) streptomycin (final concentration 50μg/ml) and 5ml of l-
glutamine were added to the growth media.  
 At days 3 and 7 (T3, T7), two gelatin treated and two non-treated scaffolds were removed 
and frozen as previously described. The media that the scaffolds were bathed in was divided 








Figure 108: First (I and IV) and Second (II and III) types of Zetos culture/loading 
chambers, a) tip piston through which load is transmitted, b) main body of chamber where 
scaffold is housed, c) rubber support with grooves to allow improved flow of media, d) 
scaffold seeded with MSC, e) bottom of chamber which screws into the main body, f) rubber 







Figure 109: Timeline flow chart of MG63 Zetos bioreactor experiment 
 
3.2.3 PCL scaffold seeded with MSCs and mechanically loaded in Zetos™ bioreactor 
All manipulations were carried out under sterile conditions. The methodology for this 
experiment resembles the previous experiment with a few differences. The cell concentration 
was the same as the previous experiment (4.2 million cells/ml) but once the cells were seeded 
on the scaffolds (250,000 cells per scaffold) (Figure 110) they were turned upside down 
every half hour for four hours to obtain an even cell distribution and to increase the number 
of cells attaching to the scaffold. If the scaffolds were not turned upside down, gravity would 
have taken effect and the cells would have ended up at the bottom of the scaffold with little 
cells attached to the scaffold. 
 Drops of media were added in between the scaffolds to increase humidity in the Petri 
dish as this would minimise the amount of evaporation from the media on the scaffolds 
(Figure 110). After four hours growth media was added to the Petri dish and the scaffolds 
were left overnight before being transferred to a 48 well plate. The scaffolds were left in 
those conditions for 7 days with media changes every two days. In this experiment, the effect 
of scaffold geometry on osteogenesis was also investigated so 2 different geometries were 
used. The first was „double strand with offset‟ (DSO) and the second „double strand with 
offset and 45º rotation‟ (DSO45) (see chapter 1). All the scaffolds were coated with 0.2% w/v 
gelatin but 4 DSO and 4 DSO45 were not seeded with cells and were used as a control. MSCs 
were also plated out in 8 wells of four different sets of 24 well plates, with two plates kept in 
an incubator where one plate seeded with MSCs was fed with growth media and the other 





Figure 110: Initial static seeding of scaffolds 
 
The other two plates were taped up to mimic the closed environmental conditions that the 
cells were experiencing in the Zetos™ chambers and kept in the walk-in Zetos™ 
environmental chamber which contained the plates, the peristaltic pump, the media and the 
Zetos loading device which were maintained at 37°C. The two plates with 8 of the wells fed 
Zetos™ osteogenic differentiation media and the remaining 8 wells were fed Zetos™ culture 
media. This experiment had four groups which included the loaded group, the flow group, the 
static group and the no cell group with three scaffolds per group. The loaded group was 
mechanically loaded daily with a preset wave pattern corresponding to physiological jumping 
exercise for 5 minutes daily using forces that engendered peak strains of 5,000 με at a 
frequency of 1 Hz (Figure 107). The flow group were in Zetos™ chambers but were not 
mechanically stimulated and only experienced fluid flow that was generated by the pump that 
provided media for the cells seeded on the scaffold. The static group which did not involve 




Zetos™ osteogenic differentiation media and the no cell group were not seeded with cells and 
were kept in the same static conditions. The media was changed every 2 days and replaced 
with fresh media. The pH of the used media was recorded (Thermo Orion, model 410) to 
provide important information regarding the efficacy of the buffer which would influence the 
environment in which the cells were present.  
Zetos™ osteogenic differentiation media comprised of 2.16g of β glycerol-2-phosphate 
(BGP) (final concentration 10mM/l) was added prior to adjusting the pH to 7.25 – 7.3 
followed by 2.5ml of ascorbic acid (final concentration 50μM/l) and 50µl of dexamethasone 
(final concentration 0.1μM/l.  
 
3.2.4 Analysis of scaffolds 
On completion of the experiment, the scaffolds were removed from the chambers and the 
media retained to measure pH levels in order to determine whether the pH was within 
physiological range. The scaffolds were then cut in half longitudinally using a disposable 
scalpel (Swann-Morton) , half was flash frozen in a super cooled hexane bath (-80ºC) for 
quantifying the amount of calcium present by the o-cresolphthalein method (see below), and 
the other half dipped in OCT embedding matrix (Raymond A Lamb) for cryostat sectioning 
before being flash frozen. The samples placed in bijous and labelled then were refrigerated 
and stored in minus eighty (-80ºC).  
The embedded samples were mounted on a bronze chuck and cryostat sectioned with 
sections 10µm thick. The sections were cut and stuck onto tape to facilitate the removal of the 
section from the cryostat blade and to maximise the integrity and quality of the section. The 
sections were then fixed with 4 % w/v paraformaldehyde (Sigma, UK) dissolved in PBS and 
then stained with DAPI which binds with cellular DNA and with Von Kossa which binds 
with calcium ions and produces a black deposit that can be viewed using a microscope. The 
stained sections were then viewed and images captured with a DXM1200 camera mounted on 
the microscope (Nikon, Eclipse E800) using a 10x/0.30 ∞/1.2 magnification lens. Four 




the PI could be seen and a bright field image was also taken so that Von Kossa staining could 
be observed. The digitally saved images were then processed using ImageJ (Collins 2007) so 
that a cell count and a mineralised area could be measured. 
The other half of the scaffold was treated using the o-cresolphthalein complexone method 
which determines the quantity of calcium resent in a given sample. This technique has been 
used in numerous other papers with positive outcomes (Lorentz 1982, Wible, Jr. and Hynes 
2004). The technique and method that was used for the analysis was taken from the American 
Clinical Chemistry database (Toffaletti and Kirvan 1980). 
Briefly two solutions were required, 2-Amino-2-methyl-1-propanol (AMP) buffer and the 
colour reagent. The AMP buffer was created by adding 15.12ml of AMP to 60ml of distilled 
water. This was then adjusted to 10.7 with a 6N hydrochloric acid (HCl) solution. The 
mixture was then poured into a volumetric flask and distilled water was added until the 
100ml mark was reached. The mixture was then stored and refrigerated in a sealed covered 
bottle to limit the exposure to air and to sunlight. Under these conditions, the mixture is stable 
for three weeks. The second mixture was prepared by adding 6ml of concentrated HCl to 10 
ml of distilled water in a 100ml volumetric flask. To the diluted HCl solution 10mg of o-
cresolphthalein (Sigma, UK) and 100mg of 8-hydroxyguinole (Sigma, UK) were added. 
Distilled water was then added until the 100ml mark was reached. The mixture was then 
transferred to a sealed covered glass bottle and stored at room temperature. The solution is 
stable for one month. 
The scaffolds were individually placed in a 1ml Eppendorf with 500μl of 1N HCl in an 
orbital shaker over night to dissolve the calcium. With this method, a calibration curve 
needed to be created so various known quantities of calcium were generated. This was 
achieved by using a calcium source, in this case calcium phosphate (CaHPO4) and weighing 
out 250mg and dissolving it in 10ml of 1N HCl. This concentration was suggested by 
Toffaletti as higher ones would yield inaccurate results as this was beyond the range of the 
assay. When the calcium had completely dissolved, the solution was then divided in two and 
5ml of 1N HCl was added to one of the solutions which halved the calcium concentration. 




To perform the analysis, 250μl of colour reagent and 250μl of AMP buffer were mixed 
together in a 1ml Eppendorf tube. 12.5μl of calcium solution was removed from the scaffold 
solution and from the prepared calcium solutions and placed in a 1ml Eppendorf tube and 
mixed vigorously. The solution turned purple if calcium was present. A 96 well plate (Costar) 
was then used and 4 x 100μl of each calcium solutions were added and read using a Cytofluor 
multi well plate reader (Series 4000). The frequency set for the plate reader was 540nm and 
the filter set at 750nm. 
 
3.2.4.1 Statistical analysis 
All statistical analysis was performed using quantative data analysis with SPSS release 
16 for Windows. Data was checked for normal distribution by applying the homogeneity of 
variance (Levene) test. In cases where the randomly selected data were shown to have normal 
(Gaussian) distribution, i.e. where 95% of the data fell within plus or minus 1.96 standard 
deviations from the mean, parametric statistical tests such as two-tailed Analysis of Variance 
(ANOVA) and the post-hoc Tukey-Kramer test were performed directly to determine 
statistical significance between the groups. When the p value of the ANOVA test was p<0.05, 
the use of the Tukey-Kramer post-hoc test allowed comparison of more than two means at 
once without introducing the type I error associated with multiple t-tests (Fielding and Gilbert 
2000, Zar 1984). Results are expressed as means ± S.E. p < 0.05 was considered to be 
statistical significance. In some cases, the homogeneity of variance was not met and therefore 
a non-parametric Mann-Whitney t-test was performed with a confidence interval of 95%. 
 
3.2.5 Combining finite element analysis measurements with manufactured scaffold 
properties 
The aim of this study was to determine whether the surface strain generated during cyclic 
mechanical stimulation of the scaffolds and the measured surface strain using the finite 
element models would coincide. Two different scaffold geometries were also tested with the 




same mechanical stimulus and additionally the Young‟s modulus of the mechanically tested 
DSO scaffolds were on average 2.6 times greater than the DSO45 scaffolds. These two 
scaffold geometries were chosen as the only difference between them is the rotation of the 
layers. It can be seen from the results in chapter 2 that greater surface strain differences exist 
between different scaffold geometries however that would involve introducing another 
variable which would make the comparison of scaffolds difficult.  
It is noted that the cellular organization is different from that in living bone to that of the 
cell-seeded scaffolds due to the absence of embedded osteocytes and functional canalicular 
networks (Kenny and Raisz 2002, Noble and Reeve 2000). However understanding the 
effects of mechanical loading on scaffolds and determining whether scaffold design is 
capable of altering MSC differentiation is important as repair sites are usually load bearing 














3.3.1 Polycaprolactone scaffold and MG63 cells in Zetos™ bioreactor 
Briefly, media was changed and the pH measured every 2 days (T2 and T4) however there 
was no media change at day six as the experiment would be terminating at day seven. Two 
coated and two non-coated scaffolds were removed at the start of the experiment (T0) and at 
day three (T3) with the remaining scaffolds removed at the end of the experiment at day 7 
(T0). Before changing the media the pH was adjusted to between 7.25 – 7.3 with 1M NaOH. 
Due to the removal of the scaffolds from the Zetos™ chambers, the table below (Table 15) 
has some missing values as at the time points the scaffolds were removed and images were 









































1 7.29 x x 
2 7.27 x x 
3 7.27 7.04 6.93 













5 7.29 x x 
6 7.29 x x 
7 7.29 7.10 6.93 




















9 7.49 x x 
10 7.46 x x 
11 7.48 7.46 7.44 













13 7.53 x x 
14 7.48 x x 
15 7.50 7.48 7.44 
16 7.55 7.51 7.45 
Table 16: pH measurement of media of MG63 in Static and in Zetos™ chambers 
 
It can be observed from the table above, that in the static condition, the pH becomes more 
acidic over time which could be due to the increased number of cells present on the scaffold 
producing more lactic acid due to anaerobic growth and also due to the smaller volume of 
media administered to avoid issues of oxygen reaching the cells seeded on the scaffold, 
improving the oxygen gradient. In the Zetos™ chambers, the pH was more alkaline than the 














Figure 112: Images of PCL seeded with MG63 cell line at T0, a) DAPI stain coated with 
0.2% gelatin, b) bright field coated with 0.2% gelatin, c) DAPI stained and d) bright field 






Figure 113: DSO scaffold seeded with MG63 at day 3 (T3) stained with DAPI 
 
 





3.3.2 Polycaprolactone scaffold and marrow stromal cells loaded in Zetos™bioreactor 
Briefly, the scaffolds were seeded statically with MSCs and placed into the Zetos system 
for 14 days. This experiment was repeated three times with the marrow stromal cells (MSCs) 
obtained from different patients for each individual experiment (Table 16). The quantity of 
calcium in half of the scaffold was then measured using the o-cresolphthalein complexone 
method, which first required a calibration curve so that the optical densities obtained from the 







Table 17: Age and sex of patients from which MSC were obtained 
 
3.3.2.1 First Zetos™ bioreactor results 
During the course of this initial experiment, the pH was measured after each media 
change to determine whether the pH of the osteogenic differentiation media stays within the 
neutral range and that there are no unexpected and unwanted changes that might affect the 
cells. From figures 115 and 116, it can be observed that the pH remains within the neutral 
range and therefore would not be expected to endanger the MSC cells. 
The next results involved quantifying the amount of calcium produced using the o-





  Age   Sex 
Run 1 70 M 
Run 2 69 F 






Figure 115: pH of media during the course of the experiment with DSO scaffold 
geometry  
 






Concentration (mg/dl) Optical density Average 
12.5 0.267 0.273 0.278 0.277 0.274 
6.25 0.15 0.15 0.152 0.156 0.152 
3.125 0.077 0.078 0.081 0.077 0.078 
1.5625 0.047 0.047 0.046 0.037 0.044 
Table 18: Calcium concentration and respective optical density 
 
 
Figure 117: Calibration curve for o-cresolphthalein complexone method 
 
From the calibration curve, a formula was then derived (  to 
represent a correlation between calcium concentration and optical density. The optical 




formula and which yielded the calcium concentration present in the scaffold solution for both 
the scaffold geometries and treatments (Figure 118 and 119). Before obtaining the 
concentration the first step of the calculation was to normalise the weight of calcium present 
in each scaffold by dividing it by the weight of the scaffold which was measured after freeze 
drying and before starting the o-cresolphthalein complexone method. The normalization 
process was required as when the scaffolds were cut in half prior to flash freezing, the halves 
were not exact as this was performed by hand and this would have skewed the results of the 
calcium concentration as larger scaffold „halves‟ would have a larger calcium concentration. 
 
Figure 118: DSO scaffolds with different treatments versus average weight of calcium 
per mg of scaffold 
 
The two different scaffold geometries tested were the double stranded offset (DSO) 
(Figure 118) and the double stranded offset with 45° rotation (DSO45) (Figure 119). Each 
scaffold with different geometry was seeded with MSCs and underwent different treatments, 




figure 118 that there was statistical difference between the static treatment and both the 
mechanically loaded and flow treatment and between the mechanically loaded and the no cell 
group, however no statistical significance was present between the other treatments. From the 
results of the DSO45 scaffold geometry (Figure 119), it can be seen that statistical 
significance was observed between the mechanically loaded and both the static and the no 
cell control treatment furthermore statistical significance was also visible between the static 
and the flow treatment. 
 
Figure 119: DSO45 scaffolds with different treatments versus average weight of calcium 
per mg of scaffold 
 
Briefly, transversal cryostat sections of 7μm were obtained from the other half of the 
scaffolds and the sections were first fixed using 4% w/v paraformaldehyde dissolved in PBS 
and allowed to dry at room temperature, then stained with Von Kossa which stains mineral in 
the section and propidium iodide (PI) which stains cellular DNA and finally the section was 
covered with a glass cover slip. The stained sections were then captured digitally using a 




imaging program (ImageJ), areas of Von Kossa and number of cells per section were 
measured. The area of Von Kossa stained mineral was measured to compare with the results 
obtained from the o-cresolphthalein complexone method for the DSO scaffold geometry 
(Figure 120). The cell count was also performed to investigate the number of cells present at 
the end of the experiment (Figure 121). Von Kossa staining can be observed in figure 124 in 
the areas I and II which represents two successive sections. This demonstrates that some 
components of the mechanical stimulus generated by the Zetos™ mechanical stimulator are 
capable of inducing osteoblastic differentiation of MSC. 
 
Figure 120: Area of mineral stained by Von Kossa measured using Image J (No 
significant difference between groups) 
 
From figure 120, it can be seen that the area of Von Kossa staining was the largest in the 
DSO loaded group and followed by the DSO flow group however no statistical significance 
was observed between the groups. This result however demonstrates that more Von Kossa 
stained mineral was observed in the DSO loaded group which was also shown in the o-
cresolphthalein results (Figure 118). A similar result can be observed with the DSO45 
scaffolds, with the largest Von Kossa staining seen in the mechanically loaded scaffold 




The PI stained cell count for the DSO scaffold (Figure 122) and the DSO45 scaffold yielded 
similar results with no statistical significance observed between the treatments. However 
there was a trend observed in both the different scaffold geometries where the static treatment 
had the highest cell count average (Figure 122 – 123) and large error bar. The mechanically 
compressed scaffold had the second highest cell count average in both cases and the scaffold 
with no cells had the lowest in both scaffold geometries (Figure 122 – 123). 
 
 
Figure 121: Area of mineral stained by Von Kossa measured using Image J (No 












Figure 122: PI stained cells counted with Image J 
 
 






Figure 124: Von Kossa staining of DSO45 Loaded of the same area of two consecutive 
sections, a) 1550 µm b) 1560 µm from top of scaffold 
 
3.3.2.2 Second Zetos™ bioreactor results 
During the course of the second experiment, the pH of the changed media was recorded 
and the values illustrated in figures 125 and 126. 
 
Figure 125: pH of media during the course of the second MSC in Zetos system 





Figure 126: pH of media during the course of the second MSC in Zetos system 
experiment with DSO45 scaffold geometry 
As previously mentioned in paragraph 3.2.1., a calibration curve was plotted (Figure 127) 
which would permit the quantity of calcium present in the scaffold to be determined. Briefly, 
calcium phosphate was dissolved in 3N HCl to an initial concentration of 25mg/dl, followed 
by a serial dilution where the final calcium ion concentration was 0.78125mg/dl. 
At the start of this experiment, the number of scaffolds per treatment was four however 
during the two week course of the experiment; three Zetos™ chambers broke which reduced 












Figure 127: Calibration curve for second Zetos bioreactor experiment 
 
 
Figure 128: Calcium concentration per weight of scaffold for all the treatments (no 





Figure 129: Calcium concentration for DSO scaffold geometry 
 
 





From the second run of the Zetos™ bioreactor it can be seen that in the DSO scaffold 
geometry group (Figure 129), statistical significance was observed between the DSO static 
and mechanically loaded group however no statistical difference was obtained between the 
other different treatments. This trend of the largest amount of calcium produced in the 
mechanically loaded group, was also observed in the initial Zetos™ run. The other treatments 
yielded similar values which were unexpected as results from fluid flow and static conditions 
were similar to the control group which had no MSC. This would imply that no calcium was 
produced in the fluid flow group, the static group as no cells were present in the final group 
and therefore no calcium could be produced. 
The other scaffold geometry DSO45 (Figure 130), statistical significance was observed 
between mechanically loaded and static scaffolds treatments which were also observed in the 
first Zetos™ run, however the treatment which generated the highest quantity of calcium was 
the fluid flow treatment where the seeded scaffolds were in individual Zetos chambers with 
the absence of mechanical compression of the scaffold. 
Image J was used to determine the area of stained mineral and the number of PI positive 
cells. The area of Von Kossa present on the four sections at a distance 150µm from the top of 
the scaffold can be observed in figure 131 for the DSO scaffolds and figure 132 for the 
DSO45 scaffolds with no statistical significance observed. The number of cells present on the 
same four sections can be observed in figure 133 for the DSO scaffolds and figure 134 for the 
DSO45 scaffolds. In the cells stained with PI statistical significance was observed between 
the DSO load group and both the DSO flow and DSO no cells group (Figure 133). However 
in the DSO45 scaffold geometry, statistical significance was only observed between the 
DSO45 group and the remaining three groups (Figure 134). Representative images used to 










Figure 131: Area of mineral stained on sections of DSO scaffolds using Von Kossa 
measured using Image J (No statistical significance) 
 
 
Figure 132: Area of mineral stained on sections of DSO45 scaffolds using Von Kossa 





Figure 133: Cells positively stained for PI which indicates average number of cells 
present at distances 150μm – 153μm from the top of the scaffolds in the DSO scaffolds 
 
 
Figure 134: Cells positively stained for PI which indicates average number of cells 





Figure 135: Representative bright field images, a) DSO Static, b) DSO45 Static, c) DSO 





Figure 136: Representative PI fluorescent images, a) DSO Static, b) DSO45 Static, c) 





3.3.2.3 Third Zetos™ bioreactor results 
For the third repeat of the experiment and due to the failed chambers from the previous 
run, new chambers were used which were all identical which would render the experiment 
more uniform and eliminate any factor which might have affected the outcome. For this 
experiment, an increased numbers of scaffolds per treatment (n=4) were used and therefore 
not enough wells were available in a 96 well plate to accommodate a calibration curve and 
solutions that were required to be measured. Therefore each treatment was allocated a 
separate calibration curve which was analysed together with the treatment; this created a 
separate calibration curve for each treatment group (Figure 137 – 140). 
 
Figure 137: Calibration curve for mechanically loaded scaffolds in Zetos bioreactor 
 
 





Figure 139: Calibration curve for static scaffolds in Zetos bioreactor 
 
 
Figure 140: Calibration curve for no cells scaffolds in Zetos bioreactor 
 
In can be seen from figure 141 that statistical significance was observed between the 
mechanically compressed (DSO loaded) group and both the DSO static and the DSO no cell 
group. In the DSO45 scaffold geometry group, statistical significance was only observed 

















Briefly, cryostat sections of 7μm were cut of all the scaffolds with different treatments 
and sections at a distance 150μm – 153μm were stained using the Von Kossa technique and 
PI. The sections were then observed using an upright microscope (Nikon, Eclipse E800) and 
the images recorded digitally so that they can be processed using an imaging program (Image 
J).  
The area of Von Kossa stained mineral for the DSO scaffolds (Figure 142) and the 
DSO45 scaffold (Figure 143) were measured. The PI positive cells were also counted using 
the program and cell numbers for the DSO scaffolds (Figure 144) and the DSO45 (Figure 
145) scaffolds were recorded.  
 
 
Figure 143: Area of stained mineral observed on sections stained by the Von Kossa 










Figure 144: Area of stained mineral observed on sections stained using the Von Kossa 
technique measured using Image J (No statistical significance) 
 
 
Figure 145: Average number of PI stained cells, comparison of different scaffold 







Figure 146: Average number of cells measured on sections 150μm – 153μm from the top 
of the scaffolds 
 
 
Figure 147: Average number of cells measured on sections 150μm - 153μm from the top 





Figure 148: Representative bright field images, a) DSO Static, b) DSO45 Static, c) DSO 





Figure 149: Representative PI fluorescent images, a) DSO Static, b) DSO45 Static, c) 





Image J was used to determine the area of stained mineral and the number of PI positive 
cells. The area of Von Kossa present on the four sections at a distance 150µm from the top of 
the scaffold can be observed in figure 148 for the DSO scaffolds and figure 149 for the 
DSO45 scaffolds with no statistical significance observed in both cases. For the PI stained 
cells the only case where statistical significance was observed between the two scaffold 
geometries was in the case of DSO load and DSO45 load (Figure 145). The number of cells 
present on the sections can be observed in figure 146 for the DSO scaffolds and figure 147 
for the DSO45 scaffolds. For the DSO scaffold group, statistical significance of the PI stained 
cells was observed between the DSO load group and both the DSO flow and DSO no cells 
group (Figure 146). However in the DSO45 scaffold geometry, no statistical significance was 
observed between any of the groups (Figure 147). Representative images used to measure the 















3.3.3 Combining FEA determined surface strain distribution and mechanically 
stimulated scaffolds in the Zetos™ bioreactor system 
 
 
Figure 150: Comparison of Young's modulus of FEA and manufactured PCL scaffolds 
 
From figure 150 it can be seen that the Young‟s modulii obtained from the mechanical 
testing and the FE analyses are in most cases fairly similar however for the DSNO45 and the 
DSO45 scaffolds the FEA determined Young‟s modulus are greatly different to the Young‟s 










Figure 151: Average surface strain distribution throughout different scaffold geometries 
 
 





3.4.1 Polycaprolactone scaffold and MG63 cells in Zetos™ bioreactor 
The aim of the first experiment was to determine whether cells could survive on test 
scaffolds in the Zetos™ chambers for a week. After the in vitro experiment where the PCL 
scaffolds were seeded with MG63 cells (see chapter 1) yielded a positive outcome, an 
experiment was undertaken which demonstrated that similar cell survival could occur in the 
Zetos™ system. 
The reason for choosing the MG63 cell line was due to their ability to proliferate more 
rapidly than the marrow stromal cells and therefore obtaining the numbers of cells required 
for the experiment (6 million cells required) speedily (approx 2 weeks). The MG63 cell line 
(Sakai et al. 2006), despite being a cancerous cell line has been reported to exhibit some 
osteoblastic traits characteristic to bone forming cells (Bachle and Kohal 2004) and has been 
widely used as a model for osteoblast research and toxicology studies (Hsu et al. 2007, 
Takagishi et al. 2006). The MG63 cell line was therefore chosen for the initial experiment to 
test their ability of survival on the PCL scaffold.  
During the course of the experiment, the pH was monitored to observe changes during 
the experiment. This was important as the polycaprolactone scaffold might have been 
breaking down and hence altering the pH of the media which would have had an effect on 
cell survival. The media used was the same as that used in similar experiments involving the 
Zetos™ bioreactor and bone cores (Mann et al. 2006) and needed to be investigated.  
As can be observed from paragraph 3.1, the pH of the media under static conditions with 
cells was more acidic compared to the control scaffold with no cells and the Zetos™ media in 
the „flow‟ and „load‟ group with cells. Statistical significance was observed between the 
„static‟ group with cells and the remaining three groups at the same time points during the 
course of the experiment at all the time points. It was also observed that that the control group 
with no cells was the least acidic at the time points which would indicate that the decrease in 
pH was due to cellular activity (Waldman et al. 2004). The pH of the media with the scaffold 




the media used in the Zetos™ system for each chambers (10ml) and that the  acidity 
decreased more rapidly in the smaller volume. As the media was circulating through the 
Zetos™ system it was being refreshed and oxygenated, which could have reduced the 
anaerobic metabolism of the cells which in turn would have reduced the lactic acid 
production of the cells (Mekhail et al. 2004). This could explaining the significant difference 
between the pH of the „static‟ group with cells and the pH of the media circulating in the 
Zetos™ system. The pH could have also been affected by the chambers which might have 
allowed a small quantity of air into the system which would have altered the pH. Overall the 
pH did not deviated greatly from the initial pH of 7.25 – 7.3 except for the static conditions 
and therefore was decided that HEPES would be a suitable buffer to use in media mixture for 
the future experiments involving the Zetos™ bioreactor (Mann et al. 2006). Although HEPES 
has been reported to be an effective buffer and has been demonstrated to inhibit acidic culture 
media with various cell types including osteoblasts (Kaysinger and Ramp 1998, Ramp et al. 
1994), bone marrow stromal cells (Kohn et al. 2002) and chondrocytes (Waldman et al. 
2004), adverse effects can arise from its use (Altura et al. 1980) including the production of 
free radicals (Simpson et al. 1988) and cytotoxic effects after exposure to light (Zigler et al. 
1985). In contrast the HCO3¯ ions which are present in the sodium bicarbonate (NaHCO3) 
added to the Zetos™ growth media, are effective buffers under acidic conditions and also 
have the additional advantage of being able to neutralize acid by removing the CO2 
(Waldman et al. 2004). However because HCO3¯ is a base, the presence of a non-bicarbonate 
buffer, i.e. HEPES, was also required to reduce the alkalization that occurs when sodium 
bicarbonate was added to the media (Levraut et al. 2001), thus the combined effect of HEPES 
and HCO3¯ should provide better maintenance of pH during the Zetos™ experiment (Mann 
et al. 2006).  
The effectiveness of the Zetos™ media was further supported by the images taken of the 
scaffolds under fluorescence which illuminated the cells present after they were stained with 
DAPI. It can be seen that at T0 in both geometries cells are visible (Figure 112) and that 
during the course of the experiment at time points T3 and T7 (Figures 113 and 114) cells were 
also present on the scaffold which demonstrates that cells were able to attach to the scaffold 




mixture described by Mann et al. It was visually observed that the number of cells at the end 
of the experiment was less than at the start however DAPI stained cells were still observed at 
the end of the experiment indicating viable cells. 
 
3.4.2 Polycaprolactone scaffold and MSC in Zetos™ bioreactor 
The aim of this experiment was to determine whether mechanical stimulation of primary 
human stromal cells seeded on PCL scaffolds maintained in the Zetos™ bioreactor system in 
osteogenic differentiation media are able to undergo osteogenesis and bone formation.  
Briefly, the scaffolds were divided into four groups, „loaded‟ where the scaffolds were 
mechanically loaded and experienced media flow, „flow‟ where the scaffolds were in the 
Zetos™ chambers but only experienced the media flow, „static‟ were the scaffolds were not 
in the Zetos™ system but in universals with no flow or mechanical loading and finally „no 
cells‟ which were scaffolds that were used as controls not seeded with cells. After 14 days, 
the scaffolds were removed and the amount of calcium produced measured as this would 
indicate which treatment created more calcium which would be synonymous with bone 
production. The pH of the media was recorded at every media change to determine whether 
the pH reached a toxic level for the cells.  
From the results of the first pH experiment it can be seen that statistical significance was 
observed between the „static‟ group and the rest of the groups. This interestingly was also 
observed in the Zetos™ bioreactor and MG63 experiment described above. The pH also 
tended to gradually decrease over time, this may have been due to the proliferation of cells 
which in turn lowered the pH by anaerobic metabolism of the cells creating lactic acid (Funes 
et al. 2007, Reyes et al. 2006) however could alternatively be due to the increased metabolic 
cellular activity.  For the calcium quantification, the scaffolds with the two different 
geometries that were seeded with MSC and that were mechanically loaded created 
statistically more calcium than the „no cells‟ group and the „static‟ group, with statistical 
significance also observed between the „flow‟ group and the „static‟ group in both scaffold 




scaffold geometries (DSO and DSO45) there was a trend towards more calcium production in 
the DSO45 scaffold although this was not statistically significant. The sections obtained of 
the scaffolds that were stained with Von Kossa further backed the presence of calcium in the 
scaffold. The images of the consecutive sections (Figure 124) demonstrated that the Von 
Kossa stains occurred at the same place on the scaffold and that the stained areas are not a 
chance occurrence. Statistical significance was observed between DSO load and both the 
DSO static and No cell groups with a similar result obtained with the DSO45 scaffold 
geometry. Similar observations were made by Duty et al, where histological examination of 
loaded scaffolds, showed a larger area of positive Von Kossa staining compared to the 
scaffold with no cells (Duty et al. 2007). In this chapter the quantification of the area stained 
with the Von Kossa technique was performed using an imaging program (Image J) which 
yielded results that reinforced what was observed with the calcium quantification technique. 
In the work performed by Duty et al, a different method was used to quantify the amount of 
bone formation on the scaffold using micro-CT (Duty et al. 2007) which was more accurate 
as the entire scaffold was scanned and not just analysed sections. From the results obtained 
from the Image J analyses to determine the positively stained PI cells, it was observed that 
the cell number was greatest in the statically treated scaffold (Figure 123). Certain problems 
occurred during the cell counting as the program sometimes was unable to distinguish 
between the scaffold and the cells which in certain cases lead to a very high or low cell count. 
These unusual cases were then reviewed and manually counted. It can also been observed 
that a cell count was measured in scaffolds that were not seeded with cells which indicates 
that the programme occasionally falsely counted cells. Previous studies have reported that 
PCL scaffolds seeded with cells were able to promote cell attachment and maintain cells 
viability (Hutmacher et al. 2001a, Mondrinos et al. 2006, Wang et al. 2004).  
For the second repeat, pH was also recorded and it was observed that statistical 
significance was observed between the static group and the other groups in both the 
experiments where the two different scaffold geometries were tested, which was also seen in 
the first repeat, this may have been due to the proliferation of cells which in turn lowered the 
pH by anaerobic metabolism of the cells creating lactic acid (Funes et al. 2007, Reyes et al. 




concentration in the DSO scaffold geometry treatments between the mechanically 
compressed (DSO load) and the „static‟ group. The static treatment yielded similar calcium 
concentrations as the scaffold seeded with no cells which would signify that no calcium was 
created. In the fluid flow treatment, the error bar was large which shows that one of the 
scaffolds seeded with MSCs under these conditions produced calcium but with the number of 
scaffolds in this treatment being only three, no statistical significance was obtained.  
In the DSO45 scaffold group, the mechanically compressed „load‟ group seeded with 
MSC yielded more calcium and was statistically significant compared to the static treatment 
(Duty et al. 2007). No statistical significance was observed between the other treatments in 
the group however the „flow‟ group produced more calcium which was unexpected as this did 
not correspond to the results obtained from the first run.  
The area of Von Kossa stains reflected the general trend that was observed in the first run 
with the loaded DSO scaffolds with this treatment expressing the highest level of Von Kossa 
however no statistical significance was observed between the treatments. The DSO45 loaded 
and the static had similar levels of Von Kossa staining which would indicate that the zone 
that was sectioned had no mineral present as the o-cresolphthalein method demonstrated the 
presence of calcium. The reason for a reading being detected the no cells treatment during the 
imaging process was due to some background noise that in some cases was detected by 
Image J (Figure 131 – 132). For the PI stained MSC the largest value was observed in the 
static group however no statistical significance was observed with this group and the other 
groups. Statistical significance was observed between the „load‟ group and both the „flow and 
„no cell‟ groups for the DSO scaffold geometry. For the DSO45 scaffold geometry statistical 
significance was observed between the static group and the three other groups.  
For the third repeat of the Zetos™ and MSC experiment, the DSO scaffold group had 
statistical significance between the mechanically loaded and both the static and the no cell 
treatments. For the DSO45 scaffold group, statistical significance was observed between the 
fluid flow group and the „no cell‟ group. Observations were also witnessed between DSO 




properties and strain distributions or different fluid flow characteristics or a combination of 
both mechanical and fluid flow. 
To the author‟s knowledge, this unique technique of using the Zetos™ bioreactor to 
mechanically stimulate cells seeded on scaffolds has not been reported in previous studies. 
This technique also demonstrated proof of principle and potential for bone regeneration with 
a few modifications. A few reasons were determined which might have had an effect on the 
results leading to reduced statistical power. Firstly during the first and second run involving 
the Zetos™ bioreactor, some of the chambers broke by releasing the media, which reduced 
the number of chambers thus affecting the outcome. Furthermore because some had failed it 
could be possible that some of the other chambers were faulty and were maybe not 
mechanically compressing the scaffolds uniformly. Secondly the rubber rings used to support 
the scaffold in the loading chambers had grooves cut out to facilitate the diffusion of media 
throughout the scaffold however on placing the ring with the scaffold into the loading 
chamber and pumping media through the system, in at least 2 cases air was trapped and 
hindered the diffusion of the media to some areas of the scaffold which would have deprived 
the cells of vital nutrients. Thirdly as previously mentioned, the Zetos™ chambers were 
designed for bone which is considerably stiffer than the scaffolds and the rubber rings. The 
results obtained tended to demonstrate that mechanically stimulated scaffolds seeded with 
MSCs created more calcium deposit. 
It has been of interest to many people for a number of years as to the effects of fluid flow 
(Klein-Nulend et al. 1997, Reich et al. 1990a) and mechanical strain (Duncan and Turner 
1995, Harter et al. 1995) and their results on osteoblasts.  During mechanical compression of 
the PCL scaffolds the deformations of the construct caused volume changes in the 
interconnecting pores which in turn resulted in temporary pressure gradients, which produced 
different fluid velocities within the scaffold (Steck et al. 2003). The magnitude and 
complexity of the fluid flow during and without compressing in the two scaffold geometries 
were probably dissimilar therefore it is difficult to determine whether the fluid flow generated 
by the compression of the scaffold had more of an effect than the surface strain. The 
mechanical compression may have had a secondary effect by further mixing the media which 




(Darling and Athanasiou 2003). Steady fluid flow as used in the Zetos bioreactor system, has 
been used in previous studies in perfusion bioreactors with scaffolds (Cartmell et al. 2003, 
Kitagawa et al. 2006) and has been shown to stimulate mineral deposition on scaffolds with 
increased deposition observed with increased flow induced shear stress (Bancroft et al. 2002, 
Sikavitsas et al. 2003). Oscillatory fluid flow has also been shown to increase bone formation 
by osteoblasts on a 3D scaffold (Vance et al. 2005) however it has also been reported that 
osteoblasts were more mechano-responsive in a 2D culture experiment to pulsatile fluid flow 
than to steady and oscillatory flow (Jacobs et al. 1998). Therefore it remains unclear which 
flow is optimal for stimulating osteoblasts on 3D scaffolds. Previous studies have reported 
that mechanically stimulated osteoblasts adapt to their mechanical environment (Jaasma et al. 
2007, Robling et al. 2002) and stimulates bone formation  
The detected presence of the calcium while using the o-cresolphthalein method and the 
positively stained areas of Von Kossa demonstrated the potential of this novel technique. 
Other studies have reported using x-ray refraction to determine bone formation which was 
proven to be highly accurate with small structures, non invasive and able to distinguish 
between bone and other less dense materials (Hashimoto et al. 2006, Kelly et al. 2008, 
Wagner et al. 2006).  In some cases, the analysed scaffolds showed low levels of calcium 
mineral relative to the other scaffolds in the same group, this might have been due to the 
efficiency at which the cells were initially seeded on the scaffold. Turning the scaffolds 
upside down every half an hour for four hours might not have increased the static seeding 
technique. The problem of successfully seeding scaffolds has been mentioned in the literature 
(Duty et al. 2007). Another factor that was observed in the literature was the loading cycle 
and the duration. In Duty et al, the seeded in vivo scaffolds were mechanically stimulated for 
30 min, three times a week for two weeks and then the scaffolds were left implanted for 
another 4 weeks to allow for mineralization to occur that was induced by the loading 
stimulus. The waveform applied was a sinusoidal one at a frequency of 1Hz (Duty et al. 
2007) however a jumping waveform delivered daily has also been shown to yield positive 
results (Mann et al. 2006) with other groups also delivering a daily load to trabecular bone in 




The MSC used for the experiments came from three different patients which could 
explain the differences between the experiments and the varied results for the same 
treatments as has been reported in the literature (Bernardo et al. 2007, Temenoff et al. 2004).  
From the results obtained it can be observed that in most cases the FEA determined 
Young‟s modulus and the mechanically determined Young‟s modulii coincide, however for 
the DSNO45 and the DSO45 the two modulii are different. This demonstrates that the FE 
method can be a powerful tool in predicting mechanical properties however it does not mean 
that mechanical testing should be completely replaced by FE modelling as proven by the two 
cases that do not follow the FE analyses (Li and Wang 2006). In theses FEA analyses, 
tetrahedral elements were chosen as they were the default setting on the ABAQUS software 
however they have a tendency to be overly stiff which might have affected the results 
obtained comparing the Young‟s modulii of the manufactured and the computer models 
especially in the cases of the DSNO45 and DSO45 scaffold geometry (Figure 150). An 
alternative method could have been to design the meshing of the strands with a different 
element i.e. hexahedral. As the beam span was short compared to the overall scaffold design 
the use of tetrahedral elements appropriate however more accurate results would have been 














It can be observed from the results of the calcium content of the scaffolds that in the first 
run, the mechanically loaded scaffold seeded with MSC in both the DSO and the DSO45 
scaffold group generated the most calcium mineral. The fluid flow treatment produced the 
second highest calcium concentration in both the scaffold groups. The results obtained from 
the first run of the experiment are the results that were expected as from the literature 
mechanical loading and fluid flow can affect MSC and potentially turn them into osteoblasts. 
In the first run, the results suggest that mechanical loading of the scaffold seeded with MSC 
had a greater effect and differentiated the MSC into osteoblasts with greater success.  
The second run had much less statistical significance between treatments however in the 
DSO scaffold group the mechanically loaded produced more calcium compared to the other 
treatments with statistical significance. The DSO45 scaffolds seeded with MSCs only had 
statistical significance between the mechanically loaded and the static group. The results 
obtained from the second run would indicate that mechanical loading of the scaffold affects 
the MSC which are seeded on them but without statistical significance in the DSO group it is 
impossible to be certain.  
The results obtained from the third repeat would suggest that in the DSO scaffold seeded 
with MSC, the mechanically loaded treatment produced the greatest amount of calcium 
followed by the fluid flow treatment. These results follow the same trend as the results 
obtained in the first run. In the DSO45 scaffold geometry seeded with MSC, no statistical 
significance was observed between the DSO45 Flow and No Cells treatments. 
From all the results obtained from the three Zetos™ runs, it can be concluded that 
mechanical loading has an effect on the MSCs seeded on the PCL scaffolds even though 
patient variability may have affected the results in some cases, overall the mechanically 
loaded scaffolds seeded with MSCs produced more calcium mineral. This is encouraging and 
demonstrates that mechanically stimulated polycaprolactone scaffolds seeded with MSCs 














Chapter 4.  












Scaffolds were created using natural and synthetic materials. Out of the natural materials, 
none of the scaffolds would have been suitable as load bearing scaffolds however many other 
natural materials exist which could be used to manufacture scaffolds and this could be 
investigated in the future. Out of the synthetic materials, scaffolds manufactured using PCL 
were by far mostly used in the experiments involving scaffolds and MSCs due to the 
biocompatibility, availability of the polymer and the mechanical properties of the scaffolds. It 
was demonstrated that cells seeded on the scaffold were capable of survival in vitro and in 
vivo for numerous weeks. The PCL scaffolds also required a gelatin coating which introduced 
additional complexity which could be investigated to further understand the effect of the 
coating on cellular adhesion.  
PLGA has been widely used in medical applications and several papers have been 
published reporting the benefits of this polymer. It would be interesting to further investigate 
PLGA as a scaffold material and perform similar experiments as with the PCL scaffolds. 
Particularly interesting would be to mechanically test the PLGA scaffolds as the literature 
suggests that PLGA has a higher Young‟s modulus than PCL therefore making it capable of 
bearing greater loads (Cao et al. 2006) and determine the osteogenic potential of MSC 
cultured on PLGA scaffolds which has been reported to be successful (Chastain et al. 2006).  
The finite element analysis experiment demonstrated that the values of the Young‟s 
modulus obtained by mechanically loading the manufactured scaffolds were similar as those 
that were obtained from the finite element analysis. Due to these similarities in Young‟s 
modulii between the mechanically loaded and finite element analyses it can be assumed that 
the predicted strains distributed throughout the scaffold by the finite element analyses would 
correspond to the strain distribution that would occur in the mechanically stimulated 
manufactured scaffolds. An interesting future experiment would be to determine other 
scaffold geometries which would distribute strain even more throughout the scaffold 
compared to the geometries that were tested. The mechanical properties of different materials 
i.e. PLGA, would be interesting to include in the finite element analysis to determine the 




From the Zetos™ bioreactor experiment with the mechanically compressed PCL 
scaffolds seeded with MSC, it was observed that the calcium mineral deposited was greater 
than in the scaffolds with no form of mechanical stimulation. The MSC seeded on the 
scaffolds which were only mechanically stimulated by fluid flow also produced more calcium 
deposit than those MSCs that had no mechanical stimulation. These results were encouraging 
and demonstrated that mechanical loading of scaffolds seeded with MSCs had the potential to 
push the MSCs down the osteoblastic lineage and generate calcium deposits. Interesting 
experiments would be to involve manufacturing scaffolds with different types of such as 
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Technovit 9100 Process 
 
1a. „Pre-infiltration 1‟ solution was prepared on the day by a mixing a 1:1 concentration 
of xylene and stabilised Technovit 9100. 
1b. „Pre-infiltration 2‟ solution was made up in the following proportions: 200ml of 
stabilised Technovit 9100 solution and 1g of „hardener 1‟ (dibenzoyl peroxide), which was 
prepared on the day. 
1c. „Pre-infiltration 3‟ solution was prepared with 200ml of Technovit 9100 destabilised 
solution and 1g of „hardener 1‟, the solution was stored at room temperature.  
2. „Infiltration solution‟ was prepared by adding 20g of polymethylmethacrelate 
(PMMA) powder, 1g of „hardener 1‟ (dibenzoyl peroxide) to 250ml of destabilised basic 
solution.  
3a. „Stock solution A‟ was prepared by adding 80g of PMMA stepwise to approximately 
400ml of destabilised basic solution. When fully in solution 3g of „hardener 1‟ was added 
with continuous stirring. Finally the basic solution is added until the 500ml graduation mark 
has been reached. 
3b. „Stock solution B‟ was prepared by adding 4ml of „hardener 2‟ (N,N-3,5-
tetramethylaniline) and 2ml of „regulator‟ (decane-1-thiol) to 50 ml of destabilised basis 
solution.  
The pre-infiltration, infiltration and stock solutions were kept a 4°C. 
Before embedding, the samples were dehydrated in increasing concentrations of alcohol, 
starting at 70%, 80%, 96% and finally 100% ethanol for one hour in each concentration. The 
samples were then immersed in xylene for 48 hours with a change of xylene at 24 hours. 
Samples are then transferred to „pre-infiltration 1‟ for 12 hours at room temperature. Samples 




infiltration step involves „pre-infiltration 3‟ solution in which the sample stayed immersed for 
2 days at 4°C. The samples were then ready to undergo the infiltration step by leaving them 
in the „infiltration solution‟ for 2 days at 4°C. 
Polymerisation of the samples was achieved by mixing the cooled stock solution A with 
cooled stock solution B in the proportions of 9:1 directly before use. This step was performed 
in a beaker using a glass stirring rod to stir the mixture. Samples were then positioned in 
containers and completely covered with the polymerisation mixture and left to stand at 4°C 
for ten minutes to allow any air bubbles to escape. The resulting blocks were then placed in a 
sealed container with no air above the specimen and left to polymerise at -20°C for 24 hours. 
Once polymerisation had occurred, the samples were transferred to 4°C for at least an hour 
before being allowed to come slowly to room temperature. The samples were not exposed to 
the atmosphere before they had reached equilibrium with room temperature. The samples 
were then mounted and sections were cut using a microtome. When cutting the specimens, 
30% ethanol was used as the cutting fluid and the sections mounted on superfrost plus slides 
with 50% ethanol and covered with PVC-foil. The excess fluid was removed with filter paper 
and then sections loaded into a section press. 
Prior to staining, the polymer was removed by washing the slides twice in xylene for 20 
minutes then once for 20 minutes in 2-methoxyethylacetate (2-MEA) followed by two 














Title:- MSC culture 
SOP Number:- MTEC/068 
Laboratories:- GU 501 
Personnel to carry out 
procedure:- This protocol must be carried out by appropriately trained staff 
See References:- 
S.O.P.:-   
Equipment:-   
COSHH:-   
Manual Handling:-  
SOP prepared by:- Christine Huber, MTEC  










DMEM (Sigma D5671) complete with 
10% FBS (Gibco) 
5% L-Glu (Gibco) 
5% Pen/Strep (Gibco) 
Dressing packs (Vernaid small, obtained from University pharmacy, £3.15/pack) 
Bone cutters         
Universals 
PROCEDURE 
1) Open an new sterile dressing pack 
2) Use clean bone cutters 
3) From the femoral head scoop as much of the trabecular bone as possible into a 
universal. 
4) Add 7mls of complete DMEM to universal and stir vigorously for ~1 min 
5) Remove medium into a new universal 
6) Repeat step 4 twice more until the bone chips become “white”. Transfer medium (total 
of 14 mls) into the universal. 
7) Transfer medium (total of 21mls) to a T75 flask*. 
8) Number the flask according to the numbering and fill in the rest of the details in the 
purple folder (TC room). 
9) Put Presept in the pot and leave it in the cold room to get cleaned. 
 When transferring the medium from the universal to the T75 flask try to avoid the fat 
layer. 
 The size of the flask and the volume of the medium varies according to the amount of 
bone obtained from each femoral head. 
10) Leave the flask in the incubator for 5 days without touching it or moving it. 
11) On the 5th day wash the surface with media and add fresh media 
12) Change the media again on the 6th day 
13) Keep feeding them until they become ~80% confluent.  








Musculo-Skeletal Research Unit, The University of Edinburgh 
Standard Operating Procedure 
 
Title:                                                   Bioplotter and scaffold manufacture 
SOP number: 
Personnel to carry out procedure:      Must be carried out by appropriately trained staff 
See references:                                   Bioplotter manual 
 SOP:  
 Equipment: 
 COSHH:      Read COSHH forms for all reagents used 
 Manual Handling:  
SOP prepared by:          Phil Vadillo 












Musculo-Skeletal Research Unit, The University of Edinburgh 
Standard Operating Procedure 




Connect nitrogen cylinder via yellow tubing to regulator 
Connect PC to Bioplotter via SCSI cable 
Switch on computer (username: phil, password: mtec) 
Double click on shortcut to „PrimCAM.exe‟ on desktop 
Open a „Data set‟, i.e. Dispensing Data.DAT 
Click on the „magnifying glass‟ icon then on a line of the subset to alter plotting 
parameters and notes can be added to remind the operator (i.e. name, layer thickness, strand 
distance, speed, offset, layer orientation). Click on „OK‟ when all alterations have been made. 
Click on „CAM‟ icon („IMPORT‟ will come up when pointer is hovered over icon) and 
select an appropriate STL file with dimensions of extruded scaffold in title. Alternatively the 
scaffold dimensions and geometry can be created in „SolidWorks‟ (shortcut also present on 
desktop). File should then be saved in the .STL format in the folder c:\bioplotter-backup\cad-
data. 
Select the data subset where changes were made 
Click on „NC‟ icon and confirm 
Click on „Start dispensing machine‟ icon which is situated below the „NC‟ icon 
Load the barrel of the syringe, fasten needle via luer lock and place in holder on 
Bioplotter. Fasten pressure outlet (orange bung connected to tubing) to the top of the syringe 
barrel. 
Turn valve at the top of the nitrogen cylinder anticlockwise, turn the regulator attached to 




Bioplotter via red switch on right hand side and press green button marked „Steuerung EIN‟, 
then extruding pressure can be accurately controlled with dial marked „Druck‟ at the front. 
Click on the „REF‟ icon which moves the Bioplotter to it starting position 
Initial dispensing height can be altered with icon „parameters‟ 
Place plotting bath in position 
Press „spulen‟ to extrude some material this prevents any material that might have dried 
up in the needle tip to be removed and allow smooth flow during extrusion. 
Click the „RUN‟ icon when satisfied that everything is correctly connected and in place. 
Make sure the working area of the Bioplotter is clear of any bottles and tubes as these may 
hinder the movement of the arms. 
IMPORTANT: Emergency stop button is at the front of the Bioplotter and marked 
‘NOT AUS’ 
The programme will then prompt for the needle length which is 30mm 
Once the scaffold has been manufactured the arms will automatically move back to their 
starting position and the scaffold may be removed. However if the operator wishes to stop the 
plotting process prematurely, the „STOP‟ icon should be pressed followed by the „REF‟ icon 
to move the arms back to their starting position. 
At this stage the operator may wish to change some parameters which can be 
accomplished by pressing the „EXIT‟ icon (Top right) which will return the operator to the 
data subset screen. N.B. if parameters are altered, a new NC code has to be created before 
plotting is restarted. 
Before exiting the programme which can be accomplished by pressing the „EXIT‟ icon at 
the top right of the screen, the nitrogen cylinder regulator should be turn anti clockwise to 
close and the valve at the top closed before pressing „Spulen‟ to evacuate the remaining gas 
in the system. The operator should remove the syringe, the plotting bath and clean for future 
use. 
The Bioplotter should be switched off and the SCSI cable carefully removed and the 
yellow tubing removed from the Bioplotter regulator. Close the hood and switch off 
computer. 
 
